Last data updates: 12 November 2010Peiris, J.S.M., Lai, S.T., Poon, L.L.M., Guan, Y., Yam, L.Y.C., Lim, W., Nicholls, J., Yee, W.K.S., Yan, W.W., Cheung, M.T., Cheng, V.C.C., Chan, K.H., Tsang, D.N.C., Yung, R.W.H., Ng, T.K. and Yuen, K.Y. (2003), Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 361 (9366), 1319-1325.Document type: Article Language: English Cited references: 15 Times cited: 1055 Times self cited: 149Abstract: Background An outbreak of severe acute respiratory syndrome (SARS) has been reported in Hong Kong. We investigated the viral cause and clinical presentation among 50 patients.Methods We analysed case notes and microbiological findings for 50 patients with SARS, representing more than five separate epidemiologically linked transmission clusters. We defined the clinical presentation and risk factors associated with severe disease and investigated the causal agents by chest radiography and laboratory testing of nasopharyngeal aspirates and sera samples. We compared the laboratory findings with those submitted for microbiological investigation of other diseases from patients whose identity was masked.Findings Patients, age ranged from 23 to 74 years. Fever, chills, myalgia, and cough were the most frequent complaints. When compared with chest radiographic changes, respiratory symptoms and auscultatory findings were disproportionally mild. Patients who were household contacts of other infected people and had older age, lymphopenia, and liver dysfunction were associated with severe disease. A virus belonging to the family Coronaviridae was isolated from two patients. By use of serological and reverse-transcriptase PCR specific for this virus, 45 of 50 patients with SARS, but no controls, had evidence of infection with this virus.Interpretation A coronavirus was isolated from patients with SARS that might be the primary agent associated with this disease. Serological and molecular tests specific for the virus permitted a definitive laboratory diagnosis to be made and allowed further investigation to define whether other cofactors play a part in disease progression.KeyWords Plus: Human-Disease; Virus; Infections; DiagnosisReprint Address: Peiris, JSM (reprint author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Pokfulam Rd, Hong Kong, Hong Kong Peoples R ChinaAddresses: 1. Univ Hong Kong, Queen Mary Hosp, Dept Pathol & Microbiol, Hong Kong, Hong Kong Peoples R China2. Princess Margaret Hosp, Dept Med Intens Care & Pathol, Hong Kong, Hong Kong Peoples R China3. Dept Hlth, Govt Virus Unit, Hong Kong, Hong Kong Peoples R China4. Pamela Youde Nethersole Eastern Hosp, Dept Pathol & Med, Hong Kong, Hong Kong Peoples R China5. Kwong Wah Hosp, Dept Med, Hong Kong, Hong Kong Peoples R China6. Queen Elizabeth Hosp, Dept Pathol, Kowloon, Hong Kong Peoples R China

1. Anderson, L.J. and Tong, S.X. (2010), Update on SARS research and other possibly zoonotic coronaviruses. International Journal of Antimicrobial Agents, 36, S21-S25.

2. Zhao, K., Yang, B.Y., Xu, Y.Q. and Wu, C.Y. (2010), CD8(+) T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein. Vaccine, 28 (41), 6666-6674.

3. Kostoff, R.N. (2010), The highly cited SARS research literature. Critical Reviews in Microbiology, 36 (4), 299-317.

4. Renukaradhya, G.J., Alekseev, K., Jung, K., Fang, Y. and Saif, L.J. (2010), Porcine reproductive and respiratory syndrome virus-induced immunosuppression exacerbates the inflammatory response to porcine respiratory coronavirus in pigs. Viral Immunology, 23 (5), 457-466.

5. Chuck, C.P., Chong, L.T., Chen, C., Chow, H.F., Wan, D.C.C. and Wong, K.B. (2010), Profiling of substrate specificity of SARS-CoV 3CL(pro). Plos One, 5 (10.

6. Pyrc, K., Sims, A.C., Dijkman, R., Jebbink, M., Long, C., Deming, D., Donaldson, E., Vabret, A., Baric, R., van der Hoek, L. and Pickles, R. (2010), Culturing the unculturable: human coronavirus HKU1 infects, replicates, and produces progeny virions in human ciliated airway epithelial cell cultures. Journal of Virology, 84 (81), 11255-11263.

7. Lau, S.K.P., Poon, R.W.S., Wong, B.H.L., Wang, M., Huang, Y., Xu, H.F., Guo, R.T., Li, K.S.M., Gao, K., Chan, K.H., Zheng, B.J., Woo, P.C.Y. and Yuen, K.Y. (2010), Coexistence of different genotypes in the same bat and serological characterization of rousettus bat coronavirus HKU9 belonging to a novel betacoronavirus subgroup. Journal of Virology, 84 (81), 11385-11394.

8. Hou, Y.X., Peng, C., Yu, M., Li, Y., Han, Z.G., Li, F., Wang, L.F. and Shi, Z.L. (2010), Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry. Archives of Virology, 155 (10), 1563-1569.

9. Hui, D.S.C. and Chan, P.K.S. (2010), Severe acute respiratory syndrome and coronavirus. Infectious Disease Clinics of North America, 24 (3), 619-638.

10. Sorensen, M.D., Sorensen, B., Gonzalez-Dosal, R., Melchjorsen, C.J., Weibel, J., Wang, J., Jun, C.W., Yang, H.M. and Kristensen, P. (2006), Severe acute respiratory syndrome (SARS) development of diagnostics and antivirals. Understanding and Modulating Aging, 1067, 500-505.

11. Leibowitz, J.L., Srinivasa, R., Williamson, S.T., Chua, M.M., Liu, M.F., Wu, S., Kang, H., Ma, X.Z., Zhang, J.H., Shalev, I., Smith, R., Phillips, M.J., Levy, G.A. and Weiss, S.R. (2010), Genetic Determinants of Mouse Hepatitis Virus Strain 1 Pneumovirulence. Journal of Virology, 84 (18), 9278-9291.

12. Zhao, J.C., Zhao, J.X. and Perlman, S. (2010), T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice. Journal of Virology, 84 (18), 9318-9325.

13. Bender, S.J. and Weiss, S.R. (2010), Pathogenesis of Murine Coronavirus in the Central Nervous System. Journal of Neuroimmune Pharmacology, 5 (3), 336-354.

14. Rose, K.M. and Weiss, S.R. (2009), Murine coronavirus cell type dependent interaction with the type I interferon response. Viruses-Basel, 1 (3), 689-712.

15. Moriyama, Y., Hamada, H., Okada, M., Tsuchiya, N., Maru, H., Shirato, Y., Maeda, Y., Hirose, Y., Yoshida, M., Omura, Y., Honda, T., Muto, A., Hayashi, K. and Terai, M. (2010), Distinctive clinical features of human bocavirus in children younger than 2 years. European Journal of Pediatrics, 169 (9), 1087-1092.

16. Yu, M., Tachedjian, M., Cramen, G., Shi, Z.L. and Wang, L.F. (2010), Identification of key amino acid residues required for horseshoe bat angiotensin-I converting enzyme 2 to function as a receptor for severe acute respiratory syndrome coronavirus. Journal of General Virology, 91), 1706-1710.

17. Wang, Q., Li, C.A., Zhang, Q.F., Wang, T., Li, J.D., Guan, W.X., Yu, J.S., Liang, M.F. and Li, D.X. (2010), Interactions of SARS Coronavirus Nucleocapsid Protein with the host cell proteasome subunit p42. Virology Journal, 7, article number: 99.

18. Ghosh, A.K., Takayama, J., Rao, K.V., Ratia, K., Chaudhuri, R., Mulhearn, D.C., Lee, H., Nichols, D.B., Baliji, S., Baker, S.C., Johnson, M.E. and Mesecar, A.D. (2010), Severe Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein-Ligand X-ray Structure and Biological Evaluation. Journal of Medicinal Chemistry, 53 (13), 4968-4979.

19. Lau, S.K.P., Woo, P.C.Y., Wong, B.H.L., Wong, A.Y.P., Tsoi, H.W., Wang, M., Lee, P., Xu, H.F., Poon, R.W.S., Guo, R.T., Li, K.S.M., Chan, K.H., Zheng, B.J. and Yuen, K.Y. (2010), Identification and complete genome analysis of three novel paramyxoviruses, Tuhoko virus 1, 2 and 3, in fruit bats from China. Virology, 404 (1), 106-116.

20. Paasche, A., Schiller, M., Schirmeister, T. and Engels, B. (2010), Mechanistic Study of the Reaction of Thiol-Containing Enzymes with alpha,beta-Unsaturated Carbonyl Substrates by Computation and Chemoassays. Chemmedchem, 5 (6), 869-880.

2

21. Yasui, F., Kai, C., Saito, K., Inoue, S., Yoneda, M., Morita, K., Mizuno, K. and Kohara, M. (2010), Analysis of the mechanism by which BALB/c mice having prior immunization with nucleocapsid protein of SARS-CoV develop severe pneumonia after SARS-CoV infection. (1), 44-50.

22. Alvarez, E., DeDiego, M.L., Nieto-Torres, J.L., Jimenez-Guardeno, J.M., Marcos-Villar, L. and Enjuanes, L. (2010), The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated. Virology, 402 (2), 281-291.

23. Ramajayam, R., Tan, K.P., Liu, H.G. and Liang, P.H. (2010), Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease. Bioorganic & Medicinal Chemistry Letters, 20 (12), 3569-3572.

24. Barrila, J., Gabelli, S.B., Bacha, U., Amzel, L.M. and Freire, E. (2010), Mutation of Asn28 Disrupts the Dimerization and Enzymatic Activity of SA RS 3CL(pro). Biochemistry, 49 (20), 4308-4317.

25. Rose, K.M., Elliott, R., Martinez-Sobrido, L., Garcia-Sastre, A. and Weiss, S.R. (2010), Murine Coronavirus Delays Expression of a Subset of Interferon-Stimulated Genes. Journal of Virology, 84 (11), 5656-5669.

26. Lu, B.J., Huang, Y., Huang, L., Li, B., Zheng, Z.H., Chen, Z., Chen, J.J., Hu, Q.X. and Wang, H.Z. (2010), Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice. Immunology, 130 (2), 254-261.

27. Ulasli, M., Verheije, M.H., de Haan, C.A.M. and Reggiori, F. (2010), Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus. Cellular Microbiology, 12 (6), 844-861.

28. Casanova, L.M., Jeon, S., Rutala, W.A., Weber, D.J. and Sobsey, M.D. (2010), Effects of Air Temperature and Relative Humidity on Coronavirus Survival on Surfaces. Applied and Environmental Microbiology, 76 (9), 2712-2717.

29. Risku, M., Lappalainen, S., Rasanen, S. and Vesikari, T. (2010), Detection of human coronaviruses in children with acute gastroenteritis. Journal of Clinical Virology, 48 (1), 27-30.

30. Wevers, B.A. and van der Hoek, L. (2010), Renin-angiotensin system in human coronavirus pathogenesis. Future Virology, 5 (2), 145-161.

31. Lau, S.K.P., Li, K.S.M., Huang, Y., Shek, C.T., Tse, H., Wang, M., Choi, G.K.Y., Xu, H.F., Lam, C.S.F., Guo, R.T., Chan, K.H., Zheng, B.J., Woo, P.C.Y. and Yuen, K.Y. (2010), Ecoepidemiology and Complete Genome Comparison of Different Strains of Severe Acute Respiratory Syndrome-Related Rhinolophus Bat Coronavirus in China Reveal Bats as a Reservoir for Acute, Self-Limiting Infection That Allows Recombination Events. Journal of Virology, 84 (6), 2808-2819.

32. Graham, R.L. and Baric, R.S. (2010), Recombination, Reservoirs, and the Modular Spike: Mechanisms of Coronavirus Cross-Species Transmission. Journal of Virology, 84 (7), 3134-3146.

33. Fang, Y.T., Lin, C.F., Liao, P.C., Kuo, Y.M., Wang, S.W., Yeh, T.M., Shieh, C.C.K., Su, I.J., Lei, H.Y. and Lin, Y.S. (2010), Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies. Molecular Immunology, 47 (5), 1000-1009.

34. Tang, P. and Chiu, C. (2010), Metagenomics for the discovery of novel human viruses. Future Microbiology, 5 (2), 177-189.

35. Lai, T.S.T. and Yu, W.C. (2010), The lessons of SARS in Hong Kong. Clinical Medicine, 10 (1), 50-53.

36. O'Keefe, B.R., Giomarelli, B., Barnard, D.L., Shenoy, S.R., Chan, P.K.S., McMahon, J.B., Palmer, K.E., Barnett, B.W., Meyerholz, D.K., Wohlford-Lenane, C.L. and Mccray, P.B. (2010), Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein

3

Griffithsin against Emerging Viruses of the Family Coronaviridae. Journal of Virology, 84 (5), 2511-2521.

37. Yoshikawa, T., Hill, T.E., Yoshikawa, N., Popov, V.L., Galindo, C.L., Garner, H.R., Peters, C.J. and Tseng, C.T. (2010), Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection. Plos One, 5 (1.

38. Tregoning, J.S. and Schwarze, J. (2010), Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology. Clinical Microbiology Reviews, 23 (1), 74-+.

39. Xiao, H., Xu, L.H., Yamada, Y. and Liu, D.X. (2008), Coronavirus Spike Protein Inhibits Host Cell Translation by Interaction with eIF3f. Plos One, 3 (1.

40. Bai, B.K., Hu, Q.X., Hu, H., Zhou, P., Shi, Z.L., Meng, J., Lu, B.J., Huang, Y., Mao, P.Y. and Wang, H. (2008), Virus-Like Particles of SARS-Like Coronavirus Formed by Membrane Proteins from Different Origins Demonstrate Stimulating Activity in Human Dendritic Cells. Plos One, 3 (7.

41. Ammann, C.G., Messer, R.J., Peterson, K.E. and Hasenkrug, K.J. (2009), Lactate Dehydrogenase-Elevating Virus Induces Systemic Lymphocyte Activation via TLR7-Dependent IFN alpha Responses by Plasmacytoid Dendritic Cells. Plos One, 4 (7.

42. Xu, X.L., Lou, Z.Y., Ma, Y.L., Chen, X.H., Yang, Z.S., Tong, X.H., Zhao, Q., Xu, Y.Y., Deng, H.Y., Bartlam, M. and Rao, Z.H. (2009), Crystal Structure of the C-Terminal Cytoplasmic Domain of Non-Structural Protein 4 from Mouse Hepatitis Virus A59. Plos One, 4 (7.

43. Yip, C.W., Hon, C.C., Shi, M., Lam, T.T.Y., Chow, K.Y.C., Zeng, F. and Leung, F.C.C. (2009), Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses. Infection Genetics and Evolution, 9 (6), 1185-1196.

44. Lv, Y.B., Ruan, Z.H., Wang, L., Ni, B. and Wu, Y.Z. (2009), Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV. Bmc Immunology, 10.

45. Day, C.W., Baric, R., Cai, S.X., Frieman, M., Kumaki, Y., Morrey, J.D., Smee, D.F. and Barnard, D.L. (2009), A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo. Virology, 395 (2), 210-222.

46. Zhang, X.P., Wang, J.X., Wen, K., Mou, Z.R., Zou, L.Y., Che, X.Y., Ni, B. and Wu, Y.Z. (2009), Antibody Binding Site Mapping of SARS-CoV Spike Protein Receptor-Binding Domain by a Combination of Yeast Surface Display and Phage Peptide Library Screening. Viral Immunology, 22 (6), 407-415.

47. Kang, Y.M., Chen, A.S., Wang, B. and Zheng, G.X. (2009), Protein Transfer Enhances Cellular Immune Responses to DNA Vaccination Against SARS-CoV. Viral Immunology, 22 (6), 417-422.

48. Wu, K.L., Li, W.K., Peng, G.Q. and Li, F. (2009), Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proceedings of the National Academy of Sciences of the United States of America, 106 (47), 19970-19974.

49. Funk, C.J., Manzer, R., Miura, T.A., Groshong, S.D., Ito, Y., Travanty, E.A., Leete, J., Holmes, K.V. and Mason, R.J. (2009), Rat respiratory coronavirus infection: replication in airway and alveolar epithelial cells and the innate immune response. Journal of General Virology, 90), 2956-2964.

50. Wevers, B.A. and van der Hoek, L. (2009), Recently Discovered Human Coronaviruses. Clinics in Laboratory Medicine, 29 (4), 715-+.

51. Zhao, J.C., Zhao, J.X., Van Rooijen, N. and Perlman, S. (2009), Evasion by Stealth: Inefficient Immune Activation Underlies Poor T Cell Response and Severe Disease in SARS-CoV-Infected Mice. Plos Pathogens, 5 (10.

52. Kuri, T., Zhang, X.N., Habjan, M., Martinez-Sobrido, L., Garcia-Sastre, A., Yuan, Z.H. and Weber, F. (2009), Interferon priming enables cells to partially overturn the SARS

4

coronavirus-induced block in innate immune activation. Journal of General Virology, 90), 2686-2694.

53. Xu, L.L., Zhang, Y.F., Liu, Y., Chen, Z.W., Deng, H.K., Ma, Z.B., Wang, H.L., Hu, Z.H. and Deng, F. (2009), Angiotensin-converting enzyme 2 (ACE2) from raccoon dog can serve as an efficient receptor for the spike protein of severe acute respiratory syndrome coronavirus. Journal of General Virology, 90), 2695-2703.

54. Lau, A.T.Y. and Chiu, J.F. (2009), Biomarkers of Lung-Related Diseases: Current Knowledge by Proteomic Approaches. Journal of Cellular Physiology, 221 (3), 535-543.

55. Miura, T.A. and Holmes, K.V. (2009), Host-pathogen interactions during coronavirus infection of primary alveolar epithelial cells. Journal of Leukocyte Biology, 86 (5), 1145-1151.

56. Kohyama, S., Ohno, S., Suda, T., Taneichi, M., Yokoyama, S., Mori, M., Kobayashi, A., Hayashi, H., Uchida, T. and Matsui, M. (2009), Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a. Antiviral Research, 84 (2), 168-177.

57. Feng, D., de Vlas, S.J., Fang, L.Q., Han, X.N., Zhao, W.J., Sheng, S., Yang, H., Jia, Z.W., Richardus, J.H. and Cao, W.C. (2009), The SARS epidemic in mainland China: bringing together all epidemiological data. Tropical Medicine & International Health, 14), 4-13.

58. Maxwell, C., McGeer, A., Tai, K.F.Y. and Sermer, M. (2009), Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS) No. 225, April 2009. International Journal of Gynecology & Obstetrics, 107 (1), 82-86.

59. Hu, H., Tao, L., Wang, Y.B., Chen, L.Y., Yang, J.H. and Wang, H.Z. (2009), Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice. Biotechnology Letters, 31 (11), 1685-1693.

60. Huang, J.C., Chang, Y.F., Chen, K.H., Su, L.C., Lee, C.W., Chen, C.C., Chen, Y.M.A. and Chou, C. (2009), Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in human serum using a localized surface plasmon coupled fluorescence fiber-optic biosensor. Biosensors & Bioelectronics, 25 (2), 320-325.

61. Ditt, V. and Schildgen, O. (2009), Severe acute respiratory syndrome-coronavirus and human coronavirus-NL63: an updated overview. Reviews in Medical Microbiology, 20 (2), 19-28.

62. Hollingsworth, T.D. (2009), Controlling infectious disease outbreaks: Lessons from mathematical modelling. Journal of Public Health Policy, 30 (3), 328-341.

63. Siu, K.L., Chan, C.P., Chan, C., Zheng, B.J. and Jin, D.Y. (2009), Severe acute respiratory syndrome coronavirus nucleocapsid protein does not modulate transcription of the human FGL2 gene. Journal of General Virology, 90), 2107-2113.

64. Lau, S.K.P., Yip, C.C.Y., Lin, A.W.C., Lee, R.A., So, L.Y., Lau, Y.L., Chan, K.H., Woo, P.C.Y. and Yuen, K.Y. (2009), Clinical and Molecular Epidemiology of Human Rhinovirus C in Children and Adults in Hong Kong Reveals a Possible Distinct Human Rhinovirus C Subgroup. Journal of Infectious Diseases, 200 (7), 1096-1103.

65. Ghosh, A.K., Takayama, J., Aubin, Y., Ratia, K., Chaudhuri, R., Baez, Y., Sleeman, K., Coughlin, M., Nichols, D.B., Mulhearn, D.C., Prabhakar, B.S., Baker, S.C., Johnson, M.E. and Mesecar, A.D. (2009), Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease. Journal of Medicinal Chemistry, 52 (16), 5228-5240.

66. Stramer, S.L., Hollinger, F.B., Katz, L.M., Kleinman, S., Metzel, P.S., Gregory, K.R. and Dodd, R.Y. (2009), Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion, 49), 1S-235S.

67. Lee, C., Lee, J.M., Lee, N.R., Kim, D.E., Jeong, Y.J. and Chong, Y. (2009), Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)

5

NTPase/helicase by dihydroxychromone derivatives. Bioorganic & Medicinal Chemistry Letters, 19 (16), 4538-4541.

68. Shabbir, M.Z., Rabbani, M., Muhammad, K., Ahmad, A., Anwar, I. and Yaqub, T. (2009), Detection of Canine Distemper Virus from Lymphopenic Dogs by RT-PCR Amplification of Nudeoprotein Gene. Pakistan Journal of Zoology, 41 (5), 424-428.

69. Pybus, O.G. and Rambaut, A. (2009), Evolutionary analysis of the dynamics of viral infectious disease. Nature Reviews Genetics, 10 (8), 540-550.

70. Kawachi, S., San, T.L., Shigematsu, M., Furuya, H., Thuy, T.B.P., Phuc, H.P., Nunoi, H., Liem, T.N. and Suzuki, K. (2009), Risk Parameters of Fulminant Acute Respiratory Distress Syndrome and Avian Influenza (H5N1) Infection in Vietnamese Children. Journal of Infectious Diseases, 200 (4), 510-515.

71. Roper, R.L. and Rehm, K.E. (2009), SARS vaccines: where are we? Expert Review of Vaccines, 8 (7), 887-898.

72. Brug, J., Aro, A.R. and Richardus, J.H. (2009), Risk Perceptions and Behaviour: Towards Pandemic Control of Emerging Infectious Diseases International Research on Risk Perception in the Control of Emerging Infectious Diseases. International Journal of Behavioral Medicine, 16 (1), 3-6.

73. Ohno, S., Kohyama, S., Taneichi, M., Moriya, O., Hayashi, H., Oda, H., Mori, M., Kobayashi, A., Akatsuka, T., Uchida, T. and Matsui, M. (2009), Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice. Vaccine, 27 (29), 3912-3920.

74. Geller, C., Fontanay, S., Finance, C. and Duval, R.E. (2009), A new Sephadex (TM)-based method for removing microbicidal and cytotoxic residues when testing antiseptics against viruses: Experiments with a human coronavirus as a model. Journal of Virological Methods, 159 (2), 217-226.

75. Muradrasoli, S., Mohamed, N., Hornyak, A., Fohlman, J., Olsen, B., Belak, S. and Blomberg, J. (2009), Broadly targeted multiprobe QPCR for detection of coronaviruses: Coronavirus is common among mallard ducks (Anas platyrhynchos). Journal of Virological Methods, 159 (2), 277-287.

76. Law, H.K.W., Cheung, C.Y., Sia, S.F., Chan, Y.O., Peiris, J.S.M. and Lau, Y.L. (2009), Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells. Bmc Immunology, 10.

77. Fan, Y.Y., Huang, Z.T., Li, L., Wu, M.H., Yu, T., Koup, R.A., Bailer, R.T. and Wu, C.Y. (2009), Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection. Archives of Virology, 154 (7), 1093-1099.

78. Xu, K., Zheng, B.J., Zeng, R., Lu, W., Lin, Y.P., Xue, L., Li, L., Yang, L.L., Xu, C., Dai, J., Wang, F., Li, Q., Dong, Q.X., Yang, R.F., Wu, J.R. and Sun, B. (2009), Severe acute respiratory syndrome coronavirus accessory protein 9b is a virion-associated protein. Virology, 388 (2), 279-285.

79. Hu, T.C., Zhang, Y., Li, L.W., Wang, K.F., Chen, S., Chen, J., Ding, J.P., Jiang, H.L. and Shen, X. (2009), Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure. Virology, 388 (2), 324-334.

80. Fukushima, A., Fukuda, N., Lai, Y.M., Ueno, T., Moriyama, M., Taguchi, F., Iguchi, A., Shimizu, K. and Kuroda, K. (2009), Development of a Chimeric DNA-RNA Hammerhead Ribozyme Targeting SARS Virus. Intervirology, 52 (2), 92-99.

81. Wang, Y., Yan, J.W., Shi, Y.L., Li, P., Liu, C.X., Ma, Q.J., Yang, R.F., Wang, X.Y., Zhu, L.N., Yang, X. and Cao, C. (2009), Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection. Bmc Infectious Diseases, 9.

82. Du, L.Y., Zhao, G.Y., Li, L., He, Y.X., Zhou, Y.S., Zheng, B.J. and Jiang, S.B. (2009), Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably

6

expressed in CHO cells. Biochemical and Biophysical Research Communications, 384 (4), 486-490.

83. Pak, J.E., Sharon, C., Satkunarajah, M., Auperin, T.C., Cameron, C.M., Kelvin, D.J., Seetharaman, J., Cochrane, A., Plummer, F.A., Berry, J.D. and Rini, J.M. (2009), Structural Insights into Immune Recognition of the Severe Acute Respiratory Syndrome Coronavirus S Protein Receptor Binding Domain. Journal of Molecular Biology, 388 (4), 815-823.

84. Barrett, P.N., Mundt, W., Kistner, O. and Howard, M.K. (2009), Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Review of Vaccines, 8 (5), 607-618.

85. Guillen, J., De Almeida, R.F.M., Prieto, M. and Villalain, J. (2009), Interaction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes. Molecular Membrane Biology, 26 (4), 236-248.

86. Tang, X.C., Li, G., Vasilakis, N., Zhang, Y., Shi, Z.L., Zhong, Y., Wang, L.F. and Zhang, S.Y. (2009), Differential stepwise evolution of SARS coronavirus functional proteins in different host species. Bmc Evolutionary Biology, 9.

87. Sung, S.C., Chao, C.Y., Jeng, K.S., Yang, J.Y. and Lai, M.M.C. (2009), The 8ab protein of SARS-CoV is a luminal ER membrane-associated protein and induces the activation of ATF6. Virology, 387 (2), 402-413.

88. Wu, Y.P., Liu, Z.H., Wei, R., Pan, S.D., Mao, N.Y., Chen, B., Han, J.J., Zhang, F.S., Holmskov, U., Xia, Z.L., de Groot, P.G., Reid, K.B.M., Xu, W.B. and Sorensen, G.L. (2009), Elevated Plasma Surfactant Protein D (SP-D) Levels and a Direct Correlation with Anti-severe Acute Respiratory Syndrome Coronavirus-specific IgG Antibody in SARS Patients. Scandinavian Journal of Immunology, 69 (6), 508-515.

89. Liu, T.C., Chang, W.H., Jiang, B.C., Maa, S.H., Chien, D.K. and Tang, W.R. (2009), Mortality Factor Survey of Severe Acute Respiratory Syndrome in Taiwan. International Journal of Gerontology, 3 (1), 31-38.

90. Tong, T.R. (2009), Therapies for coronaviruses. Part I of II - viral entry inhibitors. Expert Opinion on Therapeutic Patents , 19 (3), 357-367.

91. Foulongne, V. and Segondy, M. (2009), Human bocavirus (HBoV). Pathologie Biologie, 57 (2), 197-202.

92. Wang, B., Mortazavi, R. and Haghighat, F. (2009), Evaluation of Modeling and Measurement Techniques of Ultraviolet Germicidal Irradiation Effectiveness - Towards the Design of Immune Buildings. Indoor and Built Environment, 18 (2), 101-112.

93. Hu, H., Huang, X.Q., Tao, L., Huang, Y., Cui, B.A. and Wang, H.Z. (2009), Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model. Vaccine, 27 (11), 1758-1763.

94. Farinas, M.P.S.S. (2008), Direct techniques of diagnosis and detection of new virus. Neurologia, ), 18-23.

95. Yoshikawa, T., Hill, T., Li, K., Peters, C.J. and Tseng, C.T.K. (2009), Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic Cells. Journal of Virology, 83 (7), 3039-3048.

96. Lee, C.C., Kuo, C.J., Ko, T.P., Hsu, M.F., Tsui, Y.C., Chang, S.C., Yang, S., Chen, S.J., Chen, H.C., Hsu, M.C., Shih, S.R., Liang, P.H. and Wang, A.H.J. (2009), Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds. Journal of Biological Chemistry, 284 (12), 7646-7655.

97. Prabakaran, P., Zhu, Z.Y., Xiao, X.D., Biragyn, A., Dimitrov, A.S., Broder, C.C. and Dimitrov, D.S. (2009), Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. Expert Opinion on Biological Therapy, 9 (3), 355-368.

98. Ji, H.L., Song, W.F., Gao, Z., Su, X.F., Nie, H.G., Jiang, Y., Peng, J.B., He, Y.X., Liao, Y., Zhou, Y.J., Tousson, A. and Matalon, S. (2009), SARS-CoV proteins decrease levels and

7

activity of human ENaC via activation of distinct PKC isoforms. American Journal of Physiology-Lung Cellular and Molecular Physiology, 296 (3), L372-L383.

99. Yan, K.X., Tan, W.J., Wang, H.J., Wang, Y., Zhang, X.M., Li, Y. and Ruan, L. (2009), SARS-CoV Spike Proteins Expressed by the Vaccinia Virus Tiantan Strain: Secreted SQ Protein Induces Robust Neutralization Antibody in Mice. Viral Immunology, 22 (1), 57-65.

100. Du, L.Y., He, Y.X., Zhou, Y.S., Liu, S.W., Zheng, B.J. and Jiang, S.B. (2009), The spike protein of SARS-CoV - a target for vaccine and therapeutic development. Nature Reviews Microbiology, 7 (3), 226-236.

101. Krahling, V., Stein, D.A., Spiegel, M., Weber, F. and Muhlberger, E. (2009), Severe Acute Respiratory Syndrome Coronavirus Triggers Apoptosis via Protein Kinase R but Is Resistant to Its Antiviral Activity. Journal of Virology, 83 (5), 2298-2309.

102. Barcena, M., Oostergetel, G.T., Bartelink, W., Faas, F.G.A., Verkleij, A., Rottier, P.J.M., Koster, A.J. and Bosch, B.J. (2009), Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proceedings of the National Academy of Sciences of the United States of America, 106 (2), 582-587.

103. de Lang, A., Baas, T., Smits, S.L., Katze, M.G., Osterhaus, A.D.M.E. and Haagmans, B.L. (2009), Unraveling the complexities of the interferon response during SARS-CoV infection. Future Virology, 4 (1), 71-78.

104. Chiang, M.F., Lin, P.W., Lin, L.F., Chiou, H.Y., Chien, C.W., Chu, S.F. and Chiu, W.T. (2008), Mass Screening of Suspected Febrile Patients with Remote-sensing Infrared Thermography: Alarm Temperature and Optimal Distance. Journal of the Formosan Medical Association, 107 (12), 937-944.

105. Mu, F., Niu, D.S., Mu, J.S., He, B., Han, W.G., Fan, B.X., Huang, S.Y., Qiu, Y., You, B. and Chen, W.J. (2008), The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus. Bmc Microbiology, 8.

106. Lu, B.J., Tao, L., Wang, T., Zheng, Z.H., Li, B., Chen, Z., Huang, Y., Hu, Q.X. and Wang, H.Z. (2009), Humoral and Cellular Immune Responses Induced by 3a DNA Vaccines against Severe Acute Respiratory Syndrome (SARS) or SARS-Like Coronavirus in Mice. Clinical and Vaccine Immunology, 16 (1), 73-77.

107. Woo, P.C.Y., Lau, S.K.P., Lam, C.S.F., Lai, K.K.Y., Huang, Y., Lee, P., Luk, G.S.M., Dyrting, K.C., Chan, K.H. and Yuen, K.Y. (2009), Comparative Analysis of Complete Genome Sequences of Three Avian Coronaviruses Reveals a Novel Group 3c Coronavirus. Journal of Virology, 83 (2), 908-917.

108. Yang, J.B., James, E., Roti, M., Huston, L., Gebe, J.A. and Kwok, W.W. (2009), Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals. International Immunology, 21 (1), 63-71.

109. Becker, M.M., Graham, R.L., Donaldson, E.F., Rockx, B., Sims, A.C., Sheahan, T., Pickles, R.J., Corti, D., Johnston, R.E., Baric, R.S. and Denison, M.R. (2008), Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proceedings of the National Academy of Sciences of the United States of America, 105 (50), 19944-19949.

110. Lien, T.C., Sung, C.S., Lee, C.H., Kao, H.K., Huang, Y.C., Liu, C.Y., Perng, R.P. and Wang, J.H. (2008), Characteristic features and outcomes of severe acute respiratory syndrome found in severe acute respiratory syndrome intensive care unit patients. Journal of Critical Care, 23 (4), 557-564.

111. Dimitrov, D.S. (2008), Human Monoclonal Antibodies Against HIV and Emerging Viruses. National Institute of Allergy and Infectious Diseases, Nih, Vol 1: Frontiers in Research, ), 299-308.

112. Shum, K.T. and Tanner, J.A. (2008), Differential Inhibitory Activities and Stabilisation of DNA Aptamers against the SARS Coronavirus Helicase. Chembiochem, 9 (18), 3037-3045.

113. Severance, E.G., Bossis, I., Dickerson, F.B., Stallings, C.R., Origoni, A.E., Sullens, A., Yolken, R.H. and Viscidi, R.P. (2008), Development of a Nucleocapsid-Based Human

8

Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a US Metropolitan Population. Clinical and Vaccine Immunology, 15 (12), 1805-1810.

114. Tsai, M.H., Lin, T.Y., Chiu, C.H., Lin, P.Y., Huang, Y.C., Tsao, K.C., Huang, C.G., Hsu, K.H., Lin, M.C., Hwang, K.P. and Yang, K.D. (2008), Seroprevalence of SARS Coronavirus Among Residents Near a Hospital with a Nosocomial Outbreak. Journal of the Formosan Medical Association, 107 (11), 885-891.

115. Hsieh, Y.C., Li, H.C., Chen, S.C. and Lo, S.Y. (2008), Interactions between M protein and other structural proteins of severe, acute respiratory syndrome-associated coronavirus. Journal of Biomedical Science, 15 (6), 707-717.

116. Yasui, F., Kai, C., Kitabatake, M., Inoue, S., Yoneda, M., Yokochi, S., Kase, R., Sekiguchi, S., Morita, K., Hishima, T., Suzuki, H., Karamatsu, K., Yasutomi, Y., Shida, H., Kidokoro, M., Mizuno, K., Matsushima, K. and Kohara, M. (2008), Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV. Journal of Immunology, 181 (9), 6337-6348.

117. Siu, Y.L., Teoh, K.T., Lo, J., Chan, C.M., Kien, F., Escriou, N., Tsao, S.W., Nicholls, J.M., Altmeyer, R., Peiris, J.S.M., Bruzzone, R. and Nal, B. (2008), The M, E, and N Structural Proteins of the Severe Acute Respiratory Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles. Journal of Virology, 82 (22), 11318-11330.

118. Bhatnagar, P.K., Das, D. and Suresh, M.R. (2008), Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV). Journal of Pharmacy and Pharmaceutical Sciences, 11 (2), 1-13.

119. Yang, X.N., Yang, H.L., Zhou, G.Q. and Zhao, G.P. (2008), Infectious disease in the genomic era. Annual Review of Genomics and Human Genetics, 9), 21-48.

120. Osterhaus, A.D.M.E. (2008), New respiratory viruses of humans. Pediatric Infectious Disease Journal, 27 (10), S71-S74.

121. Minosse, C., Selleri, M., Zaniratti, M.S., Cappiello, G., Spano, A., Schifano, E., Lauria, F.N., Gualano, G., Puro, V., Campanini, G., Gerna, G. and Capobianchi, M.R. (2008), Phylogenetic analysis of human coronavirus NL63 circulating in Italy. Journal of Clinical Virology, 43 (1), 114-119.

122. Baas, T., Roberts, A., Teal, T.H., Vogel, L., Chen, J., Tumpey, T.M., Katze, M.G. and Subbarao, K. (2008), Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus. Journal of Virology, 82 (19), 9465-9476.

123. Bonanno, G.A., Ho, S.A.Y., Chan, J.C.K., Kwong, R.S.Y., Cheung, C.K.Y., Wong, C.P.Y. and Wong, V.C.W. (2008), Psychological resilience and dysfunction among hospitalized survivors of the SARS epidemic in Hong kong: A latent class approach. Health Psychology, 27 (5), 659-667.

124. Hsu, C.H., Hwang, K.C., Chao, C.L., Chang, S.G.N., Ho, M.S., Lin, J.G., Chang, H.H., Kao, S.T., Chen, Y.M. and Chou, P. (2008), An evaluation of the additive effect of natural herbal medicine on SARS or SARS-like infectious diseases in 2003: A randomized, double-blind, and controlled pilot study. Evidence-Based Complementary and Alternative Medicine, 5 (3), 355-362.

125. Kammila, S., Das, D., Bhatnagar, P.K., Sunwoo, H.H., Zayas-Zamora, G., King, M. and Suresh, M.R. (2008), A rapid point of care immunoswab assay for SARS-CoV detection. Journal of Virological Methods, 152 (1-2), 77-84.

126. Yang, M., Ng, M.H.L., Li, C.K., Chan, P.K.S., Liu, C., Ye, J.Y. and Chong, B.H. (2008), Thrombopoietin levels increased in patients with severe acute respiratory syndrome. Thrombosis Research, 122 (4), 473-477.

127. Chatterjee, A., Johnson, M.A., Serrano, P., Pedrini, B. and Wuthrich, K. (2007), NMR assignment of the domain 513-651 from the SARS-CoV nonstructural protein nsp3. Biomolecular Nmr Assignments, 1 (2), 191-194.

9

128. Wong, S.S.Y. and Yuen, K.Y. (2008), The management of coronavirus infections with particular reference to SARS. Journal of Antimicrobial Chemotherapy, 62 (3), 437-441.

129. Padhan, K., Minakshi, R., Bin Towheed, M.A. and Jameel, S. (2008), Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. Journal of General Virology, 89), 1960-1969.

130. Lewison, G. (2008), The reporting of the risks from severe acute respiratory syndrome (SARS) in the news media, 2003-2004. Health Risk & Society, 10 (3), 241-262.

131. El-Manzalawy, Y., Dobbs, D. and Honavar, V. (2008), Predicting linear B-cell epitopes using string kernels. Journal of Molecular Recognition, 21 (4), 243-255.

132. Maffey, A.F. (2008), New viruses associated to respiratory infections in children. Archivos Argentinos de Pediatria, 106 (4), 341-350.

133. Netland, J., Meyerholz, D.K., Moore, S., Cassell, M. and Perlman, S. (2008), Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. Journal of Virology, 82 (15), 7264-7275.

134. Zhou, B., Liu, J.L., Wang, Q., Liu, X., Li, X.R., Li, P., Ma, Q.J. and Cao, C. (2008), The nucleocapsid protein of severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and proliferation by interacting with translation elongation factor 1 alpha. Journal of Virology, 82 (14), 6962-6971.

135. Li, F. (2008), Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. Journal of Virology, 82 (14), 6984-6991.

136. Van den Brand, J.M.A., Haagmans, B.L., Leijten, L., Van Riel, D., Martina, B.E.E., Osterhaus, A.D.M.E. and Kuiken, T. (2008), Pathology of experimental SARS coronavirus infection in cats and ferrets. Veterinary Pathology, 45 (4), 551-562.

137. Han, M.F., Yan, W.M., Huang, Y.C., Yao, H.N., Wang, Z.H., Xi, D., Li, W.N., Zhou, Y.Y., Hou, J.L., Luo, X.P. and Ning, Q. (2008), The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha. Journal of Biochemistry, 144 (1), 51-62.

138. Eyles, K. and Brownlie, J. (2008), Canine respiratory coronavirus: An emerging pathogen in the canine infectious respiratory disease complex. Veterinary Clinics of North America-Small Animal Practice, 38 (4), 815-+.

139. Verschueren, K.H.G., Pumpor, K., Anemuller, S., Chen, S., Mesters, J.R. and Hilgenfeld, R. (2008), A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters. Chemistry & Biology, 15 (6), 597-606.

140. Bacha, U., Barrila, J., Gabelli, S.B., Kiso, Y., Amzel, L.M. and Freire, E. (2008), Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro). Chemical Biology & Drug Design, 72 (1), 34-49.

141. Barnard, D.L., Day, C.W., Bailey, K., Heiner, M., Montgomery, R., Lauridsen, L., Jung, K.H., Li, J.K.K., Chan, P.K.S. and Sidwell, R.W. (2008), Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model. Antiviral Research, 79 (2), 105-113.

142. DeDiego, M.L., Pewe, L., Alvarez, E., Rejas, M.T., Perlman, S. and Enjuanes, L. (2008), Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice. Virology, 376 (2), 379-389.

143. Kinga, K., Magdalena, L., Jan, W. and Dorota, N. (2008), SARS-CoV infection and pregnancy. Ginekologia Polska, 79 (1), 47-50.

144. Nagata, N., Iwata, N., Hasegawa, H., Fukushi, S., Harashima, A., Sato, Y., Saijo, M., Taguchi, F., Morikawa, S. and Sata, T. (2008), Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. American Journal of Pathology, 172 (6), 1625-1637.

10

145. Pacciarini, F., Ghezzi, S., Canducci, F., Sims, A., Sampaolo, M., Ferioli, E., Clementi, M., Poli, G., Conaldi, P.G., Baric, R. and Vicenzi, E. (2008), Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein. Journal of Virology, 82 (11), 5137-5144.

146. Chen, S., Zhang, J., Hu, T.C., Chen, K.X., Jiang, H.L. and Shen, X. (2008), Residues on the dimer interface of SARS coronavirus 3C-like protease: Dimer stability characterization and enzyme catalytic activity analysis. Journal of Biochemistry, 143 (4), 525-536.

147. Kumaki, Y., Day, C.W., Wandersee, M.K., Schow, B.P., Madsen, J.S., Grant, D., Roth, J.P., Smee, D.F., Blatt, L.M. and Barnard, D.L. (2008), Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells. Biochemical and Biophysical Research Communications , 371 (1), 110-113.

148. Chu, D.K.W., Peiris, J.S.M., Chen, H., Guan, Y. and Poon, L.L.M. (2008), Genomic characterizations of bat coronaviruses (1A, 1B and HKU8) and evidence for co-infections in Miniopterus bats. Journal of General Virology, 89), 1282-1287.

149. Sandrock, C. and Stollenwerk, N. (2008), Acute febrile respiratory illness in the ICU - Reducing disease transmission. Chest , 133 (5), 1221-1231.

150. Imberta, I., Snijder, E.J., Dimitrova, M., Guillemot, J.C., Lecine, P. and Canard, B. (2008), The SARS-coronavirus PLnc domain of nsp3 as a replication/transcription scaffolding protein. Virus Research, 133 (2), 136-148.

151. Chu, Y.K., Ali, G.D., Jia, F., Li, Q.J., Kelvin, D., Couch, R.C., Harrod, K.S., Hutt, J.A., Cameron, C., Weiss, S.R. and Jonsson, C.B. (2008), The SARS-CoV ferret model in an infection-challenge study. Virology, 374 (1), 151-163.

152. Lipkin, W.I. (2008), Pathogen discovery. Plos Pathogens, 4 (4.153. Vidal, S.M., Malo, D., Marquis, J.F. and Gros, P. (2008), Forward genetic dissection of

immunity to infection in the mouse. Annual Review of Immunology, 26), 81-132.154. Shao, Y.M., Yang, W.B., Kuo, T.H., Tsai, K.C., Lin, C.H., Yang, A.S., Liang, P.H. and

Wong, C.H. (2008), Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease. Bioorganic & Medicinal Chemistry, 16 (8), 4652-4660.

155. Spurgers, K.B., Sharkey, C.M., Warfield, K.L. and Bavari, S. (2008), Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses. Antiviral Research, 78 (1), 26-36.

156. Canard, B., Joseph, J.S. and Kuhn, P. (2008), International research networks in viral structural proteomics: Again, lessons from SARS. Antiviral Research, 78 (1), 47-50.

157. Grum-Tokars, V., Ratia, K., Begaye, A., Baker, S.C. and Mesecar, A.D. (2008), Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery. Virus Research, 133 (1), 63-73.

158. Shi, Z.L. and Hu, Z.H. (2008), A review of studies on animal reservoirs of the SARS coronavirus. Virus Research, 133 (1), 74-87.

159. Bechill, J., Chen, Z.B., Brewer, J.W. and Baker, S.C. (2008), Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression. Journal of Virology, 82 (9), 4492-4501.

160. Hui, D.S. and Chan, P.K.S. (2008), Clinical features, pathogenesis and immunobiology of severe acute respiratory syndrome. Current Opinion in Pulmonary Medicine, 14 (3), 241-247.

161. Golda, A. and Pyrc, K. (2008), Recent antiviral strategies against human coronavirus-related respiratory illnesses. Current Opinion in Pulmonary Medicine, 14 (3), 248-253.

162. Lin, H.X., Fen, Y., Wong, G., Wang, L.P., Li, B., Zhao, X.S., Li, Y., Smaill, F. and Zhang, C.S. (2008), Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction. Journal of General Virology, 89), 1015-1024.

11

163. Goebel, S.J., Taylor, J., Barr, B.C., Kielm, T.E., Castro-Malaspina, H.R., Hedvat, C.V., Rush-Wilson, K.A., Kelly, C.D., Davis, S.W., Samsonoffl, W.A., Hurst, K.R., Behr, M.J. and Masters, P.S. (2007), Isolation of avian paramyxovirus 1 from a patient with a lethal case of pneumonia. Journal of Virology, 81 (22), 12709-12714.

164. Lancee, W.J., Maunder, R.G. and Goldbloom, D.S. (2008), Prevalence of psychiatric disorders among Toronto hospital workers one to two years after the SARS outbreak. Psychiatric Services, 59 (1), 91-95.

165. Xue, X.Y., Yu, H.W., Yang, H.T., Xue, F., Wu, Z.X., Shen, W., Li, J., Zhou, Z., Ding, Y., Zhao, Q., Zhang, X.J.C., Liao, M., Bartlam, M. and Rao, Z. (2008), Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design. Journal of Virology , 82 (5), 2515-2527.

166. Niu, C., Yin, J., Zhang, J., Vederas, J.C. and James, M.N.G. (2008), Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV M-pro. Bioorganic & Medicinal Chemistry, 16 (1), 293-302.

167. Cibrelus, L., Noel, V., Emmanuelli, J., Breton, G., Longuet, P., Rigolli, B., Leport, C. and Vilde, J.L. (2007), Management of 90 patients presenting with suspected severe acute respiratory syndrome. Experience of a collaboration between epidemiologists and clinicians facing an emerging infectious disease health alert. Medecine et Maladies Infectieuses, 37), S242-S250.

168. Kahn, J. (2008), Human bocavirus: clinical significance and implications. Current Opinion in Pediatrics, 20 (1), 62-66.

169. Huang, Y., Lau, S.K.P., Woo, P.C.Y. and Yuen, K.Y. (2008), CoVDB: a comprehensive database for comparative analysis of coronavirus genes and genomes. Nucleic Acids Research, 36), D504-D511.

170. Shao, C., Wang, J.P., Yang, G.C., Su, Z.M., Hu, D.H. and Sun, C.C. (2008), Interactions of [Mo6O19](2-) and its derivatives substituted with organic groups inhibitor with SARS-CoV 3CL(pro) by molecular modeling. Chemical Journal of Chinese Universities-Chinese, 29 (1), 165-169.

171. Wu, S.W., Xu, J.Q., Liu, J.X., Yan, X., Zhu, X.D., Xiao, G.F., Sun, L.Q. and Tien, P. (2007), An efficient RNA-cleaving DNA enzyme can specifically target the 5 '-untranslated region of severe acute respiratory syndrome associated coronavirus (SARS-CoV). Journal of Gene Medicine, 9 (12), 1080-1086.

172. Sandrock, C.E. (2008), Severe febrile respiratory illnesses as a cause of mass critical care. Respiratory Care, 53 (1), 40-53.

173. Fujimoto, K., Chan, K.H., Takeda, K., Lo, K.F., Leung, R.H.K. and Okamoto, T. (2008), Sensitive and specific enzyme-linked immunosorbent assay using chemiluminescence for detection of severe acute respiratory syndrome viral infection. Journal of Clinical Microbiology, 46 (1), 302-310.

174. Wan, Y.L., Tsay, P.K., Cheung, Y.C., Chiang, P.C., Wang, C.H., Tsai, Y.H., Kuo, H.P., Tsao, K.C. and Lin, T.Y. (2007), A correlation between the severity of lung lesions on radiographs and clinical findings in patients with sever acute respiratory syndrome. Korean Journal of Radiology, 8 (6), 466-474.

175. Du, L.Y., Zhao, G.Y., Lin, Y.P., Sui, H.Y., Chan, C., Ma, S., He, Y.X., Jiang, S.B., Wu, C.Y., Yuen, K.Y., Jin, D.Y., Zhou, Y.S. and Zheng, B.J. (2008), Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. Journal of Immunology , 180 (2), 948-956.

176. Xiong, P., Zeng, X., Song, M.S., Jia, S.W., Zhong, M.H., Xiao, L.L., Lan, W., Cai, C., Wu, X.W., Gong, F.L. and Wang, W. (2008), Lack of association between HLA-A, -B and-DRB1 alleles and the development of SARS: a cohort of 95 SARS-recovered individuals in

12

a population of Guangdong, southern China. International Journal of Immunogenetics, 35 (1), 69-74.

177. Mark, B., Xue, X. and Rao, Z. (2008), The search for a structural basis for therapeutic intervention against the SARS coronavirus. Acta Crystallographica Section A, 64), 204-213.

178. Robertson, S.J., Ammann, C.G., Messer, R.J., Carmody, A.B., Myers, L., Dittmer, U., Nair, S., Gerlach, N., Evans, L.H., Cafruny, W.A. and Hasenkrug, K.J. (2008), Suppression of acute anti-friend virus CD8(+) T-cell responses by coinfection with lactate dehydrogenase-elevating virus. Journal of Virology, 82 (1), 408-418.

179. Chen, S., Hu, T., Zhang, J., Chen, J., Chen, K., Ding, J., Jiang, H. and Shen, X. (2008), Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease - Crystal structure with molecular dynamics simulations. Journal of Biological Chemistry, 283 (1), 554-564.

180. Guo, Z.M., Lu, J.H., Han, W.Y., Liu, Z.Y., Li, G.W., Liao, J.W., Wang, S.M., Wu, Y.S., Zheng, H.Y., Zhong, N.S. and Zhu, X.Q. (2007), Comparison of effectiveness of whole viral, N and N199 proteins, by ELISA for the rapid diagnosis of severe acute respiratory syndrome coronavirus. Chinese Medical Journal, 120 (24), 2195-2199.

181. Lee, Y.C., Leu, S.J.C., Hu, C.J., Shih, N.Y., Huang, I.J., Wu, H.H., Hsieh, W.S., Chiang, B.L., Chiu, W.T. and Yang, Y.Y. (2007), Chicken single-chain variable fragments against the SARS-CoV spike protein. Journal of Virological Methods, 146 (1-2), 104-111.

182. Greger, M. (2007), The human/animal interface: Emergence and resurgence of zoonotic infectious diseases. Critical Reviews in Microbiology, 33 (4), 243-299.

183. Guillen, J., Moreno, M.R., Perez-Berna, A.J., Bernabeu, A. and Villalain, J. (2007), Interaction of a peptide from the pre-transmembrane domain of the severe acute respiratory syndrome coronavirus spike protein with phospholipid membranes. Journal of Physical Chemistry B, 111 (49), 13714-13725.

184. Tan, J., Kusov, Y., Mutschall, D., Tech, S., Nagarajan, K., Hilgenfeld, R. and Schmidt, C.L. (2007), The "SARS-unique domain" (SUD) of SARS coronavirus is an oligo(G)-binding protein. Biochemical and Biophysical Research Communications, 364 (4), 877-882.

185. Peiris, J.S.M., Guan, Y., Poon, L.L.M., Cheng, V.C.C., Nicholls, J.M. and Yuen, K.Y. (2007), Severe acute respiratory syndrome (SARS). ), 23-+.

186. Khoon, C.C. (2006), Risk perception and coping responses in a SARS outbreak in Malaysia. Population Dynamics and Infectious Diseases in Asia, ), 351-368.

187. Woo, P.C.Y., Wong, B.H.L., Huang, Y., Lau, S.K.P. and Yuen, K.Y. (2007), Cytosine deamination and selection of CpG suppressed clones are the two major independent biological forces that shape codon usage bias in coronaviruses. Virology, 369 (2), 431-442.

188. Nagata, N., Iwata, N., Hasegawa, H., Sato, Y., Morikawa, S., Saijo, M., Itamura, S., Saito, T., Ami, Y., Odagiri, T., Tashiro, M. and Sata, T. (2007), Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes. International Journal of Experimental Pathology, 88 (6), 403-414.

189. Lu, X.Y., Chen, Y., Bai, B.K., Hu, H., Tao, L., Yang, J.H., Chen, J.J., Chen, Z., Hu, Z.H. and Wang, H.Z. (2007), Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice. Immunology, 122 (4), 496-502.

190. Chan, K.H., Sonnenberg, K., Niedrig, M., Lam, S.Y., Pang, C.M., Chan, K.M., Ma, S.K., Seto, W.H. and Peiris, J.S.M. (2007), Use of antibody avidity assays for diagnosis of severe acute respiratory syndrome coronavirus infection. Clinical and Vaccine Immunology, 14 (11), 1433-1436.

191. Zhang, J.Q., Guy, J.S., Snijder, E.J., Denniston, D.A., Timoney, P.J. and Balasuriya, U.B.R. (2007), Genomic characterization of equine coronavirus. Virology, 369 (1), 92-104.

192. Shao, X.P., Guo, X.J., Esper, F., Weibel, C. and Kahn, J.S. (2007), Seroepidemiology of group I human coronaviruses in children. Journal of Clinical Virology, 40 (3), 207-213.

13

193. Pozo, F., Garcia-Garcia, M.L., Calvo, C., Cuesta, I., Perez-Brena, P. and Casas, I. (2007), High incidence of human bocavirus infection in children in Spain. Journal of Clinical Virology, 40 (3), 224-228.

194. Lau, S.K.P., Yip, C.C.Y., Tsoi, H.W., Lee, R.A., So, L.Y., Lau, Y.L., Chan, K.H., Woo, P.C.Y. and Yuen, K.Y. (2007), Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic previously undetected HRV cluster, probably representing a species, HRV-C, associated with acute respiratory illness in children. Journal of Clinical Microbiology, 45 (11), 3655-3664.

195. Han, D.P., Lohani, M. and Cho, M.W. (2007), Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-Mediated severe acute respiratory syndrome coronavirus entry. Journal of Virology, 81 (21), 12029-12039.

196. Chen, Y.X., Chan, V.S.F., Zheng, B.J., Chan, K.Y.K., Xu, X.N., To, L.Y.F., Huang, F.P., Khoo, U.S. and Lin, C.L.S. (2007), A novel subset of putative stem/progenitor CD34(+)Oct-4(+) cells is the major target for SARS coronavirus in human lung. Journal of Experimental Medicine, 204 (11), 2529-2536.

197. Pyrc, K., Berkhout, B. and van der Hoek, L. (2007), Identification of new human coronaviruses. Expert Review of Anti-Infective Therapy, 5 (2), 245-253.

198. Huang, J., Cao, Y.N., Du, J.L., Bu, X.Z., Ma, R. and Wu, C.Y. (2007), Priming with SARS CoVS DNA and boosting with SARS CoVS epitopes specific for CD4(+) and CD8(+) T cells promote cellular immune responses. Vaccine, 25 (39-40), 6981-6991.

199. Cheng, V.C.C., Lau, S.K.P., Woo, P.C.Y. and Yuen, K.Y. (2007), Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clinical Microbiology Reviews, 20 (4), 660-+.

200. Li, W.H., Sui, J.H., Huang, I.C., Kuhn, J.H., Radoshitzky, S.R., Marasco, W.A., Choe, H. and Farzan, M. (2007), The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology, 367 (2), 367-374.

201. Lau, S.K.P., Woo, P.C.Y., Li, K.S.M., Huang, Y., Wang, M., Lam, C.S.F., Xu, H.F., Guo, R.T., Chan, K.H., Zheng, B.J. and Yuen, K.Y. (2007), Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome. Virology, 367 (2), 428-439.

202. Kesson, A.M. (2007), Respiratory virus infections. Paediatric Respiratory Reviews, 8 (3), 240-248.

203. Qin, Z.L., Zhao, P., Cao, M.M. and Qi, Z.T. (2007), siRNAs targeting terminal sequences of the SARS-associated coronavirus membrane gene inhibit M protein expression through degradation of M mRNA. Journal of Virological Methods, 145 (2), 146-154.

204. Wang, L.F. and Eaton, B.T. (2007), Bats, Civets and the emergence of SARS. Wildlife and Emerging Zoonotic Diseases: the Biology, Circumstances and Consequences of Cross-Species Transmission, 315), 325-344.

205. Kumar, P., Gunalan, V., Liu, B., Chow, V.T.K., Druce, J., Birch, C., Catton, M., Fielding, B.C., Tan, Y.J. and Lal, S.K. (2007), The nonstructural protein 8 (nsp8) of the SARS coronavirus interacts with its ORF6 accessory protein. Virology, 366 (2), 293-303.

206. Chen, P., Jiang, M., Hu, T., Liu, Q.Z., Chen, X.S.J. and Guo, D. (2007), Biochemical characterization of exoribonuclease encoded by SARS coronavirus. Journal of Biochemistry and Molecular Biology, 40 (5), 649-655.

207. Ma, Y., Chan, C.Y. and He, M.L. (2007), RNA interference and antiviral therapy. World Journal of Gastroenterology, 13 (39), 5169-5179.

208. Lau, S.K.P., Yip, C.C.Y., Que, T.L., Lee, R.A., Au-Yeung, R.K.H., Zhou, B., So, L.Y., Lau, Y.L., Chan, K.H., Woo, P.C.Y. and Yuen, K.Y. (2007), Clinical and molecular epidemiology of human bocavirus in respiratory and fecal samples from children in Hong Kong. Journal of Infectious Diseases, 196 (7), 986-993.

14

209. Ba, L., Yi, C.E., Zhang, L.Q., Ho, D.D. and Chen, Z. (2007), Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus. Applied Microbiology and Biotechnology, 76 (5), 1131-1136.

210. Wang, W., Ye, L.B., Ye, L., Li, B.Z., Gao, B., Zeng, Y.C., Kong, L.B., Fang, X.N., Zheng, H., Wu, Z.H. and She, Y.L. (2007), Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappa B pathway. Virus Research, 128 (1-2), 1-8.

211. Yang, N., Tanner, J.A., Zheng, B.J., Watt, R.M., He, M.L., Lu, L.Y., Jiang, J.Q., Shum, K.T., Lin, Y.P., Wong, K.L., Lin, M.C.M., Kung, H.F., Sun, H.Z. and Huang, J.D. (2007), Bismuth complexes inhibit the SARS coronavirus. Angewandte Chemie-International Edition, 46 (34), 6464-6468.

212. Clem, A.L., Sims, J., Telang, S., Eaton, J.W. and Chesney, J. (2007), Virus detection and identification using random multiplex (RT)-PCR with 3 '-locked random primers. Virology Journal, 4.

213. Shelgrove, R., Gwyer, E. and Hussell, T. (2006), Modulation of immunity to respiratory viral infection. Future Virology, 1 (4), 471-481.

214. Foulongne, V. and Segondy, M. (2007), Human bocavirus: a new respiratory pathogen? Future Virology, 2 (2), 173-181.

215. Muller, M.A., Paweska, J.T., Leman, P.A., Drosten, C., Grywna, K., Kemp, A., Braack, L., Sonnenberg, K., Niedrig, M. and Swanepoel, R. (2007), Coronavirus antibodies in African bat species. Emerging Infectious Diseases, 13 (9), 1367-1370.

216. Roberts, A., Deming, D., Paddock, C.D., Cheng, A., Yount, B., Vogel, L., Herman, B.D., Sheahan, T., Heise, M., Genrich, G.L., Zaki, S.R., Baric, R. and Subbarao, K. (2007), A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. Plos Pathogens, 3 (1), 23-37.

217. Stoltz, M., Ahim, C., Lundkvist, A. and Klingstrom, J. (2007), Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-gamma-Induced nitric oxide production. Journal of Virology, 81 (16), 8685-8691.

218. Hu, M.C., Jones, T., Kenney, R.T., Barnard, D.L., Burt, D.S. and Lowell, G.H. (2007), Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice. Vaccine, 25 (34), 6334-6340.

219. Tasaki, T. and Ohto, H. (2007), Nineteen years of experience with autotransfusion for elective surgery in children: more troublesome than we expected. Transfusion, 47 (8), 1503-1509.

220. Zhu, Z.Y., Chakraborti, S., He, Y., Roberts, A., Sheahan, T., Xiao, X.D., Hensley, L.E., Prabakaran, P., Rockx, B., Sidorov, I.A., Corti, D., Vogel, L., Feng, Y., Kim, J.O., Wang, L.F., Baric, R., Lanzavecchia, A., Curtis, K.M., Nabel, G.J., Subbarao, K., Jiang, S. and Dimitrov, D.S. (2007), Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America, 104 (29), 12123-12128.

221. Bitko, V. and Barik, S. (2007), Intranasal antisense therapy: Preclinical models with a clinical future? Current Opinion in Molecular Therapeutics, 9 (2), 119-125.

222. Liu, Z.X., Wang, Z.H., Liu, Y.L., Dong, W. and Qi, Y.P. (2007), Analysis of proteins that interact with nucleocapsid protein of SARS-CoV using 15-mer phage-displayed library. Chinese Science Bulletin, 52 (15), 2072-2080.

223. Fenouillet, E., Barbouche, R. and Jones, I.M. (2007), Cell entry by enveloped viruses: Redox considerations for HIV and SARS-coronavirus. Antioxidants & Redox Signaling, 9 (8), 1009-1034.

224. Zhao, J.C., Wang, W., Wang, W.L., Zhao, Z.D., Zhang, Y., Lv, P., Ren, F.R. and Gao, X.M. (2007), Comparison of immunogylobulin G responses to the spike and nucleocapsid proteins

15

of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS. Clinical and Vaccine Immunology, 14 (7), 839-846.

225. Hu, H., Lu, X.Y., Tao, L., Bai, B.K., Zhang, Z.F., Chen, Y., Zheng, F.L., Chen, J.J., Chen, Z. and Wang, H.Z. (2007), Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice. Clinical and Vaccine Immunology, 14 (7), 894-901.

226. Chen, C.Y., Ping, Y.H., Lee, H.C., Chen, K.H., Lee, Y.M., Chan, Y.J., Lien, T.C., Jap, T.S., Lin, C.H., Kao, L.S. and Chen, Y.M.A. (2007), Open reading frame 8a of the human severe acute respiratory syndrome coronavirus not only promotes viral replication but also induces apoptosis. Journal of Infectious Diseases, 196 (3), 405-415.

227. Satija, N. and Lal, S.K. (2007), The molecular biology of SARS coronavirus. ), 26-38.228. Sampath, R., Hall, T.A., Massire, C., Li, F., Blyn, L.B., Eshoo, M.W., Hofstadler, S.A. and

Ecker, D.J. (2007), Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry. Biology of Emerging Viruses: Sars, Avian and Human Influenza, Metapneumovirus, Nipah, West Nile, and Ross River Virus, 1102), 109-120.

229. Ng, M.W., Zhou, G.Q., Chong, W.P., Lee, L.W.Y., Law, H.K.W., Zhang, H.X., Wong, W.H.S., Fok, S.F.S., Zhai, Y., Yung, R.W.H., Chow, E.Y., Au, K.L., Chan, E.Y.T., Lim, W., Peiris, J.S.M., He, F.C. and Lau, Y.L. (2007), The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese. Bmc Infectious Diseases, 7.

230. Spiegel, M. and Weber, F. (2006), Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus. Virology Journal, 3.

231. He, Z.P., Zhuang, H., Zhao, C.H., Dong, Q.M., Peng, G. and Dwyer, D.E. (2007), Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV). Virology Journal, 4.

232. Ho, P.L., Becker, M. and Chan-Yeung, M.M. (2007), Emerging occupational lung infections. International Journal of Tuberculosis and Lung Disease, 11 (7), 710-721.

233. Shin, G.C., Chung, Y.S., Kim, I.S., Cho, H.W. and Kang, C. (2007), Antigenic characterization of severe acute respiratory syndrome-coronavirus nucleocapsid protein expressed in insect cells: The effect of phosphorylation on immunoreactivity and specificity. Virus Research, 127 (1), 71-80.

234. Pokrovskaya, A.V. (2007), Severe acute respiratory syndrome. Terapevticheskii Arkhiv, 79 (3), 66-70.

235. Dong, B.Q., Liu, W., Fan, X.H., Vijaykrishna, D., Tang, X.C., Gao, F., Li, L.F., Li, G.J., Zhang, J.X., Yang, L.Q., Poon, L.L.M., Zhang, S.Y., Peiris, J.S.M., Smith, G.J.D., Chen, H. and Guan, Y. (2007), Detection of a novel and highly divergent coronavirus from Asian leopard cats and Chinese ferret badgers in southern China. Journal of Virology, 81 (13), 6920-6926.

236. Roth-Cross, J.K., Martinez-Sobrido, L., Scott, E.P., Garcia-Sastre, A. and Weiss, S.R. (2007), Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels. Journal of Virology, 81 (13), 7189-7199.

237. Thomas, M., Lu, J.J., Chen, J.Z. and Klibanov, A.M. (2007), Non-viral siRNA delivery to the lung. Advanced Drug Delivery Reviews, 59 (2-3), 124-133.

238. Du, L.Y., Kao, R.Y., Zhou, Y.S., He, Y.X., Zhao, G.Y., Wong, C., Jiang, S.B., Yuen, K.Y., Jin, D.Y. and Zheng, B.J. (2007), Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity. Biochemical and Biophysical Research Communications, 359 (1), 174-179.

16

239. Chen, Z.B., Wang, Y.H., Ratia, K., Mesecar, A.D., Wilkinson, K.D. and Baker, S.C. (2007), Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63. Journal of Virology, 81 (11), 6007-6018.

240. Zhao, J.C., Huang, Q.R., Wang, W., Zhang, Y., Lv, P. and Gao, X.M. (2007), Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus. Journal of Virology, 81 (11), 6079-6088.

241. Liu, L., Fang, Q., Deng, F., Wang, H.Z., Yi, C.E., Ba, L., Yu, W.J., Lin, R.D., Li, T.S., Hu, Z.H., Ho, D.D., Zhang, L.Q. and Chen, Z.W. (2007), Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus. Journal of Virology, 81 (9), 4694-4700.

242. Hamming, I., Cooper, M.E., Haagmans, B.L., Hooper, N.M., Korstanje, R., Osterhaus, A.D.M.E., Timens, W., Turner, A.J., Navis, G. and van Goor, H. (2007), The emerging role of ACE2 in physiology and disease. Journal of Pathology, 212 (1), 1-11.

243. Chen, J. and Subbarao, K. (2007), The immunobiology of SARS. Annual Review of Immunology, 25), 443-472.

244. Stertz, S., Reichelt, M., Spiegel, M., Kuri, T., Martinez-Sobrido, L., Garcia-Sastre, A., Weber, F. and Kochs, G. (2007), The intracellular sites of early replication and budding of SARS-coronavirus. Virology, 361 (2), 304-315.

245. Okada, M., Okuno, Y., Hashimoto, S., Kita, Y., Kanamaru, N., Nishida, Y., Tsunai, Y., Inoue, R., Nakatani, H., Fukamizu, R., Namie, Y., Yamada, J., Takao, K., Asai, R., Asaki, R., Kase, T., Takemoto, Y., Yoshida, S., Peiris, J.S.M., Chen, P.J., Yamamoto, N., Nomura, T., Ishida, I., Morikawa, S., Tashiro, M. and Sakatani, M. (2007), Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models. Vaccine, 25 (16), 3038-3040.

246. Ho, T.Y., Wu, S.L., Chen, J.C., Li, C.C. and Hsiang, C.Y. (2007), Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Research, 74 (2), 92-101.

247. Petit, C.M., Chouljenko, V.N., Iyer, A., Colgrove, R., Farzan, M., Knipe, D.M. and Kousoulas, K.G. (2007), Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion. Virology, 360 (2), 264-274.

248. Brucz, K., Miknis, Z.J., Schultz, L.W. and Umland, T.C. (2007), Expression, purification and characterization of recombinant severe acute respiratory syndrome coronavirus non-structural protein 1. Protein Expression and Purification, 52 (2), 249-257.

249. Greenberg, S.B. (2007), Rhinovirus and coronavirus infections. Seminars in Respiratory and Critical Care Medicine, 28 (2), 182-192.

250. Muller, M.P. and McGeer, A. (2007), Severe acute respiratory syndrome (SARS) coronavirus. Seminars in Respiratory and Critical Care Medicine, 28 (2), 201-212.

251. Ge, F., Luo, Y.H., Liew, P.X. and Hung, E. (2007), Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening. Virology, 360 (1), 150-158.

252. Yu, I.T., Xie, Z.H., Tsoi, K.K., Chiu, Y.L., Lok, S.W., Tang, X.P., Hui, D.S., Lee, N., Li, Y.M., Huang, Z.T., Liu, T., Wong, T.W., Zhong, N.S. and Sung, J.J. (2007), Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? Clinical Infectious Diseases, 44 (8), 1017-1025.

253. Haynes, L.M., Miao, C.R., Harcourt, J.L., Montgomery, J.M., Le, M.Q., Dryga, S.A., Kamrud, K.I., Rivers, B., Babcock, G.J., Oliver, J.B., Comer, J.A., Reynolds, M., Uyeki, T.M., Bausch, D., Ksiazek, T., Thomas, W., Alterson, H., Smith, J., Ambrosino, D.M. and Anderson, L.J. (2007), Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins. Clinical and Vaccine Immunology, 14 (3), 331-333.

17

254. Yu, H., Jiang, L.F., Fang, D.Y., Yan, H.J., Zhou, J.J., Zhou, J.M., Liang, Y., Gao, Y., Zhao, W. and Long, B.G. (2007), Selection of SARS-Coronavirus-specific B cell epitopes by phage peptide library screening and evaluation of the immunological effect of epitope-based peptides on mice. Virology, 359 (2), 264-274.

255. Zhao, J.C., Wang, W., Yuan, Z.H., Jia, R.J., Zhao, Z.D., Xu, X.J., Lv, P., Zhang, Y., Jiang, C.Y. and Gao, X.M. (2007), A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus. Virology, 359 (2), 362-370.

256. Gerna, G., Percivalle, E., Sarasini, A., Campanini, G., Piralla, A., Rovida, F., Genini, E., Marchi, A. and Baldanti, F. (2007), Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients. Journal of Clinical Virology, 38 (3), 244-250.

257. Xi, X.G. (2007), Helicases as antiviral and anticancer drug targets. Current Medicinal Chemistry, 14 (8), 883-915.

258. Anderson, L.J. (2007), Human bocavirus: A new viral pathogen. Clinical Infectious Diseases, 44 (7), 911-912.

259. Lee, T.W., Cherney, M.M., Liu, J., James, K.E., Powers, J.C., Eltis, L.D. and James, M.N.G. (2007), Crystal structures reveal an induced-fit binding of a substrate-like aza-peptide epoxide to SARS coronavirus main peptidase. Journal of Molecular Biology, 366 (3), 916-932.

260. Xue, X.Y., Yang, H.T., Shen, W., Zhao, Q., Li, J., Yang, K.L., Chen, C., Jin, Y.H., Bartlam, M. and Rao, Z.H. (2007), Production of authentic SARS-CoV M-pro with enhanced activity: Application as a novel tag-cleavage endopeptidase for protein overproduction. Journal of Molecular Biology, 366 (3), 965-975.

261. Severson, W.E., Shindo, N., Sosa, M., Fletcher, T., White, E.L., Ananthan, S. and Jonsson, C.B. (2007), Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library. Journal of Biomolecular Screening, 12 (1), 33-40.

262. Woo, P.C.Y., Wang, M., Lau, S.K.P., Xu, H.F., Poon, R.W.S., Guo, R.T., Wong, B.H.L., Gao, K., Tsoi, H.W., Huang, Y., Li, K.S.M., Lam, C.S.F., Chan, K.H., Zheng, B.J. and Yuen, K.Y. (2007), Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. Journal of Virology, 81 (4), 1574-1585.

263. DeDiego, M.L., Alvarez, E., Almazan, F., Rejas, M.T., Lamirande, E., Roberts, A., Shieh, W.J., Zaki, S.R., Subbarao, K. and Enjuanes, L. (2007), A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. Journal of Virology, 81 (4), 1701-1713.

264. Nagata, N., Iwata, N., Hasegawa, H., Fukushi, S., Yokoyama, M., Harashima, A., Sato, Y., Saijo, M., Morikawa, S. and Sata, T. (2007), Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. Journal of Virology, 81 (4), 1848-1857.

265. Rainer, T.H., Lee, N., Ip, M., Galvani, A.P., Antonio, G.E., Wong, K.T., Chan, D.P.N., Ng, A.W.H., Shing, K.K., Chau, S.S.L., Mak, P., Chan, P.K.S., Ahuja, A.T., Hui, D.S. and Sung, J.J.Y. (2007), Features discriminating SARS from other severe viral respiratory tract infections. European Journal of Clinical Microbiology & Infectious Diseases, 26 (2), 121-129.

266. Salehi, R. and Ali, S.H. (2006), The social and political context of disease outbreaks: The case of SARS in Toronto. Canadian Public Policy-Analyse de Politiques, 32 (4), 373-385.

267. Hsu, C.H., Hwang, K.C., Chao, C.L., Chang, S.G.N., Ker, C.C., Chien, L.C., Ho, M.S., Lin, J.G., Chen, Y.M. and Chou, P. (2006), The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients. American Journal of Chinese Medicine, 34 (6), 927-935.

18

268. Kitabatake, M., Inoue, S., Yasui, F., Yokochi, S., Arai, M., Morita, K., Shida, H., Kidokoro, M., Murai, F., Mai, Q.L., Mizuno, K., Matsushima, K. and Kohara, M. (2007), SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus. Vaccine, 25 (4), 630-637.

269. Zhang, X., Wu, K.L., Yue, X., Zhu, Y. and Wu, J.G. (2007), Inhibition of SARS-CoV gene expression by adenovirus-delivered small hairpin RNA. Intervirology, 50 (2), 63-70.

270. Hu, D., Shao, C., Guan, W., Su, Z.M. and Sun, J.Z. (2007), Studies on the interactions of Ti-containing polyoxometalates (POMs) with SARS-CoV 3CL(pro) by molecular modeling. Journal of Inorganic Biochemistry, 101 (1), 89-94.

271. Yip, C.W., Hon, C.C., Zeng, F.Y., Chow, K.Y.C., Chan, K.H., Peiris, J.S.M. and Leung, F.C.C. (2007), Naturally occurring anti-Escherichia coli protein antibodies in the sera of healthy humans cause analytical interference in a recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay for serodiagnosis of severe acute respiratory syndrome. Clinical and Vaccine Immunology, 14 (1), 99-101.

272. Ghosh, A.K., Xi, K., Johnson, M.E., Baker, S.C. and Mesecar, A.D. (2006), Progress in anti-SARS coronavirus chemistry, biology and chemotherapy. Annual Reports in Medicinal Chemistry, Vol 41, 41), 183-196.

273. Stockman, L.J., Massoudi, M.S., Helfand, R., Erdman, D., Siwek, A.M., Anderson, L.J. and Parashar, U.D. (2007), Severe acute respiratory syndrome in children. Pediatric Infectious Disease Journal, 26 (1), 68-74.

274. Schaecher, S.R., Mackenzie, J.M. and Pekosz, A. (2007), The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles. Journal of Virology, 81 (2), 718-731.

275. Mccray, P.B., Pewe, L., Wohlford-Lenane, C., Hickey, M., Manzel, L., Shi, L., Netland, J., Jia, H.P., Halabi, C., Sigmund, C.D., Meyerholz, D.K., Kirby, P., Look, D.C. and Perlman, S. (2007), Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. Journal of Virology, 81 (2), 813-821.

276. Leroy, O. (2006), Contribution of microbiological investigations to the diagnosis of lower respiratory tract infections. Medecine et Maladies Infectieuses, 36 (11-12), 570-598.

277. Law, A.H.Y., Lee, D.C.W., Cheung, B.K.W., Yirn, H.C.H. and Lau, A.S.Y. (2007), Role for nonstructural protein 1 of severe acute respiratory syndrome coronavirus in chemokine dysregulation. Journal of Virology, 81 (1), 416-422.

278. Yang, H.T., Bartlam, M. and Rao, Z.H. (2006), Drug design targeting the main protease, the Achilles' heel of coronaviruses. Current Pharmaceutical Design, 12 (35), 4573-4590.

279. Escutenaire, S., Mohamed, N., Isaksson, M., Thoren, P., Klingeborn, B., Belak, S., Berg, M. and Blomberg, J. (2007), SYBR Green real-time reverse transcription-polymerase chain reaction assay for the generic detection of coronaviruses. Archives of Virology, 152 (1), 41-58.

280. Li, J., Shen, W., Liao, M. and Bartlam, M. (2007), Preliminary crystallographic analysis of avian infectious bronchitis virus main protease. Acta Crystallographica Section F-Structural Biology and Crystallization Communications, 63), 24-26.

281. Barrila, J., Bacha, U. and Freire, E. (2006), Long-range cooperative interactions modulate dimerization in SARS 3CL(pro). Biochemistry, 45 (50), 14908-14916.

282. Roberts, A., Wood, J., Subbarao, K., Ferguson, M., Wood, D. and Cherian, T. (2006), Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25-26 August 2005, London, UK. Vaccine, 24 (49-50), 7056-7065.

283. Timen, A., Doornum, G.J.J., Schutten, M., Conyn-van Spaendonck, M.A.E., van der Meer, J.W.M., OsterhauS, A.D.M.E. and van Steenbergen, J.E. (2006), Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak. Clinical Microbiology and Infection, 12 (12), 1214-1220.

284. Wu, Y.S., Lin, W.H., Hsu, J.T.A. and Hsieh, H.P. (2006), Antiviral Drug Discovery Against SARS-CoV. Current Medicinal Chemistry, 13 (17), 2003-2020.

19

285. Qi, C., Chen, Y.Y., Wang, Z.H. and Jin, G. (2005), Investigation of interactions between two monoclonal antibodies and SARS virus with a label-free protein array. ), 1305-1308.

286. Cheng, S.W. (2005), Improvement of protection and comfort for long-range airliner passenger in the post-SARS age. 2005 IEEE Aerospace Conference, Vols 1-4, ), 2875-2882.

287. Li, T.S., Xie, J., He, Y.X., Fan, H.W., Baril, L., Qiu, Z.F., Han, Y., Xu, W.B., Zhang, W.H., You, H., Zuo, Y.L., Fang, Q., Yu, J., Chen, Z.W. and Zhang, L.Q. (2006), Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus. Plos One, 1 (1.

288. Han, M.G., Cheon, D.S., Zhang, X.M. and Saif, L.J. (2006), Cross-protection against a human enteric coronavirus and a virulent bovine enteric coronavirus in gnotobiotic calves. Journal of Virology, 80 (24), 12350-12356.

289. Maunder, R.G., Lancee, W.J., Balderson, K.E., Bennett, J.P., Borgundvaag, B., Evans, S., Fernandes, C.M.B., Goldbloom, D.S., Gupta, M., Hunter, J.J., Hall, L.M., Nagle, L.M., Pain, C., Peczeniuk, S.S., Raymond, G., Read, N., Rourke, S.B., Steinberg, R.J., Stewart, T.E., VanDeVelde-Coke, S., Veldhorst, G.G. and Wasylenki, D.A. (2006), Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak. Emerging Infectious Diseases, 12 (12), 1924-1932.

290. Shao, H.W., Lan, D.M., Duan, Z.H., Liu, Z.H., Min, J., Zhang, L.C., Huang, J., Su, J., Chen, S.W. and Xu, A.L. (2006), Upregulation of mitochondrial gene expression in PBMC from convalescent SARS patients. Journal of Clinical Immunology, 26 (6), 546-554.

291. Stockman, L.J., Bellamy, R. and Garner, P. (2006), SARS: Systematic review of treatment effects. Plos Medicine, 3 (9), 1525-1531.

292. Haagmans, B.L. and Osterhaus, A.D.M.E. (2006), Are nonhuman primates good models for SARS? Authors' response to Hogan. Plos Medicine, 3 (9), 1657-1658.

293. Peng, H., Yang, L.T., Li, J., Lu, Z.Q., Wang, L.Y., Koup, R.A., Bailer, R.T. and Wu, C.Y. (2006), Human memory T cell responses to SARS-CoV E protein. Microbes and Infection, 8 (9-10), 2424-2431.

294. Fan, J., Kraft, A.J. and Henrickson, K.J. (2006), Current methods for the rapid diagnosis of bioterrorism-related infectious agents. Pediatric Clinics of North America, 53 (5), 817-+.

295. He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., Wang, H., Li, Z., Zhao, L., Geng, J., Deng, Y., Yang, L., Li, J., Cai, J., Qiu, L., Wen, K., Xu, X. and Jiang, S. (2006), Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2(+) cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. Journal of Pathology, 210 (3), 288-297.

296. Esposito, S., Bosis, S., Niesters, H.G.M., Tremolati, E., Begliatti, E., Rognoni, A., Tagliabue, C., Principi, N. and Osterhaus, A.D.M.E. (2006), Impact of human coronavirus infections in otherwise healthy children who attended an emergency department. Journal of Medical Virology, 78 (12), 1609-1615.

297. Zhan, J., Deng, R.S., Tang, J.M., Zhang, B., Tang, Y., Wang, J.K., Li, F., Anderson, V.M., Mcnutt, M.A. and Gu, J. (2006), The spleen as a target in severe acute respiratory syndrome. Faseb Journal, 20 (13), 2321-2328.

298. Shih, Y.P., Chen, C.Y., Liu, S.J., Chen, K.H., Lee, Y.M., Chao, Y.C. and Chen, Y.M.A. (2006), Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus. Journal of Virology, 80 (21), 10315-10324.

299. Ren, W., Li, W.D., Yu, M., Hao, P., Zhang, Y., Zhou, P., Zhang, S.Y., Zhao, G.P., Zhong, Y., Wang, S.Y., Wang, L.F. and Shi, Z. (2006), Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis. Journal of General Virology, 87), 3355-3359.

300. Liu, M., Liang, W.N., Chen, Q., Xie, X.Q., Wu, J., He, X. and Liu, Z.J. (2006), Risk factors for SARS-related deaths in 2003, Beijing. Biomedical and Environmental Sciences, 19 (5), 336-339.

20

301. Li, W.H., Choe, H. and Farzan, M. (2006), Insights from the association of SARS-CoV S-protein with its receptor, ACE2. ), 209-218.

302. Gillim-Ross, L., Heller, L.K., Olivieri, E.R. and Wentworth, D.E. (2006), Increased viral titers and subtle changes in plaque morphology upon passage of SARS-CoV in cells from different species. ), 259-263.

303. Poon, L.L.M. (2006), Sars and other coronaviruses in humans and animals. ), 457-462.304. Van der Hoek, L., Sure, K., Ihorst, G., Stang, A., Pyrc, K., Jebbink, M.F., Petersen, G.,

Forster, J., Berkhout, B. and Uberla, K. (2006), Human coronavirus NL63 infection is associated with croup. ), 485-491.

305. Nagata, N., Iwata, N., Hasegawa, H., sahi-Ozaki, Y., Sato, Y., Harashima, A., Morikawa, S., Saijo, M., Itamura, S., Saito, T., Odagiri, T., Tashiro, M., Ami, Y. and Sata, T. (2006), Pathological and virological analyses of severe acute respiratory syndrome-associated coronavirus infections in experimental animals. ), 515-518.

306. Okada, M., Takemoto, Y., Okuno, Y., Hashimoto, S., Fukunaga, Y., Tanaka, T., Kita, Y., Kuwayama, S., Muraki, Y., Kanamaru, N., Takai, H., Okada, C., Sakaguchi, Y., Furukawa, I., Yamada, K., Izumiya, M., Yoshida, S., Matsumoto, M., Kase, T., Peiris, J.S.M., Demello, D.E., Chen, P.J., Yamamoto, N., Yoshinaka, Y., Nomura, T., Ishida, I., Morikawa, S., Tashiro, M. and Sakatani, M. (2006), Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models. ), 561-566.

307. Almazan, F., DeDiego, M.L., Galan, C., Alvarez, E. and Enjuanes, L. (2006), Identification of essential genes as a strategy to select a SARS candidate vaccine using a SARS-CoV infectious cDNA. Nidoviruses: Toward Control of Sars and Other Nidovirus Diseases, 581), 579-583.

308. Zeng, F.Y., Hon, C.C., Yip, C.W., Law, K.M., Yeung, Y.S., Chan, K.H., Peiris, J.S.M. and Leung, F.C.C. (2006), Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: Implications for the functional roles of S2 subunit. Febs Letters, 580 (24), 5612-5620.

309. Gillim-Ross, L. and Subbarao, K. (2006), Emerging respiratory viruses: Challenges and vaccine strategies. Clinical Microbiology Reviews, 19 (4), 614-+.

310. Bricaire, F. and Bossi, P. (2006), Emerging viral diseases. Bulletin de l Academie Nationale de Medecine, 190 (3), 597-608.

311. Fan, Z., Zhuo, Y., Tan, X.Y., Zhou, Z., Yuan, J.G., Qiang, B.Q., Yan, J.H., Peng, X.Z. and Gao, G.F. (2006), SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system. Journal of Medical Virology, 78 (11), 1365-1373.

312. de Lang, A., Osterhaus, A.D.M.E. and Haagmans, B.L. (2006), Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells. Virology, 353 (2), 474-481.

313. Woo, P.C.Y., Lau, S.K.P. and Yuen, K. (2006), Infectious diseases emerging from Chinese wet-markets: zoonotic origins of severe respiratory viral infections. Current Opinion in Infectious Diseases, 19 (5), 401-407.

314. Liu, M., Gu, C.F., Wu, J.G. and Zhu, Y. (2006), Amino acids 1 to 422 of the spike protein of SARS associated coronavirus are required for induction of cyclooxygenase-2. Virus Genes, 33 (3), 309-317.

315. Li, H.Y., Ramalingam, S. and Chye, M.L. (2006), Accumulation of recombinant SARS-CoV spike protein in plant cytosol and chloroplasts indicate potential for development of plant-derived oral vaccines. Experimental Biology and Medicine, 231 (8), 1346-1352.

316. Luo, H.B., Chen, J., Chen, K.X., Shen, X. and Jiang, H.L. (2006), Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: Self-association analysis and nucleic acid binding characterization. Biochemistry, 45 (39), 11827-11835.

317. Balzarini, J., Keyaerts, E., Vijgen, L., Egberink, H., De Clercq, E., Van Ranst, M., Printsevskaya, S.S., Olsufyeva, E.N., Solovieva, S.E. and Preobrazhenskaya, M.N. (2006),

21

Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics. Antiviral Research, 72 (1), 20-33.

318. Qian, C., Qin, D., Tang, Q., Zeng, Y., Tang, G.X. and Lu, C. (2006), Identification of a B-cell antigenic epitope at the N-terminus of SARS-CoV M protein and characterization of monoclonal antibody against the protein. Virus Genes, 33 (2), 147-156.

319. Du, L.Y., He, Y.X., Wang, Y.J., Zhang, H.J., Ma, S., Wong, C.K.L., Wu, S.H.W., Ng, F., Huang, J.D., Yuen, K.Y., Jiang, S.B., Zhou, Y.S. and Zheng, B.J. (2006), Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines. Virology, 353 (1), 6-16.

320. Masters, P.S. (2006), The molecular biology of coronaviruses. Advances in Virus Research, Vol 66, 66), 193-292.

321. Leung, D.T.M., van Maren, W.W.C., Chan, F.K.L., Chan, W.S., Lo, A.W.I., Ma, C.H., Tam, F.C.H., To, K.F., Chan, P.K.S., Sung, J.J.Y. and Lim, P.L. (2006), Extremely low exposure of a community to severe acute respiratory syndrome coronavirus: False seropositivity due to use of bacterially derived antigen. Journal of Virology, 80 (18), 8920-8928.

322. Chan, C.P., Siu, K.L., Chin, K.T., Yuen, K.Y., Zheng, B.J. and Jin, D.Y. (2006), Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein. Journal of Virology, 80 (18), 9279-9287.

323. Tripet, B., Kao, D.J., Jeffers, S.A., Holmes, K.V. and Hodges, R.S. (2006), Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus. Journal of Structural Biology, 155 (2), 176-194.

324. Haagmans, B.L. and Osterhaus, A.D.M.E. (2006), Coronaviruses and their therapy. Antiviral Research, 71 (2-3), 397-403.

325. Chu, D.K.W., Poon, L.L.M., Chan, K.H., Chen, H., Guan, Y., Yuen, K.Y. and Peiris, J.S.M. (2006), Coronaviruses in bent-winged bats (Miniopterus spp.). Journal of General Virology, 87), 2461-2466.

326. Smuts, H. and Hardie, D. (2006), Human bocavirus in hospitalized children, South Africa. Emerging Infectious Diseases, 12 (9), 1457-1458.

327. Chang, H.L., Chen, K.T., Lai, S.K., Kuo, H.W., Su, I.J., Lin, R.S. and Sung, F.C. (2006), Hematological and biochemical factors predicting SARS fatality in Taiwan. Journal of the Formosan Medical Association, 105 (6), 439-450.

328. Zhou, M.H., Xu, D.P., Li, X.J., Li, H.T., Shan, M., Tang, J.R., Wang, M., Wang, F.S., Zhu, X.D., Tao, H., He, W., Tien, P. and Gao, G.F. (2006), Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. Journal of Immunology, 177 (4), 2138-2145.

329. Ishii, K., Hasegawa, H., Nagata, N., Mizutani, T., Morikawa, S., Suzuki, T., Taguchi, F., Tashiro, M., Takemori, T., Miyamura, T. and Tsunetsugu-Yokota, Y. (2006), Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. Virology, 351 (2), 368-380.

330. Peng, H., Yang, L.T., Wang, L.Y., Li, J., Huang, J., Lu, Z.Q., Koup, R.A., Bailer, R.T. and Wu, C.Y. (2006), Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology, 351 (2), 466-475.

331. Schroeder, J.A., Gelderblom, H.R., Hauroeder, B., Schmetz, C., Milios, J. and Hofstaedter, F. (2006), Microwave-assisted tissue processing for same-day EM-diagnosis of potential bioterrorism and clinical samples. Micron, 37 (6), 577-590.

332. Yang, S., Chen, S.J., Hsu, M.F., Wu, J.D., Tseng, C.T.K., Liu, Y.F., Chen, H.C., Kuo, C.W., Wu, C.S., Chang, L.W., Chen, W.C., Liao, S.Y., Chang, T.Y., Hung, H.H., Shr, H.L., Liu, C.Y., Huang, Y.A., Chang, L.Y., Hsu, J.C., Peters, C.J., Wang, A.H.J. and Hsu, M.C. (2006), Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a

22

potent SARS coronavirus 3CL protease inhibitor. Journal of Medicinal Chemistry, 49 (16), 4971-4980.

333. Yang, L.T., Peng, H., Zhu, Z.L., Li, G., Huang, Z.T., Zhao, Z.X., Koup, R.A., Bailer, R.T. and Wu, C.Y. (2006), Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients. Clinical Immunology, 120 (2), 171-178.

334. Qi, C., Duan, J.Z., Wang, Z.H., Chen, Y.Y., Zhang, P.H., Zhan, L., Yan, X.Y., Cao, W.C. and Jin, G. (2006), Investigation of interaction between two neutralizing monoclonal antibodies and SARS virus using biosensor based on imaging ellipsometry. Biomedical Microdevices, 8 (3), 247-253.

335. Sainz, B., Mossel, E.C., Gallaher, W.R., Wimley, W.C., Peters, C.J., Wilson, R.B. and Garry, R.F. (2006), Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein. Virus Research, 120 (1-2), 146-155.

336. Woo, P.C.Y., Lau, S.K.P., Li, K.S.M., Poon, R.W.S., Wong, B.H.L., Tsoi, H.W., Yip, B.C.K., Huang, Y., Chan, K.H. and Yuen, K.Y. (2006), Molecular diversity of coronaviruses in bats. Virology, 351 (1), 180-187.

337. Subbarao, K. and Roberts, A. (2006), Is there an ideal animal model for SARS? Trends in Microbiology, 14 (7), 299-303.

338. Huang, C., Ito, N., Tseng, C.T.K. and Makino, S. (2006), Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein. Journal of Virology, 80 (15), 7287-7294.

339. Tang, X.C., Zhang, J.X., Zhang, S.Y., Wang, P., Fan, X.H., Li, L.F., Li, G., Dong, B.Q., Liu, W., Cheung, C.L., Xu, K.M., Song, W.J., Vijaykrishna, D., Poon, L.L.M., Peiris, J.S.M., Smith, G.J.D., Chen, H. and Guan, Y. (2006), Prevalence and genetic diversity of coronaviruses in bats from China. Journal of Virology, 80 (15), 7481-7490.

340. Lai, C.W., Chan, Z.R., Yang, D.G., Lo, W.H., Lai, Y.K., Chang, M.D.T. and Hu, Y.C. (2006), Accelerated induction of apoptosis in insect cells by baculovirus-expressed SARS-CoV membrane protein. Febs Letters, 580 (16), 3829-3834.

341. McBryde, E.S., Gibson, G., Pettitt, A.N., Zhang, Y., Zhao, B. and McElwain, D.L.S. (2006), Bayesian modelling of an epidemic of severe acute respiratory syndrome. Bulletin of Mathematical Biology, 68 (4), 889-917.

342. de Haan, C.A.M. and Rottier, P.J.M. (2006), Hosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection. Cellular Microbiology, 8 (8), 1211-1218.

343. Follis, K.E., York, J. and Nunberg, J.H. (2006), Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. Virology, 350 (2), 358-369.

344. Li, F., Berardi, M., Li, W.H., Farzan, M., Dormitzer, P.R. and Harrison, S.C. (2006), Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain. Journal of Virology, 80 (14), 6794-6800.

345. Woo, P.C.Y., Lau, S.K.P., Yip, C.C.Y., Huang, Y., Tsoi, H.W., Chan, K.H. and Yuen, K.Y. (2006), Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1. Journal of Virology, 80 (14), 7136-7145.

346. Spiegel, M., Schneider, K., Weber, F., Weidmann, M. and Hufert, F.T. (2006), Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. Journal of General Virology, 87), 1953-1960.

347. Yang, J.K., Feng, Y., Yuan, M.Y., Yuan, S.Y., Fu, H.J., Wu, B.Y., Sun, G.Z., Yang, G.R., Zhang, X.L., Wang, L., Xu, X., Xu, X.P. and Chan, J.C.N. (2006), Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabetic Medicine , 23 (6), 623-628.

23

348. Han, D.P., Penn-Nicholson, A. and Cho, M.W. (2006), Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology, 350 (1), 15-25.

349. Huang, J., Ma, R. and Wu, C.Y. (2006), Immunization with SARS-CoV S DNA vaccine generates memory CD4(+) and CD8(+) T cell immune responses. Vaccine, 24 (23), 4905-4913.

350. He, Y.X., Li, J.J., Du, L.Y., Yan, X.X., Hu, G.G., Zhou, Y.S. and Jiang, S.B. (2006), Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccine. Vaccine, 24 (26), 5498-5508.

351. Lau, S.K.P., Woo, P.C.Y., Yip, C.C.Y., Tse, H., Tsoi, H.W., Cheng, V.C.C., Lee, P., Tang, B.S.F., Cheung, C.H.Y., Lee, R.A., So, L.Y., Lau, Y.L., Chan, K.H. and Yuen, K.Y. (2006), Coronavirus HKU1 and other coronavirus infections in Hong Kong. Journal of Clinical Microbiology, 44 (6), 2063-2071.

352. Liang, P.H. (2006), Characterization and inhibition of SARS-coronavirus main protease. Current Topics in Medicinal Chemistry , 6 (4), 361-376.

353. Chen, M.I.C., Leo, Y.S., Ang, B.S.P., Heng, B.H. and Choo, P. (2006), The outbreak of SARS at Tan Tock Seng hospital - Relating epidemiology to control. Annals Academy of Medicine Singapore, 35 (5), 317-325.

354. Leong, H.N., Earnest, A., Lim, H.H., Chin, C.F., Tan, C.S.H., Puhaindran, M.E., Tan, A.C.H., Chen, M.I.C. and Leo, Y.S. (2006), SARS in Singapore - Predictors of disease severity. Annals Academy of Medicine Singapore, 35 (5), 326-331.

355. Leong, H.N., Chan, K.P., Oon, L.L.E., Koay, E.S.C., Ng, L.C., Lee, M.A., Barkham, T., Chen, M.I.C., Heng, B.H., Ling, A.E. and Leo, Y.S. (2006), Clinical and laboratory findings of SARS in Singapore. Annals Academy of Medicine Singapore, 35 (5), 332-339.

356. Lim, W., Ng, K.C. and Tsang, D.N.C. (2006), Laboratory containment of SARS virus. Annals Academy of Medicine Singapore, 35 (5), 354-360.

357. Tai, D.Y.H. (2006), SARS: how to manage future outbreaks? Annals Academy of Medicine Singapore, 35 (5), 368-373.

358. He, Y.X., Li, J.J., Heck, S., Lustigman, S. and Jiang, S.B. (2006), Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: Implication for vaccine design. Journal of Virology, 80 (12), 5757-5767.

359. Snijder, E.J., van der Meer, Y., Zevenhoven-Dobbe, J., Onderwater, J.J.M., van der Meulen, J., Koerten, H.K. and Mommaas, A.M. (2006), Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. Journal of Virology, 80 (12), 5927-5940.

360. Pasternak, A.O., Spaan, W.J.M. and Snijder, E.J. (2006), Nidovirus transcription: how to make sense ... ? Journal of General Virology, 87), 1403-1421.

361. Lee, P.P.W., Wong, W.H.S., Leung, G.M., Chiu, S.S., Chan, K.H., Peiris, J.S.M., Lam, T.H. and Lau, Y.L. (2006), Risk-stratified seroprevalence of severe acute respiratory syndrome coronavirus among children in Hong Kong. Pediatrics, 117 (6), E1156-E1162.

362. Gerna, G., Campanini, G., Rovida, F., Percivalle, E., Sarasini, A., Marchi, A. and Baldanti, F. (2006), Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. Journal of Medical Virology, 78 (7), 938-949.

363. Prabakaran, P., Gan, J.H., Feng, Y., Zhu, Z.Y., Choudhry, V., Xiao, X.D., Ji, X.H. and Dimitrov, D.S. (2006), Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. Journal of Biological Chemistry, 281 (23), 15829-15836.

24

364. Jamieson, D.J., Ellis, J.E., Jernigan, D.B. and Treadwell, T.A. (2006), Emerging infectious disease outbreaks: Old lessons and new challenges for obstetrician-gynecologists. American Journal of Obstetrics and Gynecology, 194 (6), 1546-1555.

365. Chong, W.P., Ip, W.E., Tso, G.H.W., Ng, M.W., Wong, W.H.S., Law, H.K.W., Yung, R.W.H., Chow, E.Y., Au, K.L., Chan, T., Lim, W., Peiris, J.S.M. and Lau, Y.L. (2006), The interferon gamma gene polymorphism+874 A/T is associated with severe acute respiratory syndrome. Bmc Infectious Diseases, 6.

366. Chu, W.C.W., Li, A.M., Ng, A.W.H., So, H.K., Lam, W.W.M., Lo, K.L., Yeung, M.C.A., Yau, Y.S., Chiu, W.K., Leung, C.W., Ng, P.C., Hon, K.L., Mo, K.W., Fok, T.F. and Ahuja, A.T. (2006), Thin-section CT 12 months after the diagnosis of severe acute respiratory syndrome in pediatric patients. American Journal of Roentgenology, 186 (6), 1707-1714.

367. He, Y.X., Li, J.J., Li, W.H., Lustigman, S., Farzan, M. and Jiang, S.B. (2006), Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. Journal of Immunology, 176 (10), 6085-6092.

368. Yuan, X.L., Shan, Y.J., Yao, Z.Y., Li, J.Y., Zhao, Z.H., Chen, J.P. and Cong, Y.W. (2006), Mitochondrial location of severe acute respiratory syndrome coronavirus 3B protein. Molecules and Cells, 21 (2), 186-191.

369. Tarnovitski, N., Matthews, L.J., Sui, J.H., Gershoni, J.M. and Marasco, W.A. (2006), Mapping a neutralizing epitope on the SARS coronavirus spike protein: Computational prediction based on affinity-selected peptides. Journal of Molecular Biology, 359 (1), 190-201.

370. Chang, Z. and Hu, J. (2006), Can siRNAs conquer SARS? Gene Therapy, 13 (11), 871-872.371. He, M.L., Zheng, B.J., Chen, Y., Wong, K.L., Huang, J.D., Lin, M.C., Peng, Y., Yuen, K.Y.,

Sung, J.J.Y. and Kung, H.F. (2006), Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus. Febs Letters, 580 (10), 2414-2420.

372. Liu, J.Y., Shao, H.X., Tao, Y.L., Yang, B., Qian, L.S., Yang, X.L., Cao, B., Hu, G.X., Tachibana, H. and Cheng, X.J. (2006), Production of an anti-severe acute respiratory syndrome (SARS) coronavirus human monoclonal antibody Fab fragment by using a combinatorial immunoglobulin gene library derived from patients who recovered from SARS. Clinical and Vaccine Immunology, 13 (5), 594-597.

373. Biot, C., Daher, W., Chavain, N., Fandeur, T., Khalife, J., Dive, D. and De Clercq, E. (2006), Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. Journal of Medicinal Chemistry, 49 (9), 2845-2849.

374. He, Y.X., Li, J.J. and Jiang, S.B. (2006), A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity. Biochemical and Biophysical Research Communications, 344 (1), 106-113.

375. Zhou, Z.M., Post, P., Chubet, R., Holtz, K., McPherson, C., Petric, M. and Cox, M. (2006), A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice. Vaccine, 24 (17), 3624-3631.

376. Nicholls, J.M., Butany, J., Poon, L.L.M., Chan, K.H., Beh, S.L., Poutanen, S., Peiris, J.S.M. and Wong, M. (2006), Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. Plos Medicine, 3 (2), 222-229.

377. Chu, L.H.M., Choy, W.Y., Tsai, S.N., Rao, Z.H. and Ngai, S.M. (2006), Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Protein Science, 15 (4), 699-709.

378. Maache, M., Komurian-Pradel, F., Rajoharison, A., Perret, M., Berland, J.L., Pouzol, S., Bagnaud, A., Duverger, B., Xu, J.G., Osuna, A. and Paranhos-Baccala, G. (2006), False-

25

positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based Western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV. Clinical and Vaccine Immunology, 13 (3), 409-414.

379. Zhu, H., Hu, S.H., Jona, G., Zhu, X.W., Kreiswirth, N., Willey, B.M., Mazzulli, T., Liu, G.Z., Song, Q.F., Chen, P., Cameron, M., Tyler, A., Wang, J., Wen, J., Chen, W.J., Compton, S. and Snyder, M. (2006), Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proceedings of the National Academy of Sciences of the United States of America, 103 (11), 4011-4016.

380. Wu, C.Y., King, K.Y., Kuo, C.J., Fang, J.M., Wu, Y.T., Ho, M.Y., Liao, C.L., Shie, J.J., Liang, P.H. and Wong, C.H. (2006), Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease. Chemistry & Biology, 13 (3), 261-268.

381. Duan, J.Z., Ji, X., Feng, J., Han, W., Zhang, P.H., Cao, W.C., Guo, X.M., Qi, C., Yang, D.L., Jin, G., Gao, G.X. and Yan, X.Y. (2006), A human neutralizing antibody against a conformational epitope shared by oligomeric SARS S1 protein. Antiviral Therapy, 11 (1), 117-123.

382. Lin, K., Fong, D.Y.K., Zhu, B.L. and Karlberg, J. (2006), Environmental factors on the SARS epidemic: air temperature, passage of time and multiplicative effect of hospital infection. Epidemiology and Infection, 134 (2), 223-230.

383. Kim, O.J., Lee, D.H. and Lee, C.H. (2006), Close relationship between SARS-coronavirus and group 2 coronavirus. Journal of Microbiology, 44 (1), 83-91.

384. Kariwa, H., Fujii, N. and Takashima, K. (2006), Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology, 212), 119-123.

385. Reghunathan, R., Jayapal, M., Hsu, L.Y., Chng, H.H., Tai, D., Leung, B.P. and Melendez, A.J. (2005), Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. Bmc Immunology, 6.

386. Khattari, Z., Brotons, G., Akkawi, M., Arbely, E., Arkin, I.T. and Salditt, T. (2006), SARS coronavirus E protein in phospholipid bilayers: An X-ray study. Biophysical Journal, 90 (6), 2038-2050.

387. Huang, Y.P. and Wang, C.H. (2006), Development of attenuated vaccines from Taiwanese infectious bronchitis virus strains. Vaccine, 24 (6), 785-791.

388. Chang, C.Y., Hong, W.W.L., Chong, P.L. and Wu, S.C. (2006), Influence of intron and exon splicing enhancers on mammalian cell expression of a truncated spike protein of SARS-CoV and its implication for subunit vaccine development. Vaccine, 24 (8), 1132-1141.

389. Ali, S.H. and Keil, R. (2006), Global cities and the spread of infectious disease: The case of severe acute respiratory syndrome (SARS) in Toronto, Canada. Urban Studies, 43 (3), 491-509.

390. Mo, H.Y., Zeng, G.Q., Ren, X.L., Li, H., Ke, C.W., Tan, Y.X., Cai, C.D., Lai, K.F., Chen, R.C., Chan-Yeung, M.R. and Zhong, N.S. (2006), Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. Respirology, 11 (1), 49-53.

391. Kahn, J.S. (2006), The widening scope of coronaviruses. Current Opinion in Pediatrics, 18 (1), 42-47.

392. Oostra, M., de Haan, C.A.M., de Groot, R.J. and Rottier, P.J.M. (2006), Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M. Journal of Virology, 80 (5), 2326-2336.

393. Chen, Y.M.A., Liang, S.Y., Shih, Y.P., Chen, C.Y., Lee, Y.M., Chang, L., Jung, S.Y., Ho, M.S., Liang, K.Y., Chen, H.Y., Chan, Y.J. and Chu, D.C. (2006), Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital

26

with the highest nosocomial infection rate in Taiwan in 2003. Journal of Clinical Microbiology, 44 (2), 359-365.

394. Wu, C.J. and Chan, Y.L. (2006), Antiviral applications of RNAi for coronavirus. Expert Opinion on Investigational Drugs, 15 (2), 89-97.

395. Sakudo, A., Suganuma, Y., Kobayashi, T., Onodera, T. and Ikuta, K. (2006), Near-infrared spectroscopy: Promising diagnostic tool for viral infections. Biochemical and Biophysical Research Communications, 341 (2), 279-284.

396. Ho, T.Y., Wu, S.L., Chen, J.C., Wei, Y.C., Cheng, S.E., Changa, Y.H., Liu, H.J. and Hsiang, C.Y. (2006), Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Research, 69 (2), 70-76.

397. Spruth, M., Kistner, O., Savidis-Dacho, H., Hitter, E., Crowe, B., Gerencer, M., Bruhl, P., Grillberger, L., Reiter, M., Tauer, C., Mundt, W. and Barrett, P.N. (2006), A double-inactivated whole virus candidate SARS coronavirus vaccine. Vaccine, 24 (5), 652-661.

398. Balzarini, J., Keyaerts, E., Vijgen, L., Vandermeer, F., Stevens, M., De Clercq, E., Egberink, H. and Van Ranst, M. (2006), Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture. Journal of Antimicrobial Chemotherapy, 57 (3), 472-481.

399. Huang, C., Narayanan, K., Ito, N., Peters, C.J. and Makino, S. (2006), Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells. Journal of Virology, 80 (1), 210-217.

400. Broer, R., Boson, B., Spaan, W., Cosset, F.L. and Corver, J. (2006), Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry. Journal of Virology, 80 (3), 1302-1310.

401. Zhong, X.F., Guo, Z.F., Yang, H.H., Peng, L.S., Xie, Y., Wong, T.Y., Lai, S.T. and Guo, Z.H. (2006), Amino terminus of the SARS coronavirus protein 3a elicits strong, potentially protective humoral responses in infected patients. Journal of General Virology, 87), 369-374.

402. Keyaerts, E., Vijgen, L., Maes, P., Duson, G., Neyts, J. and Van Ranst, M. (2006), Viral load quantitation of SARS-coronavirus RNA using a one-step real-time RT-PCR. International Journal of Infectious Diseases, 10 (1), 32-37.

403. Barkham, T.M., Chung, Y.K., Tang, K.F. and Ooi, E.E. (2006), The performance of RT-PCR compared with a rapid serological assay for acute dengue fever in a diagnostic laboratory. Transactions of the Royal Society of Tropical Medicine and Hygiene, 100 (2), 142-148.

404. Huang, C.Y., Sun, C.T., Hsieh, J.L., Chen, Y.M.A. and Lin, H.L. (2005), A novel small-world model: Using social mirror identities for epidemic simulations. Simulation-Transactions of the Society for Modeling and Simulation International, 81 (10), 671-699.

405. Kaye, M., Druce, J., Tran, T., Kostecki, R., Chibo, D., Morris, J., Catton, M. and Birch, C. (2006), SARS-associated coronavirus replication in cell lines. Emerging Infectious Diseases, 12 (1), 128-133.

406. Veiga, S., Yuan, Y.Y., Li, X.Q., Santos, N.C., Liu, G. and Castanho, M.A.R.B. (2006), Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions. Biochimica et Biophysica Acta-General Subjects, 1760 (1), 55-61.

407. Girard, M.P., Cherian, T., Pervikov, Y. and Kieny, M.P. (2005), A review of vaccine research and development: Human acute respiratory infections. Vaccine, 23 (50), 5708-5724.

408. Shaw, K. (2006), The 2003 SARS outbreak and its impact on infection control practices. Public Health, 120 (1), 8-14.

409. Chan, V.S.F., Chan, K.Y.K., Chen, Y.X., Poon, L.L.M., Cheung, A.N.Y., Zheng, B.J., Chan, K.H., Mak, W., Ngan, H.Y.S., Xu, X.N., Screaton, G., Tam, P.K.H., Austyn, J.M., Chan, L.C., Yip, S.P., Peiris, M., Khoo, U.S. and Lin, C.L.S. (2006), Homozygous L-SIGN

27

(CLEC4M) plays a protective role in SARS coronavirus infection. Nature Genetics, 38 (1), 38-46.

410. Chow, K.Y.C., Yeung, Y.S., Hon, C.C., Zeng, F.Y., Law, K.M. and Leung, F.C.C. (2005), Adenovirus-mediated expression of the C-terminal domain of SARS-CoV spike protein is sufficient to induce apoptosis in Vero E6 cells. Febs Letters, 579 (30), 6699-6704.

411. Bartlam, M., Yang, H.T. and Rao, Z.H. (2005), Structural insights into SARS coronavirus proteins. Current Opinion in Structural Biology, 15 (6), 664-672.

412. Yang, X.L. and Sun, X.D. (2005), Chemiluminescent immunometric detection of SARS-CoV in sera as an early marker for the diagnosis of SARS. Bioluminescence & Chemiluminescence: Progress and Perspectives, ), 491-494.

413. Wang, M., Yan, M.Y., Xu, H.F., Liang, W., Kan, B., Zheng, B.J., Chen, H.L., Zheng, H., Xu, Y.M., Zhang, E.M., Wang, H.X., Ye, J.R., Li, G.C., Li, M.C., Cui, Z.G., Liu, Y.F., Guo, R.T., Liu, X.N., Zhan, L.H., Zhou, D.H., Zhao, A.L., Hai, R., Yu, D.Z., Guan, Y. and Xu, J.G. (2005), SARS-CoV infection in a restaurant from palm civet. Emerging Infectious Diseases, 11 (12), 1860-1865.

414. Stadler, K. and Rappoli, R. (2005), SARS: Understanding the virus and development of rational therapy. Current Molecular Medicine, 5 (7), 677-697.

415. Timani, K.A., Liao, Q.J., Ye, L.B., Zeng, Y.C., Liu, J., Zheng, Y., Ye, L., Yang, X.J., Kong, L.B., Gao, J.R. and Zhu, Y. (2005), Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus. Virus Research, 114 (1-2), 23-34.

416. Yuan, X.L., Yao, Z.Y., Shan, Y.J., Chen, B., Yang, Z., Wu, J., Zhao, Z.H., Chen, J.P. and Cong, Y.W. (2005), Nucleolar localization of non-structural protein 3b, a protein specifically encoded by the severe acute respiratory syndrome coronavirus. Virus Research, 114 (1-2), 70-79.

417. Oxford, J.S., Manuguerra, C., Kistner, O., Linde, A., Kunze, M., Lange, W., Schweiger, B., Spala, G., de Andrade, H.R., Brena, P.R.P., Beytout, J., Brydak, L., de Stefano, D.C., Hungnes, O., Kyncl, J., Montomoli, E., de Miguel, A.G., Vranckx, R. and Osterhaus, A. (2005), A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines. Vaccine, 23 (46-47), 5440-5449.

418. Zhang, L.Q., Zhang, F.W., Yu, W.J., He, T., Yu, J., Yi, C.E., Ba, L., Li, W.H., Farzan, M., Chen, Z.W., Yuen, K.Y. and Ho, D. (2006), Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. Journal of Medical Virology, 78 (1), 1-8.

419. Cheng, M., Chan, C.W.L., Cheung, R.C.F., Bikkavilli, R.K., Zhao, Q., Au, S.W.N., Chan, P.K.S., Lee, S.S.T., Cheng, G., Ho, W.K.K. and Cheung, W.T. (2005), Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11. Biochemical and Biophysical Research Communications, 338 (3), 1654-1660.

420. Saikatendu, K.S., Joseph, J.S., Subramanian, V., Clayton, T., Griffith, M., Moy, K., Velasquez, J., Neuman, B.W., Buchmeier, M.J., Stevens, R.C. and Kuhn, P. (2005), Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1 ''-phosphate dephosphorylation by a conserved domain of nsP3. Structure, 13 (11), 1665-1675.

421. Rua, R.H., Tong, G.Z., Wang, Y.F. and Zhou, Y.J. (2005), Expression and antigenic epitopes mapping of receptor binding domain on the spike protein of severe acute respiratory syndrome coronavirus. Progress in Biochemistry and Biophysics, 32 (11), 1030-1037.

422. Li, Y.H., Li, J., Liu, X.E., Wang, L., Li, T., Zhou, Y.H. and Zhuang, H. (2005), Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: Comparison with results of other viral markers. Journal of Virological Methods, 130 (1-2), 45-50.

423. He, Z.P., Zhao, C.H., Dong, Q.M., Zhuang, H., Song, S.J., Peng, G. and Dwyer, D.E. (2005), Effects of severe acute respiratory syndrome (SARS) coronavirus infection on

28

peripheral blood lymphocytes and their subsets. International Journal of Infectious Diseases, 9 (6), 323-330.

424. Luo, H.B., Ye, F., Chen, K.X., Shen, X. and Jiang, H.L. (2005), SR-rich motif plays a pivotal role in recombinant SARS coronavirus nucleocapsid protein multimerization. Biochemistry, 44 (46), 15351-15358.

425. Wong, S.S.Y. and Yuen, K.Y. (2005), The severe acute respiratory syndrome (SARS). Journal of Neurovirology, 11 (5), 455-468.

426. Mahony, J.B. and Richardson, S. (2005), Molecular diagnosis of severe acute respiratory syndrome - The state of the art. Journal of Molecular Diagnostics, 7 (5), 551-559.

427. Yang, A.C.C., Goldberger, A.L. and Peng, C.K. (2005), Genomic classification using an information-based similarity index: Application to the SARS coronavirus. Journal of Computational Biology, 12 (8), 1103-1116.

428. Lai, S.C., Chong, P.C.S., Yeh, C.T., Liu, L.S.J., Jan, J.T., Chi, H.Y., Liu, H.W., Chen, A. and Wang, Y.C. (2005), Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV). Journal of Biomedical Science, 12 (5), 711-727.

429. Chan, K.H., Cheng, V.C.C., Woo, P.C.Y., Lau, S.K.P., Poon, L.L.M., Guan, Y., Seto, W.H., Yuen, K.Y. and Peiris, J.S.M. (2005), Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clinical and Diagnostic Laboratory Immunology, 12 (11), 1317-1321.

430. Lin, S.M., Lee, C.K., Lee, S.Y., Kao, C.L., Lin, C.W., Wang, A.B., Hsu, S.M. and Huang, L.S. (2005), Surface ultrastructure of SARS coronavirus revealed by atomic force microscopy. Cellular Microbiology, 7 (12), 1763-1770.

431. Zhai, Y.J., Sun, F., Li, X.M., Pang, H., Xu, X.L., Bartlam, M. and Rao, Z.H. (2005), Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer. Nature Structural & Molecular Biology, 12 (11), 980-986.

432. Lee, T.W., Cherney, M.M., Huitema, C., Liu, J., James, K.E., Powers, J.C., Eltis, L.D. and James, M.N.G. (2005), Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. Journal of Molecular Biology, 353 (5), 1137-1151.

433. Hong, N., Du, X.K., Nie, Z.S. and Li, S.J. (2005), Diffusion-weighted MR study of femoral head avascular necrosis in severe acute respiratory syndrome patients. Journal of Magnetic Resonance Imaging, 22 (5), 661-664.

434. Martina, E., Stiefl, N., Degel, B., Schulz, F., Breuning, A., Schiller, M., Vicik, R., Baumann, K., Ziebuhr, J. and Schirmeister, T. (2005), Screening of electrophilic compounds yields an aziridin, as new active-site directed SARS-CoV main protease inhibitor. Bioorganic & Medicinal Chemistry Letters, 15 (24), 5365-5369.

435. Kong, W.P., Xu, L., Stadler, K., Ulmer, J.B., Abrignani, S., Rappuoli, R. and Nabel, G.J. (2005), Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization. Journal of Virology, 79 (22), 13915-13923.

436. Ghosh, A.K., Xi, K., Ratia, K., Santarsiero, B.D., Fu, W.T., Harcourt, B.H., Rota, P.A., Baker, S.C., Johnson, M.E. and Mesecar, A.D. (2005), Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors. Journal of Medicinal Chemistry , 48 (22), 6767-6771.

437. Kaeppler, U., Stiefl, N., Schiller, M., Vicik, R., Breuning, A., Schmitz, W., Rupprecht, D., Schmuck, C., Baumann, K., Ziebuhr, J. and Schirmeister, T. (2005), A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods. Journal of Medicinal Chemistry, 48 (22), 6832-6842.

29

438. Woo, P.C.Y., Lau, S.K.P., Tsoi, H.W., Huang, Y., Poon, R.W.S., Chu, C.M., Lee, R.A., Luk, W.K., Wong, G.K.M., Wong, B.H.L., Cheng, V.C.C., Tang, B.S.F., Wu, A.K.L., Yung, R.W.H., Chen, H.L., Guan, Y., Chan, K.H. and Yuen, K.Y. (2005), Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. Journal of Infectious Diseases, 192 (11), 1898-1907.

439. Li, A.M. and Ng, P.C. (2005), Severe acute respiratory syndrome (SARS) in neonates and children. Archives of Disease in Childhood-Fetal and Neonatal Edition, 90 (6), F461-F465.

440. Li, W.D., Shi, Z.L., Yu, M., Ren, W.Z., Smith, C., Epstein, J.H., Wang, H.Z., Crameri, G., Hu, Z.H., Zhang, H.J., Zhang, J.H., McEachern, J., Field, H., Daszak, P., Eaton, B.T., Zhang, S.Y. and Wang, L.F. (2005), Bats are natural reservoirs of SARS-like coronaviruses. Science, 310 (5748), 676-679.

441. van den Born, E., Stein, D.A., Iversen, P.L. and Snijder, E.J. (2005), Antiviral activity of morpholino oligomers designed to block various aspects of Equine arteritis virus amplification in cell culture. Journal of General Virology, 86), 3081-3090.

442. Yeh, K.M., Chiueh, T.S., Siu, L.K., Lin, J.C., Chan, P.K.S., Peng, M.Y., Wan, H.L., Chen, J.H., Hu, B.S., Perng, C.L., Lu, J.J. and Chang, F.Y. (2005), Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital. Journal of Antimicrobial Chemotherapy, 56 (5), 919-922.

443. Lee, Y.S., Chen, C.H., Chao, A., Chen, E.S., Wei, M.L., Chen, L.K., Yang, K.D.D., Lin, M.C., Wang, Y.H., Liu, J.W., Eng, H.L., Chiang, P.C., Wu, T.S., Tsao, K.C., Huang, C.G., Tien, Y.J., Wang, T.H., Wang, H.S. and Lee, Y.S. (2005), Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV). Bmc Genomics, 6.

444. Petit, C.M., Melancon, J.M., Chouljenko, V.N., Colgrove, R., Farzan, M., Knipe, D.M. and Kousoulas, K.G. (2005), Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion. Virology, 341 (2), 215-230.

445. Ziegler, T., Matikainen, S., Ronkko, E., Osterlund, P., Sillanpaa, M., Siren, J., Fagerlund, R., Immonen, M., Melen, K. and Julkunen, L. (2005), Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells. Journal of Virology, 79 (21), 13800-13805.

446. Lai, S.T. (2005), Treatment of severe acute respiratory syndrome. European Journal of Clinical Microbiology & Infectious Diseases, 24 (9), 583-591.

447. Bauch, C.T., Lloyd-Smith, J.O., Coffee, M.P. and Galvani, A.P. (2005), Dynamically modeling SARS and other newly emerging respiratory illnesses - Past, present, and future. Epidemiology, 16 (6), 791-801.

448. Chui, L., Drebot, M., Andonov, A., Petrich, A., Glushek, M. and Mahony, J. (2005), Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods. Diagnostic Microbiology and Infectious Disease, 53 (1), 47-55.

449. Theron, M., Huang, K.J., Chen, Y.W., Liu, C.C. and Lei, H.Y. (2005), A probable role for IFN-gamma in the development of a lung immunopathology in SARS. Cytokine, 32 (1), 30-38.

450. Woo, P.C.Y., Lau, S.K.P., Huang, Y., Tsoi, H.W., Chan, K.H. and Yuen, K.Y. (2005), Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia. Archives of Virology, 150 (11), 2299-2311.

451. Scagnolari, C., Vicenzi, E., Bellomi, F., Stillitano, M.G., Pinna, D., Poli, G., Clementi, M., Dianzani, F. and Antonelli, G. (2004), Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antiviral Therapy, 9 (6), 1003-1011.

452. Follis, K.E., York, J. and Nunberg, J.H. (2005), Serine-scanning mutagenesis studies of the C-terminal heptad repeats in the SARS coronavirus S glycoprotein highlight the important role of the short helical region. Virology, 341 (1), 122-129.

30

453. Yang, H.T., Xie, W.Q., Xue, X.Y., Yang, K.L., Ma, J., Liang, W.X., Zhao, Q., Zhou, Z., Pei, D.Q., Ziebuhr, J., Hilgenfeld, R., Yuen, K.Y., Wong, L., Gao, G.X., Chen, S.J., Chen, Z., Ma, D.W., Bartlam, M. and Rao, Z. (2005), Design of wide-spectrum inhibitors targeting coronavirus main proteases. Plos Biology, 3 (10), 1742-1752.

454. Woo, P.C.Y., Huang, Y., Lau, S.K.P., Tsoi, H.W. and Yuen, K.Y. (2005), In silico analysis of ORF1ab in coronavirus HKU1 genome reveals a unique putative cleavage site of coronavirus HKU13C-like protease. Microbiology and Immunology, 49 (10), 899-908.

455. O'Brien, S.J. and Johnson, W.E. (2005), Big cat genomics. Annual Review of Genomics and Human Genetics, 6), 407-429.

456. Woo, P.C.Y., Lau, S.K.P., Tsoi, H.W., Chen, Z.W., Wong, B.H.L., Zhang, L.Q., Chan, J.K.H., Wong, L.P., He, W., Ma, C., Chan, K.H., Ho, D.D. and Yuen, K.Y. (2005), SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine, 23 (42), 4959-4968.

457. Lau, S.K.P., Woo, P.C.Y., Li, K.S.M., Huang, Y., Tsoi, H.W., Wong, B.H.L., Wong, S.S.Y., Leung, S.Y., Chan, K.H. and Yuen, K.Y. (2005), Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proceedings of the National Academy of Sciences of the United States of America, 102 (39), 14040-14045.

458. Tsao, K.C., Chen, G.W., Huang, C.G., Huang, Y.L., Lin, J.Y., Keng, M.C., Sun, C.F. and Shih, S.R. (2005), False positive antibody results against human T-cell lymphotropic virus in patients with severe acute respiratory syndrome. Journal of Medical Virology, 77 (3), 331-336.

459. Bivas-Benita, M., Ottenhoff, T.H.M., Junginger, H.E. and Borchard, G. (2005), Pulmonary DNA vaccination: Concepts, possibilities and perspectives. Journal of Controlled Release, 107 (1), 1-29.

460. Gramberg, T., Hofmann, H., Moller, P., Lalor, P.F., Marzi, A., Geier, M., Krumbiegel, M., Winkler, T., Kirchhoff, F., Adams, D.H., Becker, S., Munch, J. and Pohlmann, S. (2005), LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology, 340 (2), 224-236.

461. Kao, H.K., Wang, J.H., Sung, C.S., Huang, Y.C. and Lien, T.C. (2005), Pneumothorax and mortality in the mechanically ventilated SARS patients: a prospective clinical study. Critical Care, 9 (4), R440-R445.

462. Yip, S.P., To, S.S.T., Leung, P.H.M., Cheung, T.S., Cheng, P.K.C. and Lim, W.W.L. (2005), Use of dual TaqMan probes to increase the sensitivity of 1-step quantitative reverse transcription-PCR: Application to the detection of SARS coronavirus. Clinical Chemistry, 51 (10), 1885-1888.

463. Arroliga, A.C., az-Guzman, E. and Wiedemann, H.P. (2005), Severe acute respiratory syndrome, pulmonary function tests, and quality,of life - Lessons learned. Chest, 128 (3), 1088-1089.

464. Law, H.K.W., Cheung, C.Y., Ng, H.Y., Sia, S.F., Chan, Y.O., Luk, W., Nicholls, J.M., Peiris, J.S.M. and Lau, Y.L. (2005), Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood, 106 (7), 2366-2374.

465. Zhang, H.X., Zhou, G.Q., Zhi, L.T., Yang, H., Zhai, Y., Dong, X.J., Zhang, X.M., Gao, X., Zhu, Y.P. and He, F.C. (2005), Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. Journal of Infectious Diseases, 192 (8), 1355-1361.

466. Lau, S.K.P., To, W.K., Tse, P.W.T., Chan, A.K.H., Woo, P.C.Y., Tsoi, H., Leung, A.F.Y., Li, K.S.M., Chan, P.K.S., Lim, W.W.L., Yung, R.W.H., Chan, K.H. and Yuen, K.Y. (2005), Human parainfluenza virus 4 outbreak and the role of diagnostic tests. Journal of Clinical Microbiology, 43 (9), 4515-4521.

467. Li, F., Li, W.H., Farzan, M. and Harrison, S.C. (2005), Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science, 309 (5742), 1864-1868.

31

468. Lopez-Huertas, M.R., Casas, I., costa-Herrera, B., Garcia, M.L., Coiras, M.T. and Perez-Brena, P. (2005), Two RT-PCR based assays to detect human metapneumovirus in nasopharyngeal aspirates. Journal of Virological Methods, 129 (1), 1-7.

469. Niedrig, M., Leitmeyer, K., Lim, W., Peiris, M., Mackenzie, J.S. and Zambon, M. (2005), First external quality assurance of antibody diagnostic for SARS-new coronavirus. Journal of Clinical Virology, 34 (1), 22-25.

470. Chen, L.L., Hsu, C.W., Tian, Y.C. and Fang, J.T. (2005), Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndrome. International Journal of Clinical Practice, 59 (10), 1162-1166.

471. Williams, J.V. (2005), The clinical presentation and outcomes of children infected with newly identified respiratory tract viruses. Infectious Disease Clinics of North America, 19 (3), 569-+.

472. Wang, Z.G., Zheng, Z.H., Shang, L., Li, L.J., Cong, L.M., Feng, M.G., Luo, Y., Cheng, S.Y., Zhang, Y.J., Ru, M.G., Wang, Z.X. and Bao, Q.Y. (2005), Molecular evolution and multilocus sequence typing of 145 strains of SARS-CoV. Febs Letters, 579 (22), 4928-4936.

473. Ward, S.E., Loutfy, M.R., Blatt, L.M., Siminovitch, K.A., Chen, J.B., Hinek, A., Wolff, B., Pham, D.H., Deif, H., Lamere, E.A., Kain, K.C., Farcas, G.A., Ferguson, P., Latchford, M., Levy, G., Fung, L.S., Dennis, J.W., Lai, E.K.Y. and Fish, E.N. (2005), Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids. Antiviral Therapy, 10 (2), 263-275.

474. Zheng, B.J., Guan, Y., He, M.L., Sun, H.Z., Du, L.Y., Zheng, Y., Wong, K.L., Chen, H.L., Chen, Y., Lu, L.Y., Tanner, J.A., Watt, R.M., Niccolai, N., Bernini, A., Spiga, O., Woo, P.C.Y., Kung, H.F., Yuen, K.Y. and Huang, J.D. (2005), Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus. Antiviral Therapy, 10 (3), 393-403.

475. Pinna, D., Sampson-Johannes, A., Clementi, M., Poli, G., Rossini, S., Lin, L. and Vicenzi, E. (2005), Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates. Transfusion Medicine, 15 (4), 269-276.

476. van der Hoek, L., Sure, K., Ihorst, G., Stang, A., Pyrc, K., Jebbink, M.F., Petersen, G., Forster, J., Berkhout, B. and Uberla, K. (2005), Croup is associated with the novel coronavirus NL63. Plos Medicine, 2 (8), 764-770.

477. Li, B.J., Tang, Q.Q., Cheng, D., Qin, C., Xie, F.Y., Wei, Q., Xu, J., Liu, Y.J., Zheng, B.J., Woodle, M.C., Zhong, N.S. and Lu, P.Y. (2005), Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in rhesus macaque. Nature Medicine, 11 (9), 944-951.

478. Yi, C.E., Ba, L., Zhang, L.Q., Ho, D.D. and Chen, Z.W. (2005), Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain. Journal of Virology, 79 (18), 11638-11646.

479. Huang, J.L., Lin, H.T., Wang, Y.M., Yeh, Y.C., Peck, K., Lin, B.L., Liu, H.W., Chen, A. and Lin, C.S. (2005), Rapid and sensitive detection of multiple genes from the SARS-coronavirus using quantitative RT-PCR with dual systems. Journal of Medical Virology, 77 (2), 151-158.

480. Lai, M.Y.Y., Cheng, P.K.C. and Lim, W.W.L. (2005), Survival of severe acute respiratory syndrome coronavirus. Clinical Infectious Diseases, 41 (7), E67-E71.

481. Simon, J.H.M., Claassen, E., Correa, C.E. and Osterhaus, A.D.M.E. (2005), Managing severe acute respiratory syndrome (SARS) intellectual property rights: the possible role of patent pooling. Bulletin of the World Health Organization, 83 (9), 707-710.

482. Hsu, M.F., Kuo, C.J., Chang, K.T., Chang, H.C., Chou, C.C., Ko, T.P., Shr, H.L., Chang, G.G., Wang, A.H.J. and Liang, P.H. (2005), Mechanism of the maturation process of SARS-CoV 3CL protease. Journal of Biological Chemistry, 280 (35), 31257-31266.

32

483. Zheng, B.J., Guan, Y., Tang, Q.Q., Cheng, D., Xie, F.Y., He, M.L., Chan, K.W., Wong, K.L., Lader, E., Woodle, M.C., Lu, P.Y., Li, B.J. and Zhong, N.S. (2004), Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus. Antiviral Therapy, 9 (3), 365-374.

484. Hei, A.L. and Cai, J.P. (2005), Development of a method for concentrating and purifying SARS coronavirus RNA by a magnetic bead capture system. Dna and Cell Biology, 24 (8), 479-484.

485. Liang, L.C., He, C., Lei, M., Li, S.W., Hao, Y.X., Zhu, H. and Duan, Q. (2005), Pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from SARS patients. Dna and Cell Biology, 24 (8), 485-490.

486. Hua, R.H., Wang, Y.F., Bu, Z.G., Zhou, Y.J., Ge, J.Y., Wang, X.J. and Tong, G.Z. (2005), Identification and antigenic epitope mapping of immunodominant region amino residues 510 to 672 on the spike protein of the severe acute respiratory syndrome coronavirus. Dna and Cell Biology, 24 (8), 503-509.

487. Wang, Y.B., Chang, Z.R., Jing, O.Y., Wei, H.Y., Yang, R.Q., Chao, Y.G., Qu, J.G., Wang, J.W. and Hung, T. (2005), Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients. Dna and Cell Biology, 24 (8), 521-527.

488. Shao, C., Hu, D.H., Sun, H.Z., Yan, L.K., Su, Z.M., Wang, R.S., Zhu, W.S., Guo, J.H., Shi, N.Z., Sun, H., Li, Z.S. and Sun, C.C. (2005), Structure exploration and function prediction of SARS coronavirus E protein. Chemical Journal of Chinese Universities-Chinese, 26 (8), 1512-1516.

489. Shie, J.J., Fang, J.M., Kuo, T.H., Kuo, C.J., Liang, P.H., Huang, H.J., Wu, Y.T., Jan, J.T., Cheng, Y.S.E. and Wong, C.H. (2005), Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters. Bioorganic & Medicinal Chemistry, 13 (17), 5240-5252.

490. Lu, S.N., Jiang, D.D.S., Liu, J.W., Lin, M.C., Chen, C.L., Su, I.J. and Chen, S.S. (2005), Outbreak of severe acute respiratory syndrome in Southern Taiwan, 2003. American Journal of Tropical Medicine and Hygiene, 73 (2), 423-427.

491. Kuk, A.Y.C. and Ma, S. (2005), The estimation of SARS incubation distribution from serial interval data using a convolution likelihood. Statistics in Medicine, 24 (16), 2525-2537.

492. Qu, X.X., Hao, P., Song, X.J., Jiang, S.M., Liu, Y.X., Wang, P.G., Rao, X., Song, H.D., Wang, S.Y., Zuo, Y., Zheng, A.H., Luo, M., Wang, H.L., Deng, F., Wang, H.Z., Hu, Z.H., Ding, M.X., Zhao, G.P. and Deng, H.K. (2005), Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy. Journal of Biological Chemistry, 280 (33), 29588-29595.

493. Tripp, R.A., Haynes, L.M., Moore, D., Anderson, B., Tamin, A., Harcourt, B.H., Jones, L.P., Yilla, M., Babcock, G.J., Greenough, T., Ambrosino, D.M., Alvarez, R., Callaway, J., Cavitt, S., Kamrud, K., Alterson, H., Smith, J., Harcourt, J.L., Miao, C., Razdan, R., Comer, J.A., Rollin, P.E., Ksiazek, T.G., Sanchez, A., Rota, P.A., Bellini, W.J. and Anderson, L. (2005), Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. Journal of Virological Methods, 128 (1-2), 21-28.

494. Auyeung, T.W., Lee, J.S.W., Lai, W.K., Choi, C.H., Lee, H.K., Lee, J.S., Li, P.C., Lok, K.H., Ng, Y.Y., Wong, W.M. and Yeung, Y.M. (2005), The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. Journal of Infection, 51 (2), 98-102.

495. Lai, C.W., Chung, Y.C., Lai, Y.K., Chang, M.D.T. and Hu, Y.C. (2005), Expression and purification of N and E proteins from Severe Acute Respiratory Syndrome (SARS)-associated coronavirus: A comparative study. Biotechnology Letters, 27 (13), 883-891.

496. He, Y.X. and Jiang, S.B. (2005), Vaccine design for severe acute respiratory syndrome coronavirus. Viral Immunology, 18 (2), 327-332.

33

497. Ng, D.K., Lau, W.F., Chan, K.K., Pau, B.C., Lam, Y.Y., Chan, E.Y. and Ho, J.C. (2005), Severe acute respiratory syndrome coronavirus infection in children. Pediatrics International, 47 (4), 452-455.

498. Yang, Y.H., Huang, Y.H., Chuang, Y.H., Peng, C.M., Wang, L.C., Lin, Y.T. and Chiang, B.L. (2005), Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection. Journal of Medical Virology, 77 (1), 1-7.

499. Wang, S.X., Sakhatskyy, P., Chou, T.H.W. and Lu, S. (2005), Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV). Journal of Immunological Methods, 301 (1-2), 21-30.

500. Gu, J., Gong, E.C., Zhang, B., Zheng, J., Gao, Z.F., Zhong, Y.F., Zou, W.Z., Zhan, J., Wang, S.L., Xie, Z.G., Zhuang, H., Wu, B.Q., Zhong, H.H., Shao, H.Q., Fang, W.G., Gao, D.S., Pei, F., Li, X.W., He, Z.P., Xu, D.Z., Shi, X.Y., Anderson, V.M. and Leong, A.S.Y. (2005), Multiple organ infection and the pathogenesis of SARS. Journal of Experimental Medicine, 202 (3), 415-424.

501. Ding, L., Zhang, X.X., Wei, P., Fan, K.Q. and Lai, L.H. (2005), The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis. Analytical Biochemistry, 343 (1), 159-165.

502. Woo, P.C.Y., Lau, S.K.P., Wong, B.H.L., Tsoi, H.W., Fung, A.M.Y., Kao, R.Y.T., Chan, K.H., Peiris, J.S.M. and Yuen, K.Y. (2005), Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. Journal of Clinical Microbiology, 43 (7), 3054-3058.

503. Poon, L.L.M., Wong, B.W.Y., Chan, K.H., Ng, S.S.F., Yuen, K.Y., Guan, Y. and Peiris, J.S.M. (2005), Evaluation of real-time reverse transcriptase PCR and real-time loop-mediated amplification assays for severe acute respiratory syndrome - Coronavirus detection. Journal of Clinical Microbiology, 43 (7), 3457-3459.

504. Kogaki, H., Uchida, Y., Fujii, N., Kurano, Y., Miyake, K., Kido, Y., Kariwa, H., Takashima, I., Tamashiro, H., Ling, A.E. and Okada, M. (2005), Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus. Journal of Clinical Laboratory Analysis, 19 (4), 150-159.

505. Yang, M., Ng, M.H. and Li, C.K. (2005), Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology, 10 (2), 101-105.

506. Mandell, L.A. (2005), Etiologies of acute respiratory tract infections. Clinical Infectious Diseases, 41 (4), 503-506.

507. Liang, Y.F., Wan, Y., Qiu, L.W., Zhou, J.G., Ni, B., Guo, B., Zou, Q., Zou, L.Y., Zhou, W., Jia, Z.C., Che, X.Y. and Wu, Y.Z. (2005), Comprehensive antibody epitope mapping of the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus: Insight into the humoral immunity of SARS. Clinical Chemistry, 51 (8), 1382-1396.

508. Lin, Y.S., Lin, C.F., Fang, Y.T., Kuo, Y.M., Liao, P.C., Yeh, T.M., Hwa, K.Y., Shieh, C.C.K., Yen, J.H., Wang, H.J., Su, I.J. and Lei, H.Y. (2005), Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. Clinical and Experimental Immunology, 141 (3), 500-508.

509. Tseng, C.T.K., Tseng, J., Perrone, L., Worthy, M., Popov, V. and Peters, C.J. (2005), Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells. Journal of Virology, 79 (15), 9470-9479.

510. Lau, Y.L. and Peiris, J.S.M. (2005), Pathogenesis of severe acute respiratory syndrome. Current Opinion in Immunology, 17 (4), 404-410.

511. Lai, T.S.T., Ng, T.K., Seto, W.H., Yam, L., Law, K.I. and Chan, J. (2005), Low prevalence of subclinical severe acute respiratory syndrome-associated coronavirus infection among

34

hospital healthcare workers in Hong Kong. Scandinavian Journal of Infectious Diseases, 37 (6-7), 500-503.

512. Leung, T.W., Wong, K.S., Hui, A.C., To, K.F., Lai, S.T., Ng, W.F. and Ng, H.K. (2005), Myopathic changes associated with severe acute respiratory syndrome - A postmortem case series. Archives of Neurology , 62 (7), 1113-1117.

513. Zheng, W.X., Chen, L.L., Ou, H.Y., Gao, F. and Zhang, C.T. (2005), Coronavirus phylogeny based on a geometric approach. Molecular Phylogenetics and Evolution, 36 (2), 224-232.

514. Li, S.Y., Chen, C., Zhang, H.Q., Guo, H.Y., Wang, H., Wang, L., Zhang, X., Hua, S.N., Yu, J., Xiao, P.G., Li, R.S. and Tan, X.H. (2005), Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Research, 67 (1), 18-23.

515. Shie, J.J., Fang, J.M., Kuo, C.J., Kuo, T.H., Liang, P.H., Huang, H.J., Yang, W.B., Lin, C.H., Chen, J.L., Wu, Y.T. and Wong, C.H. (2005), Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease. Journal of Medicinal Chemistry, 48 (13), 4469-4473.

516. Poon, L.L.M., Leung, C.S.W., Chan, K.H., Yuen, K.Y., Guan, Y. and Peiris, J.S.M. (2005), Recurrent mutations associated with isolation and passage of SARS coronavirus in cells from non-human primates. Journal of Medical Virology, 76 (4), 435-440.

517. Lau, S.K.P., Che, X.Y., Woo, P.C.Y., Wong, B.H.L., Cheng, V.C.C., Woo, G.K.S., Hung, I.F.N., Poon, R.W.S., Chan, K.H., Peiris, J.S.M. and Yuen, K.Y. (2005), SARS coronavirus detection methods. Emerging Infectious Diseases, 11 (7), 1108-1111.

518. Duan, J.Z., Yan, X.Y., Guo, X.M., Cao, W.C., Han, W., Qi, C., Feng, J., Yang, D.L., Gao, G.X. and Jin, G. (2005), A human SARS-CoV neutralizing antibody against epitope on S2 protein. Biochemical and Biophysical Research Communications, 333 (1), 186-193.

519. Liu, Y.C., Huang, V., Chao, T.C., Hsiao, C.D., Lin, A., Chang, M.F. and Chow, L.P. (2005), Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease. Biochemical and Biophysical Research Communications, 333 (1), 194-199.

520. Itoyama, S., Keicho, N., Hijikata, M., Quy, T., Phi, N.C., Long, H.T., Ha, L.D., Van Ban, V., Matsushita, I., Yanai, H., Kirikae, F., Kirikae, T., Kuratsuji, T. and Sasazuki, T. (2005), Identification of an alternative 5'-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene: Lack of association with SARS in the Vietnamese population. American Journal of Medical Genetics Part A, 136A (1), 52-57.

521. Chen, H.B., Hou, J.L., Jiang, X.D., Ma, S.W., Meng, M.J., Wang, B.M., Zhang, M.H., Zhang, M.X., Tang, X.P., Zhang, F.C., Wan, T., Li, N., Yu, Y.Z., Hu, H.B., Yang, R.F., He, W., Wang, X.N. and Cao, X.T. (2005), Response of memory CD8(+) T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals. Journal of Immunology, 175 (1), 591-598.

522. Chan, S.S.C., Leung, G.M., Tiwari, A.F.Y., Salili, F., Leung, S.S.K., Wong, D.C.N., Wong, A.S.F., Lai, A.S.F. and Lam, T.H. (2005), The impact of work-related risk on nurses during the SARS outbreak in Hong Kong. Family & Community Health, 28 (3), 274-287.

523. Han, J., Chen, L., Duan, S.M., Yang, Q.X., Yang, M., Gao, C., Zhang, B.Y., He, H. and Dong, X.P. (2005), Efficient and quick inactivation of SARS coronavirus and other microbes exposed to the surfaces of some metal catalysts. Biomedical and Environmental Sciences, 18 (3), 176-180.

524. Tseng, C.T.K., Perrone, L.A., Zhu, H.B., Makino, S. and Peters, C.J. (2005), Severe acute respiratory syndrome and the innate immune responses: Modulation of effector cell function without productive infection. Journal of Immunology, 174 (12), 7977-7985.

525. Zhou, Y.M., Yang, R.Q., Tao, S.C., Li, Z., Zhang, Q., Gao, H.F., Zhang, Z.W., Du, J.Y., Zhu, P.X., Ren, L.L., Zhang, L., Wang, D., Guo, L., Wang, Y.B., Guo, Y., Zhang, Y., Zhao, C.Z., Wang, C., Jiang, D., Liu, Y.H., Yang, H.W., Rong, L., Zhao, Y.J., An, S., Li, Z., Fan, X.D., Wang, J.W., Cheng, Y., Liu, O., Zheng, Z., Zuo, H.C., Shan, Q.Z., Ruan, L., Lu, Z.X.,

35

Hung, T. and Cheng, J. (2005), The design and application of DNA chips for early detection of SARS-CoV from clinical samples. Journal of Clinical Virology, 33 (2), 123-131.

526. Sheng, B., Cheng, S.K.W., Lau, K.K., Li, H.L. and Chan, E.L.Y. (2005), The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases. European Psychiatry, 20 (3), 236-242.

527. Zheng, B.J., Cao, K.Y., Chan, C.P.Y., Choi, J.W.Y., Leung, W., Leung, M., Duan, Z.H., Gao, Y., Wang, M., Di, B., Hollidt, J.M., Bergmann, A., Lehmann, M., Renneberg, I., Tam, J.S.L., Chan, P.K.S., Cautherley, G.W.H., Fuchs, D. and Renneberg, R. (2005), Serum neopterin for early assessment of severity of severe acute respiratory syndrome. Clinical Immunology, 116 (1), 18-26.

528. Cinatl, J., Michaelis, M., Hoever, G., Preiser, W. and Doerr, H.W. (2005), Development of antiviral therapy for severe acute respiratory syndrome. Antiviral Research, 66 (2-3), 81-97.

529. Paragas, J., Blatt, L.M., Hartmann, C., Huggins, J.W. and Endy, T.P. (2005), Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models. Antiviral Research, 66 (2-3), 99-102.

530. Constans, A. and Parry, A. (2005), Speeding to the SARS sequence - A global collaboration in the face of crisis. Scientist, 19 (8), 20-21.

531. Lassnig, C., Sanchez, C.M., Egerbacher, M., Walter, I., Majer, S., Kolbe, T., Pallares, P., Enjuanes, L. and Muller, M. (2005), Development of a transgenic mouse model susceptible to human coronavirus 229E. Proceedings of the National Academy of Sciences of the United States of America, 102 (23), 8275-8280.

532. Hsiao, C.H., Chang, M.F., Hsueh, P.R. and Su, I.J. (2005), Immunohistochemical study of severeacute respiratory syndrome-associated coronavirus in tissue sections of patients. Journal of the Formosan Medical Association, 104 (3), 150-156.

533. Navas-Martin, S., Hingley, S.T. and Weiss, S.R. (2005), Murine coronavirus evolution in vivo: Functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein. Journal of Virology, 79 (12), 7629-7640.

534. Cheung, C.Y., Poon, L.L.M., Ng, I.H.Y., Luk, W., Sia, S.F., Wu, M.H.S., Chan, K.H., Yuen, K.Y., Gordon, S., Guan, Y. and Peiris, J.S.M. (2005), Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. Journal of Virology, 79 (12), 7819-7826.

535. Naylor, K., Li, G.J., Vallejo, A.N., Lee, W.W., Koetz, K., Bryl, E., Witkowski, J., Fulbright, J., Weyand, C.M. and Goronzy, J.J. (2005), The influence of age on T cell generation and TCR diversity. Journal of Immunology, 174 (11), 7446-7452.

536. Hsiao, C.H., Wu, M.Z., Chen, C.L., Hsueh, P.R., Hsueh, S.W., Yang, P.C. and Su, I.J. (2005), Evolution of pulmonary pathology in severe acute respiratory syndrome. Journal of the Formosan Medical Association, 104 (2), 75-81.

537. Che, X.Y., Qiu, L.W., Liao, Z.Y., Wang, Y.D., Wen, K., Pan, Y.X., Hao, W., Mei, Y.B., Cheng, V.C.C. and Yuen, K.Y. (2005), Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43. Journal of Infectious Diseases , 191 (12), 2033-2037.

538. He, Y.X., Lu, H., Siddiqui, P., Zhou, Y.S. and Jiang, S.B. (2005), Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. Journal of Immunology, 174 (8), 4908-4915.

539. Hu, W.Q., Bai, B.K., Hu, Z.H., Chen, Z., An, X.F., Tang, L.J., Yang, J.H., Wang, H.L. and Wang, H.Z. (2005), Development and evaluation of a multitarget real-time Taqman reverse transcription-PCR assay for detection of the severe acute respiratory syndrome-associated coronavirus and surveillance for an apparently related coronavirus found in masked palm civets. Journal of Clinical Microbiology, 43 (5), 2041-2046.

36

540. Wang, B., Potter, S.J., Lin, Y.G., Cunningham, A.L., Dwyer, D.E., Su, Y.L., Ma, X.J., Hou, Y.D. and Saksena, N.K. (2005), Rapid and sensitive detection of severe acute respiratory syndrome coronavirus by rolling circle amplification. Journal of Clinical Microbiology, 43 (5), 2339-2344.

541. Liu, I.J., Chen, P.J., Yeh, S.H., Chiang, Y.P., Huang, L.M., Chang, M.F., Chen, S.Y., Yang, P.C., Chang, S.C. and Wang, W.K. (2005), Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS) - Associated coronavirus in cells derived from throat wash samples of patients with SARS. Journal of Clinical Microbiology, 43 (5), 2444-2448.

542. Lu, J.H., Zhang, D.M., Wang, G.L., Guo, Z.M., Zhang, C.H., Tan, B.Y., Ouyang, L.P., Lin, L., Liu, Y.M., Chen, W.Q., Ling, W.H., Yu, X.B. and Zhong, N.S. (2005), Variation analysis of the severe acute respiratory syndrome coronavirus putative non-structural protein 2 gene and construction of three-dimensional model. Chinese Medical Journal, 118 (9), 707-713.

543. Chen, L.L., Gui, C.S., Luo, X.M., Yang, Q.G., Gunther, S., Scandella, E., Drosten, C., Bai, D., He, X.C., Ludewig, B., Chen, J., Luo, H.B., Yang, Y.M., Yang, Y.F., Zou, J.P., Thiel, V., Chen, K., Shen, J.H., Xu, S. and Jiang, H.L. (2005), Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. Journal of Virology, 79 (11), 7095-7103.

544. Sainz, B., Rausch, J.M., Gallaher, W.R., Garry, R.F. and Wimley, W.C. (2005), Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. Journal of Virology, 79 (11), 7195-7206.

545. Zhao, J.C., Wang, W., Wang, G.F., Li, Y.H., Hui, Z., Xu, X.Y., Ren, F., Zhao, Z.D. and Gao, X.M. (2005), Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus. Journal of Clinical Virology, 33 (1), 12-18.

546. Yam, W.C., Chan, K.H., Chow, K.H., Poon, L.L.M., Lam, H.Y., Yuen, K.Y., Seto, W.H. and Peiris, J.S.M. (2005), Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods. Journal of Clinical Virology, 33 (1), 19-24.

547. Luo, H.B., Chen, Q., Chen, J., Chen, K.X., Shen, X. and Jiang, H.L. (2005), The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1. Febs Letters, 579 (12), 2623-2628.

548. Zhanga, C.H., Lu, J.H., Wang, Y.F., Zheng, H.Y., Xiong, S., Zhang, M.Y., Liu, X.J., Li, J.X., Wan, Z.Y., Yan, X.G., Qi, S.Y., Cui, Z.Y. and Zhang, B.L. (2005), Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain. Vaccine, 23 (24), 3196-3201.

549. Zhou, J., Wang, W., Zhong, Q., Hou, W., Yang, Z.Q., Xiao, S.Y., Zhu, R.Q., Tang, Z.J., Wang, Y., Xian, Q.Y., Tang, H.B. and Wen, L. (2005), Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys. Vaccine, 23 (24), 3202-3209.

550. Mackay, I.M., Arden, K.E. and Nitsche, A. (2005), Real-time fluorescent PCR techniques to study microbial-host interactions. Microbial Imaging, 34), 255-330.

551. Tang, B.S.F., Chan, K.H., Cheng, V.C.C., Woo, P.C.Y., Lau, S.K.P., Lam, C.C.K., Chan, T.L., Wu, A.K.L., Hung, I.F.N., Leung, S.Y. and Yuen, K.Y. (2005), Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. Journal of Virology, 79 (10), 6180-6193.

552. Cheng, A., Zhang, W., Xie, Y.H., Jiang, W.H., Arnold, E., Sarafianos, S.G. and Ding, J.P. (2005), Expression, purification, and characterization of SARS coronavirus RNA polymerase. Virology, 335 (2), 165-176.

37

553. Baumeister, E.G., Lewis, A.P., Bozzini, J.P. and Savy, V.L. (2005), Severe acute respiratory syndrome. The public health laboratory in a global emergency. Medicina-Buenos Aires, 65 (1), 36-40.

554. Nal, B., Chan, C.M., Kien, F., Siu, L., Tse, J., Chu, K., Kam, J., Staropoli, I., Crescenzo-Chaigne, B., Escriou, I., van der Werf, S., Yuen, K.Y. and Altmeyer, R. (2005), Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. Journal of General Virology, 86), 1423-1434.

555. Faber, M., Lamirande, E.W., Roberts, A., Rice, A.B., Koprowski, H., Dietzschold, B. and Schnell, M.J. (2005), A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies. Journal of General Virology, 86), 1435-1440.

556. Chang, S.M., Liu, C.L., Kuo, H.T., Chen, P.J., Lee, C.M., Lin, F.J., Lin, C.C., Lee, C.H. and Lu, Y.T. (2005), Comparative study of patients with and without SARS who fulfilled the who SARS case definition. Journal of Emergency Medicine, 28 (4), 395-402.

557. Ip, W.K.E., Chan, K.H., Law, H.K.W., Tso, G.H.W., Kong, E.K.P., Wong, W.H.S., To, Y.F., Yung, R.W.H., Chow, E.Y., Au, K.L., Chan, E.Y.T., Lim, W., Jensenius, J.C., Turner, M.W., Peiris, J.S.M. and Lau, Y.L. (2005), Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. Journal of Infectious Diseases, 191 (10), 1697-1704.

558. Li, T., Zhang, Y., Fu, L., Yu, C., Li, X., Li, Y., Zhang, X., Rong, Z., Wang, Y., Ning, H., Liang, R., Chen, W., Babiuk, L.A. and Chang, Z. (2005), siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication. Gene Therapy, 12 (9), 751-761.

559. Kwan, Y.W., Leung, C.W. and Chin, M.C. (2005), Diarrhoea as the presenting sign in an adolescent suffering from severe acute respiratory syndrome. European Journal of Pediatrics, 164 (4), 227-230.

560. Leong, W.F., Tan, H.C., Ooi, E.E., Koh, D.R. and Chow, V.T.K. (2005), Microarray and real-time RT-PCR analyses of differential human gene expression patterns induced by severe acute respiratory syndrome (SARS) coronavirus infection of Vero cells. Microbes and Infection, 7 (2), 248-259.

561. Roberts, A., Paddock, C., Vogel, L., Butter, E., Zaki, S. and Subbarao, K. (2005), Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. Journal of Virology, 79 (9), 5833-5838.

562. Shieh, W.J., Hsiao, C.H., Paddock, C.D., Guarner, J., Goldsmith, C.S., Tatti, K., Packard, M., Mueller, L., Wu, M.Z., Rollin, P., Su, I.J. and Zaki, S.R. (2005), Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Human Pathology, 36 (3), 303-309.

563. Xu, D., Zhang, Z., Jin, L., Chu, F., Mao, Y., Wang, H., Liu, M., Wang, M., Zhang, L., Gao, G.F. and Wang, F.S. (2005), Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. European Journal of Clinical Microbiology & Infectious Diseases, 24 (3), 165-171.

564. Jiang, Y., Xu, J., Zhou, C.Z., Wu, Z.G., Zhong, S.Q., Liu, J.H., Luo, W., Chen, T., Qin, Q.H. and Deng, P. (2005), Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. American Journal of Respiratory and Critical Care Medicine, 171 (8), 850-857.

565. Yuan, X.L., Li, J.Y., Shan, Y.J., Yang, Z., Zhao, Z.H., Chen, B., Yao, Z.Y., Dong, B., Wang, S.Q., Chen, J.P. and Cong, Y.W. (2005), Subcellular localization and membrane association of SARS-CoV 3a protein. Virus Research, 109 (2), 191-202.

566. Wong, S.Y., Lim, W.W.C., Que, T.L. and Au, D.M.Y. (2005), Reflection on SARS precautions in a severe intellectual disabilities hospital in Hong Kong. Journal of Intellectual Disability Research, 49), 379-384.

38

567. Lan, Y.C., Liu, T.T., Yang, J.Y., Lee, C.M., Chen, Y.J., Chan, Y.J., Lu, J.J., Liu, H.F., Hsiung, C.A., Ho, M.S., Hsiao, K.J., Chen, H.Y. and Chen, Y.M.A. (2005), Molecular epidemiology of severe acute respiratory syndrome-associated coronavirus infections in Taiwan. Journal of Infectious Diseases, 191 (9), 1478-1489.

568. Tanner, J.A., Zheng, B.J., Zhou, J., Watt, R.M., Jiang, J.Q., Wong, K.L., Lin, Y.P., Lu, L.Y., He, M.L., Kung, H.F., Kesel, A.J. and Huang, J.D. (2005), The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus. Chemistry & Biology, 12 (3), 303-311.

569. Shi, Y., Yang, D.H., Xiong, J., Jia, H., Huang, B. and Jin, Y.X. (2005), Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs. Cell Research, 15 (3), 193-200.

570. Ni, L., Zhu, J.Q., Zhang, J.J., Yan, M., Gao, G.F. and Tien, P. (2005), Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain. Biochemical and Biophysical Research Communications, 330 (1), 39-45.

571. Andre, M., Talarmin, F., Le Guen, P., Nicolas, X., Garcia, J.F. and Natali, F. (2005), Asymptomatic forms of the Severe Acute Respiratory Syndrome (SARS). Revue des Maladies Respiratoires, 22 (1), 135-141.

572. Ho, S.M.Y., Kwong-Lo, R.S.Y., Mak, C.W.Y. and Wong, J.S. (2005), Fear of severe acute respiratory syndrome (SARS) among health care workers. Journal of Consulting and Clinical Psychology, 73 (2), 344-349.

573. Shiha, M.C., Peck, K., Chan, W.L., Chu, Y.P., Chen, J.C., Tsai, C.H. and Chang, J.G. (2005), SARS-CoV infection was from at least two origins in the Taiwan area. Intervirology, 48 (2-3), 124-132.

574. Birch, C.J., Clothier, H.J., Seccull, A., Tran, T., Catton, M.C., Lambert, S.B. and Druce, J.D. (2005), Human coronavirus OC43 causes influenza-like illness in residents and staff of aged-care facilities in Melbourne, Australia. Epidemiology and Infection, 133 (2), 273-277.

575. Vijayanand, P., Wilkins, E. and Woodhead, M. (2004), Severe acute respiratory syndrome (SARS): a review. Clinical Medicine, 4 (2), 152-160.

576. Muller, M.P., Tomlinson, G., Marrie, T.J., Tang, P., McGeer, A., Low, D.E., Detsky, A.S. and Gold, W.L. (2005), Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia? Clinical Infectious Diseases, 40 (8), 1079-1086.

577. Zhan, M. (2005), Civet cats, fried grasshoppers, and David Beckham's pajamas: Unruly bodies after SARS. American Anthropologist, 107 (1), 31-42.

578. Okada, M., Takemoto, Y., Okuno, Y., Hashimoto, S., Yoshida, S., Fukunaga, Y., Tanaka, T., Kita, Y., Kuwayama, S., Muraki, Y., Kanamaru, N., Takai, H., Okada, C., Sakaguchi, Y., Furukawa, I., Yamada, K., Matsumoto, M., Kase, T., deMello, D.E., Peiris, J.S.M., Chen, P.J., Yamamoto, N., Yoshinaka, Y., Nomura, T., Ishida, I., Morikawa, S., Tashiro, M.K. and Sakatani, M. (2005), The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice. Vaccine, 23 (17-18), 2269-2272.

579. Liu, J.J., Lim, S.L., Ruan, Y.J., Ling, A.E., Ng, L.F.P., Drosten, C., Liu, E.T., Stanton, L.W. and Hibberd, M.L. (2005), SARS transmission pattern in Singapore reassessed by viral sequence variation analysis. Plos Medicine, 2 (2), 162-168.

580. Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. and Van Ranst, M. (2005), Growth kinetics of SARS-coronavirus in Vero E6 cells. Biochemical and Biophysical Research Communications, 329 (3), 1147-1151.

581. Hamano, E., Hijikata, M., Itoyama, S., Quy, T., Phi, N.C., Long, H.T., Ha, L., Van Ban, V., Matsushita, I., Yanai, H., Kirikae, F., Kirikae, T., Kuratsuji, T., Sasazuki, T. and Keicho, N. (2005), Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Biochemical and Biophysical Research Communications, 329 (4), 1234-1239.

39

582. Lu, D.D., Chen, S.H., Zhang, S.M., Zhang, M.L., Zhang, W., Bo, X.C. and Wang, S.Q. (2005), Screening of specific antigens for SARS clinical diagnosis using a protein microarray. Analyst, 130 (4), 474-482.

583. Ho, O.Y.M., Lam, H.C.K., Woo, J.K.S. and van Hasselt, C.A. (2004), Tracheostomy during SARS. Journal of Otolaryngology, 33 (6), 393-396.

584. Wong, S.C.C., Chan, J.K.C., Lee, K.C., Lo, E.S.F. and Tsang, D.N.C. (2005), Development of a quantitative assay for SARS coronavirus and correlation of GAPDH mRNA with SARS coronavirus in clinical specimens. Journal of Clinical Pathology, 58 (3), 276-280.

585. Chen, K.T., Twu, S.J., Chang, H.L., Wu, Y.C., Chen, C.T., Lin, T.H., Olsen, S.J., Dowell, S.F. and Su, I.J. (2005), SARS in Taiwan: an overview and lessons learned. International Journal of Infectious Diseases, 9 (2), 77-85.

586. He, Y.X., Zhu, Q.Y., Liu, S.W., Zhou, Y.S., Yang, B.A., Li, J.M. and Jiang, S.B. (2005), Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: Importance for designing SARS vaccines. Virology, 334 (1), 74-82.

587. Groneberg, D.A., Hilgenfeld, R. and Zabel, P. (2005), Molecular mechanisms of severe acute respiratory syndrome (SARS). Respiratory Research, 6 (8-9.

588. van Kraaij, M.G.J., van Elden, L.J.R., van Loon, A.M., Hendriksen, K.A.W., Laterveer, L., Dekker, A.W. and Nijhuis, M. (2005), Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture. Clinical Infectious Diseases, 40 (5), 662-669.

589. Chen, Y.Y., Shuang, B., Tan, Y.X., Meng, M.J., Han, P., Mo, X.N., Song, Q.S., Qiu, X.Y., Luo, X., Gan, Q.N., Zhang, X., Zheng, Y., Liu, S.A., Wang, X.N., Zhong, N.S. and Ma, D.L. (2005), The protein X4 of severe acute respiratory syndrome-associated coronavirus is expressed on both virus-infected cells and lung tissue of severe acute respiratory syndrome patients and inhibits growth of Balb/c 3T3 cell line. Chinese Medical Journal, 118 (4), 267-274.

590. Groneberg, D.A., Poutonen, S.M., Low, D.E., Lode, H., Welte, T. and Zabel, P. (2005), Treatment and vaccines for severe acute respiratory syndrome. Lancet Infectious Diseases, 5 (3), 147-155.

591. Keng, C.T., Zhang, A., Shen, S., Lip, K.M., Fielding, B.C., Tan, T.H.P., Chou, C.F., Loh, C.B., Wang, S.F., Fu, J.L., Yang, X.M., Lim, S.G., Hong, W.J. and Tan, Y.J. (2005), Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: Implications for the development of vaccines and antiviral agents. Journal of Virology, 79 (6), 3289-3296.

592. Zhong, X.F., Yang, H.H., Guo, Z.F., Sin, W.Y.F., Chen, W., Xu, J.J., Fu, L., Wu, J., Mak, C.K.G., Cheng, C.S.S., Yang, Y.Z., Cao, S.Y., Wong, T.Y., Lai, S.T., Xie, Y. and Guo, Z.H. (2005), B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. Journal of Virology, 79 (6), 3401-3408.

593. Mossel, E.C., Huang, C., Narayanan, K., Makino, S., Tesh, R.B. and Peters, C.J. (2005), Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication. Journal of Virology, 79 (6), 3846-3850.

594. Sampath, R., Hofstadler, S.A., Blyn, L.B., Eshoo, M.W., Hall, T.A., Massire, C., Levene, H.M., Hannis, J.C., Harrell, P.M., Neuman, B., Buchmeier, M.J., Jiang, Y., Ranken, R., Drader, J.J., Samant, V., Griffey, R.H., Mcneil, J.A., Crooke, S.T. and Ecker, D.J. (2005), Rapid identification of emerging pathogens: Coronavirus. Emerging Infectious Diseases, 11 (3), 373-379.

595. Chen, W.J., Yan, M.H., Yang, L., Ding, B.L., He, B., Wang, Y.Z., Liu, X.L., Liu, C.H., Zhu, H., You, B., Huang, S.Y., Zhang, J.G., Mu, F., Xiang, Z., Feng, X.L., Wen, J., Fang, J.Q., Yu, J., Yang, H.M. and Wang, J. (2005), SARS-associated coronavirus transmitted from human to pig. Emerging Infectious Diseases, 11 (3), 446-448.

40

596. Kliger, Y., Levanon, E.Y. and Gerber, D. (2005), From genome to antivirals: SARS as a test tube. Drug Discovery Today, 10 (5), 345-352.

597. Moes, E., Vijgen, L., Keyaerts, E., Zlateva, K., Li, S., Maes, P., Pyrc, K., Berkhout, B., van der Hoek, L. and Van Ranst, M. (2005), A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. Bmc Infectious Diseases, 5.

598. Tan, Y.J., Lim, S.G. and Hong, W.J. (2005), Characterization of viral proteins encoded by the SARS-coronavirus genome. Antiviral Research, 65 (2), 69-78.

599. Chen, Z.W., Zhang, L.Q., Qin, C.A., Ba, L., Yi, C.E., Zhang, F.W., Wei, Q., He, T., Yu, W.J., Yu, J., Gao, H., Tu, X.M., Gettie, A., Farzan, M., Yuen, K.Y. and Ho, D.D. (2005), Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. Journal of Virology, 79 (5), 2678-2688.

600. Coley, S.E., Lavi, E., Sawicki, S.G., Fu, L., Schelle, B., Karl, N., Siddell, S.G. and Thiel, V. (2005), Recombinant mouse hepatitis virus strain a59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo. Journal of Virology, 79 (5), 3097-3106.

601. Schobesberger, M., Summerfield, A., Doherr, M.G., Zurbriggen, A. and Griot, C. (2005), Canine distemper virus-induced depletion of uninfected lymphocytes is associated with apoptosis. Veterinary Immunology and Immunopathology, 104 (1-2), 33-44.

602. Spiegel, M., Pichlmair, A., Martinez-Sobrido, L., Cros, J., Garcia-Sastre, A., Haller, O. and Weber, F. (2005), Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. Journal of Virology, 79 (4), 2079-2086.

603. Wu, D.L., Tu, C.C., Xin, C., Xuan, H., Meng, Q.W., Liu, Y.G., Yu, Y.D., Guan, Y.T., Jiang, Y., Yin, X.N., Crameri, G., Wang, M.P., Li, C.W., Liu, S.W., Liao, M., Feng, L., Xiang, H., Sun, J.F., Chen, J.D., Sun, Y.W., Gu, S.L., Liu, N.H., Fu, D.X., Eaton, B.T., Wang, L.F. and Kong, X.G. (2005), Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. Journal of Virology , 79 (4), 2620-2625.

604. Wong, T., Wallington, T., McDonald, L.C., Abbas, Z., Christian, M., Low, D.E., Gravel, D., Ofner, M., Mederski, B., Berger, L., Hansen, L., Harrison, C., King, A., Yaffe, B. and Tam, T. (2005), Late recognition of SARS in nosocomial outbreak, Toronto. Emerging Infectious Diseases, 11 (2), 322-325.

605. Chng, J., Lai, H.C., Earnest, A. and Kuperan, P. (2005), Haematological parameters in severe acute respiratory syndrome. Clinical and Laboratory Haematology, 27 (1), 15-20.

606. Yu, C.Y., Gui, C.S., Luo, H.B., Chen, L.L., Zhang, L., Yu, H., Yang, S., Jiang, W.H., Shen, J.H., Shen, X. and Jiang, H.L. (2005), Folding of the SARS coronavirus spike glycoprotein immunological fragment (SARS-S1B): Thermodynamic and kinetic investigation correlating with three-dimensional structural modeling. Biochemistry, 44 (5), 1453-1463.

607. van den Brink, E.N., ter Meulen, J., Cox, F., Jongeneelen, M.A.C., Thijsse, A., Throsby, M., Marissen, W.E., Rood, P.M.L., Bakker, A.B.H., Gelderblom, H.R., Martina, B.E., Osterhaus, A.D.M.E., Preiser, W., Doerr, H.W., de Kruif, J. and Goudsmit, J. (2005), Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. Journal of Virology, 79 (3), 1635-1644.

608. Guillen, J., Perez-Berna, A.J., Moreno, M.R. and Villalain, J. (2005), Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: Implications for the viral fusion mechanism. Journal of Virology, 79 (3), 1743-1752.

609. Wang, S.X., Chou, T.H.W., Sakhatskyy, P.V., Huang, S., Lawrence, J.M., Cao, H., Huang, X.Y. and Lu, S. (2005), Identification of two neutralizing regions on the severe acute

41

respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system. Journal of Virology, 79 (3), 1906-1910.

610. Shi, Y., Luo, H.F., Jia, J., Xiong, J., Yang, D.H., Huang, B. and Jin, Y.X. (2005), Antisense downregutation of SARS-CoV gene expression in Vero E6 cells. Journal of Gene Medicine, 7 (1), 97-107.

611. Liu, J.P., Manheimer, E., Shi, Y. and Gluud, C. (2004), Chinese herbal medicine for severe acute respiratory syndrome: A systematic review and meta-analysis. Journal of Alternative and Complementary Medicine, 10 (6), 1041-1051.

612. Wu, C.J., Huang, H.W., Liu, C.Y., Hong, C.F. and Chan, Y.L. (2005), Inhibition of SARS-CoV replication by siRNA. Antiviral Research, 65 (1), 45-48.

613. Zhao, J.C., Zhao, Z.D., Wang, W. and Gao, X.M. (2005), Prokaryotic expression, refolding, and purification of fragment 450-650 of the spike protein of SARS-coronavirus. Protein Expression and Purification , 39 (2), 169-174.

614. Chu, K.H., Tsang, W.K., Tang, C.S., Lam, M.F., Lai, F.M., To, K.F., Fung, K.S., Tang, H.L., Yan, W.W., Chan, H.W.H., Lai, T.S.T., Tong, K.L. and Lai, K.N. (2005), Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney International, 67 (2), 698-705.

615. Cheng, Y., Wong, R., Soo, Y.O.Y., Wong, W.S., Lee, C.K., Ng, M.H.L., Chan, P., Wong, K.C., Leung, C.B. and Cheng, G. (2005), Use of convalescent plasma therapy in SARS patients in Hong Kong. European Journal of Clinical Microbiology & Infectious Diseases, 24 (1), 44-46.

616. Zheng, K.W., Yu, Q.S., Jiang, Y.J., Ma, G.Z., Zhao, W.N. and Zen, M. (2005), Effects of electrostatic and hydrophobic interaction on the stability of SARS coronavirus 3CL proteinase dimer. Chemical Journal of Chinese Universities-Chinese, 26 (1), 55-60.

617. Sainz, B., Rausch, J.M., Gallaher, W.R., Garry, R.F. and Wimley, W.C. (2005), The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: Putative role during viral entry. Biochemistry, 44 (3), 947-958.

618. Lai, E.K.Y., Deif, H., Lamere, E.A., Pham, D.H., Wolff, B., Ward, S., Mederski, B. and Loutfy, M.R. (2005), Severe acute respiratory syndrome: Quantitative assessment from chest radiographs with clinical and prognostic correlation. American Journal of Roentgenology, 184 (1), 255-263.

619. Chen, S., Chen, L.L., Luo, H.B., Sun, T., Chen, J., Ye, F., Cai, J.H., Shen, J.K., Shen, X. and Jiang, H.L. (2005), Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique. Acta Pharmacologica Sinica, 26 (1), 99-106.

620. Qu, D., Zheng, B.J., Yao, X., Guan, Y., Yuan, Z.H., Zhong, N.S., Lu, L.W., Xie, J.P. and Wen, Y.M. (2005), Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice. Vaccine, 23 (7), 924-931.

621. Saif, L.J. (2004), Animal coronaviruses: what can they teach us about the severe acute respiratory syndrome? Revue Scientifique et Technique de l Office International des Epizooties, 23 (2), 643-660.

622. Tan, B.H., Loh, J.L.P., Seah, S.G.K., Koh, V.W.H., Lim, E.A.S., Liaw, C.W., Ong, C.E.L., Chew, J.S.W., Wang, D.L., Lim, E.C.P., Yap, S.H., Aw, L.T., Lim, A.P.C., Liu, Y.C., Lee, M.A., Chan, K.P., Oon, L.L.E., Bai, X.L., Kwek, P.W., Seng, E.H., Yun, S.S. and Ling, A.E. (2005), Strategies adopted and lessons learnt during the severe acute respiratory syndrome crisis in Singapore. Reviews in Medical Virology, 15 (1), 57-70.

623. Supekar, V.M., Bruckmann, C., Ingallinella, P., Bianchi, E., Pessi, A. and Carfi, A. (2004), Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein. Proceedings of the National Academy of Sciences of the United States of America, 101 (52), 17958-17963.

42

624. Hwang, D.M., Chamberlain, D.W., Poutanen, S.M., Low, D.E., Asa, S.L. and Butany, J. (2005), Pulmonary pathology of severe acute respiratory syndrome in Toronto. Modern Pathology, 18 (1), 1-10.

625. Chan-Yeung, M. (2004), Severe acute respiratory syndrome (SARS) and Healthcare workers. International Journal of Occupational and Environmental Health, 10 (4), 421-427.

626. Salto-Tellez, M., Tan, E. and Lim, B. (2005), ARDS in SARS: cytokine mediators and treatment implications. Cytokine, 29 (2), 92-94.

627. Woo, P.C.Y., Lau, S.K.P., Chu, C.M., Chan, K.H., Tsoi, H.W., Huang, Y., Wong, B.H.L., Wong, H.L., Poon, R.W.S., Cai, J.J., Luk, W.K., Poon, L.L.M., Wong, S.S.Y., Guan, Y., Peiris, J.S.M. and Yuen, K.Y. (2005), Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. Journal of Virology, 79 (2), 884-895.

628. De Groot-Mijnes, J.D.F., van Dun, J.M., van der Most, R.G. and de Groot, R.J. (2005), Natural history of a recurrent feline coronavirus infection and the role of cellular immunity in survival and disease. Journal of Virology, 79 (2), 1036-1044.

629. Chan, P.K.S., Liu, E.Y.M., Leung, D.T.M., Cheung, J.L.K., Ma, C.H., Tam, F.C.H., Hui, M.M., Tam, J.S. and Lim, P.L. (2005), Evaluation of a recombinant nucleocapsid protein-based assay for anti-SARS-CoV IgG detection. Journal of Medical Virology, 75 (2), 181-184.

630. Huang, K.J., Su, I.J., Theron, M., Wu, Y.C., Lai, S.K., Liu, C.C. and Lei, H.Y. (2005), An interferon-gamma-related cytokine storm in SARS patients. Journal of Medical Virology, 75 (2), 185-194.

631. Rovida, F., Percivalle, E., Zavattoni, M., Torsellini, M., Sarasini, A., Campanini, G., Paolucci, S., Baldanti, F., Revello, M.G. and Gerna, G. (2005), Monoclonal antibodies versus reverse transcription-PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital. Journal of Medical Virology, 75 (2), 336-347.

632. Rao, B.L., Gandhe, S.S., Pawar, S.D., Arankalle, V.A., Shah, S.C. and Kinikar, A.A. (2004), First detection of human metapneumovirus in children with acute respiratory infection in India: a preliminary report. Journal of Clinical Microbiology, 42 (12), 5961-5962.

633. Chen, S., Chen, L.L., Tan, J.Z., Chen, J., Du, L., Sun, T., Shen, J.H., Chen, K.X., Jiang, H.L. and Shen, X. (2005), Severe acute respiratory syndrome coronavirus 3C-like proteinase n terminus is indispensable for proteolytic activity but not for enzyme dimerization - Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations. Journal of Biological Chemistry, 280 (1), 164-173.

634. Huang, C.Y., Sun, C.T., Hsieh, J.L. and Lin, H. (2004), Simulating SARS: Small-world epidemiological modeling and public health policy assessments. Jasss-the Journal of Artificial Societies and Social Simulation, 7 (4.

635. Hsueh, P.R., Huang, L.M., Chen, P.J., Kao, C.L. and Yang, P.C. (2004), Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. Clinical Microbiology and Infection, 10 (12), 1062-1066.

636. Kang, X.X., Xu, Y., Wu, X.Y., Liang, Y., Wang, C., Guo, J.H., Wang, Y.J., Chen, M.H., Wu, D., Wang, Y.C., Bi, S.L., Qiu, Y., Lu, P., Cheng, J., Xiao, B., Hu, L.P., Gao, X., Liu, J.Z., Wang, Y.P., Song, Y.Z., Zhang, L.Q., Suo, F.S., Chen, T.Y., Huang, Z., Zhao, Y.Z., Lu, H., Pan, C.Q. and Tang, H. (2005), Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clinical Chemistry, 51 (1), 56-64.

637. Chen, J.H., Chang, Y.W., Yao, C.W., Chiueh, T.S., Huang, S.C., Chien, K.Y., Chen, A., Chang, F.Y., Wong, C.H. and Chen, Y.J. (2004), Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proceedings of the National Academy of Sciences of the United States of America, 101 (49), 17039-17044.

43

638. Chan, W.W., Kwan, Y.W., Wan, H.S., Leung, C.W. and Chiu, M.C. (2004), Epidemiologic linkage and public health implication of a cluster of severe acute respiratory syndrome in an extended family. Pediatric Infectious Disease Journal, 23 (12), 1156-1159.

639. Kwan, M.Y.W., Chan, W.M., Ko, P.W., Leung, C.W. and Chiu, M.C. (2004), Severe acute respiratory syndrome can be mild in children. Pediatric Infectious Disease Journal, 23 (12), 1172-1174.

640. Roberts, A., Vogel, L., Guarner, J., Hayes, N., Murphy, B., Zaki, S. and Subbarao, K. (2005), Severe acute respiratory syndrome coronavirus infection of Golden Syrian hamsters. Journal of Virology, 79 (1), 503-511.

641. Hsiao, C.H., Wu, M.Z., Hsieh, S.W., Chien, L.C., Hwang, K.C. and Su, I.J. (2004), Clinicopathology of severe acute respiratory syndrome: An autopsy case report. Journal of the Formosan Medical Association , 103 (10), 787-792.

642. Farcas, G.A., Poutanen, S.M., Mazzulli, T., Willey, B.M., Butany, J., Asa, S.L., Faure, P., Akhavan, P., Low, D.E. and Kain, K.C. (2005), Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. Journal of Infectious Diseases, 191 (2), 193-197.

643. Kiechle, F.L., Zhang, X.B. and Holland-Staley, C.A. (2004), The -omics era and its impact. Archives of Pathology & Laboratory Medicine, 128 (12), 1337-1345.

644. Mazzulli, T., Kain, K. and Butany, J. (2004), Severe acute respiratory syndrome - Overview with an emphasis, on the Toronto experience. Archives of Pathology & Laboratory Medicine, 128 (12), 1346-1350.

645. Peiris, J.S.M., Guan, Y. and Yuen, K.Y. (2004), Severe acute respiratory syndrome. Nature Medicine, 10 (12), S88-S97.

646. Wang, F.S., Chu, F.L., Jin, L., Li, Y.G., Zhang, Z., Xu, D., Shi, M., Wu, H. and Moulds, J.M. (2005), Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome. Clinical and Experimental Immunology, 139 (1), 112-119.

647. Zhang, C.H., Guo, Z.M., Zheng, H.Y., Lu, J.H., Wang, Y.F., Yan, X.G., Zhao, Y., Du, X.W., Qi, S.Y. and Yu, X.B. (2004), Humoral immune responses in rabbits induced by an experimental inactivated severe acute respiratory syndrome coronavirus vaccine prepared from F69 strain. Chinese Medical Journal, 117 (11), 1625-1629.

648. Yi, R., He, Q.Y., Fan, J.Q., Jones, B., Yuan, Z., Yi, X., Cheung, C.Y., Wu, A., Chiu, J.F., Peiris, J.S.M. and Tam, P.K.H. (2004), The use of proteomics in the discovery of serum biomarkers from patients with severe acute respiratory syndrome. Proteomics, 4 (11), 3477-3484.

649. Li, A.M., So, H.K., Chu, W., Ng, P.C., Hon, K.L., Chiu, W., Leung, C.W., Yau, Y.S., Mo, W. and Fok, T.F. (2004), Radiological and pulmonary function outcomes of children with SARS. Pediatric Pulmonology, 38 (6), 427-433.

650. Harcourt, B.H., Jukneliene, D., Kanjanahaluethai, A., Bechill, J., Severson, K.M., Smith, C.M., Rota, P.A. and Baker, S.C. (2004), Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. Journal of Virology, 78 (24), 13600-13612.

651. Tan, Y.J., Fielding, B.C., Goh, P.Y., Shen, S., Tan, T.H.P., Lim, S.G. and Hong, W.J. (2004), Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway. Journal of Virology, 78 (24), 14043-14047.

652. Kariwa, H., Fujii, N. and Takashima, I. (2004), Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents. Japanese Journal of Veterinary Research, 52 (3), 105-112.

653. Drosten, C., Doerr, H.W., Lim, W., Stohr, K. and Niedrig, M. (2004), SARS molecular detection external quality assurance. Emerging Infectious Diseases, 10 (12), 2200-2203.

44

654. Chu, C.M., Poon, L.L.M., Cheng, V.C.C., Chan, K.S., Hung, I.F.N., Wong, M.M.L., Chan, K.H., Leung, W.S., Tang, B.S.F., Chan, V.L., Ng, W.L., Sim, T.C., Ng, P.W., Law, K.I., Tse, D.M.W., Peiris, J.S.M. and Yuen, K.Y. (2004), Initial viral load and the outcomes of SARS. Canadian Medical Association Journal, 171 (11), 1349-1352.

655. Mu, X.N., Tang, Y.C., Tian, L.Q., Xu, P.S. and Huang, S.D. (2003), Glucocorticoid in treatment of severe acute respiratory syndrome patients. Proceedings of the 2003 Symposium of China Postdoctors and Academicians on Life Science, ), 354-356.

656. Mackenzie, J.S., Drury, P., Ellis, A., Grein, T., Leitmeyer, K.C., Mardel, S., Merianos, A., Olowokure, B., Roth, C., Slattery, R., Thomson, G., Werker, D., Ryan, M., Leduc, J.W., Pflieger, A., Breiman, R.F., Evans, M.R., Preiser, W., Maguire, J., Schnur, A., Li, A.L., Bekedam, H., MacKenzie, J.S., Low, D.E., Cetron, M., Maloney, S., Koppaka, R., Simone, P., Abdullah, A.S.M., Tomlinson, B., Thomas, G.N. and Cockram, C.S. (2004), SARS: Emergence, detection, and response. Learning from Sars - Preparing for the Next Disease Outbreak, ), 41-90.

657. Saif, L.J., Denison, M.R., Guan, Y., Zheng, B.J., He, Y.Q., Liu, X.L., Zhuang, Z.X., Cheung, C.L., Luo, S.W., Li, P.H., Zhang, L.J., Guan, Y.J., Butt, K.M., Wong, K.L., Chan, K.W., Lin, W., Shortridge, K.F., Yuen, K.Y., Peiris, J.S.M. and Poon, L.L.M. (2004), Microbiology, ecology, and natural history of coronaviruses. Learning from Sars - Preparing for the Next Disease Outbreak, ), 137-172.

658. Yam, W.C., Chan, K.H., Poon, L.L.M., Guan, Y., Yuen, K.Y., Seto, W.H., Peiris, J.S.M., Sampath, R., Ecker, D.J., Matthews, D.A., Patick, A.K., Baker, R.O., Brothers, M.A., Dragovich, P.S., Hartmann, C.J., Johnson, T.O., Mucker, E.M., Reich, S.H., Rejto, P.A., Rose, P.W., Zwiers, S.H., Huggins, J.W., Schentag, J.J., Akers, C., Campagna, P. and Chirayath, P. (2004), Diagnostics, therapeutics, and other technologies to control SARS. ), 173-205.

659. Poon, L.L.M., Chan, K.H., Nicholls, J.M., Zheng, B.J., Yuen, K.Y., Guan, Y. and Peiris, J.S.M. (2004), Characterization of a novel coronavirus responsible for severe acute respiratory syndrome. Options for the Control of Influenza V, 1263), 805-808.

660. Meyers, L.A., Pourbohloul, B., Newman, M.E.J., Skowronski, D.M. and Brunham, R.C. (2005), Network theory and SARS: predicting outbreak diversity. Journal of Theoretical Biology, 232 (1), 71-81.

661. Wilson, L., Mckinlay, C., Gage, P. and Ewart, G. (2004), SARS coronavirus E protein forms cation-selective ion channels. Virology, 330 (1), 322-331.

662. Ming, G., Hsiao, Y.C., Tan, P.H., Shuo, S., Goh, P.Y., Tan, Y.J., Pang, P.H., Yang, L., Fong, P.Y. and Chin, D. (2004), Use of viral lysate antigen combined with recombinant protein in western immunoblot assay as confirmatory test for serodiagnosis of severe acute respiratory syndrome. Clinical and Diagnostic Laboratory Immunology, 11 (6), 1148-1153.

663. Jiang, X.G., Xing, G., Han, Z., Yan, M.Y., Liang, W.L., Shao, Z.J., Wei, L., Zhang, E.M., Yuan, H., Rong, H., Yu, D.Z., Biao, K. and Xu, J.G. (2004), Specific immunoglobulin G antibody detected in umbilical blood and amniotic fluid from a pregnant woman infected by the coronavirus associated with severe acute respiratory syndrome. Clinical and Diagnostic Laboratory Immunology, 11 (6), 1182-1184.

664. He, Y.X., Zhou, Y.S., Siddiqui, P. and Jiang, S.B. (2004), Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry. Biochemical and Biophysical Research Communications, 325 (2), 445-452.

665. Lateef, F. (2004), SARS changes the ED paradigm. American Journal of Emergency Medicine, 22 (6), 483-487.

666. Adachi, D., Johnson, G., Draker, R., Ayers, M., Mazzulli, T., Talbot, P.J. and Tellier, R. (2004), Comprehensive detection and identification of human coronaviruses, including the SARS-associated coronavirus, with a single RT-PCR assay. Journal of Virological Methods, 122 (1), 29-36.

45

667. Wong, K.T., Antonio, G.E., Hui, D.S.C., Ho, C., Chan, P.N., Ng, W.H., Shing, K.K., Wu, A., Lee, N., Yap, F., Joynt, G.M., Sung, J.J.Y. and Ahuja, A. (2004), Severe acute respiratory syndrome - Thin-section computed tomography feotures, temporal chonges, ond clinicoradiologic correlotion during the convolescent period. Journal of Computer Assisted Tomography, 28 (6), 790-795.

668. Xu, Y.H., Lou, Z.Y., Liu, Y.W., Pang, H., Tien, P., Gao, G.F. and Rao, Z.H. (2004), Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core. Journal of Biological Chemistry, 279 (47), 49414-49419.

669. Chan, B.C.P., Lee, C.P. and Tang, G.W.K. (2004), Universal SARS preventive measures in an obstetrics unit: Experience of health care staff. American Journal of Infection Control, 32 (7), 417-420.

670. Fang, H.P., Chen, J.X., Hu, J. and Xu, L.X. (2004), On the origin of the super-spreading events in the SARS epidemic. Europhysics Letters, 68 (1), 147-152.

671. Luo, H.B., Ye, F., Sun, T., Yue, L.D., Peng, S.Y., Chen, J., Li, G.W., Du, Y., Xie, Y.H., Yang, Y.M., Shen, J.H., Wang, Y., Shen, X. and Jiang, H.L. (2004), In vitro biochemical and thermodynamic characterization of nucleocapsid protein of SARS. Biophysical Chemistry, 112 (1), 15-25.

672. He, Y.X., Zhou, Y.S., Liu, S.W., Kou, Z.H., Li, W.H., Farzan, M. and Jiang, S.B. (2004), Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochemical and Biophysical Research Communications, 324 (2), 773-781.

673. Qin, Z.L., Zhao, P., Zhang, X.L., Yu, J.G., Cao, M.M., Zhao, L.J., Luan, J. and Qi, Z.T. (2004), Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells. Biochemical and Biophysical Research Communications, 324 (4), 1186-1193.

674. Sainz, B., Mossel, E.C., Peters, C.J. and Garry, R.F. (2004), Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology, 329 (1), 11-17.

675. Poon, L.L.M., Guan, Y., Nicholls, J.M., Yuen, K.Y. and Peiris, J.S.M. (2004), The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infectious Diseases, 4 (11), 663-671.

676. Ho, M.S. and Su, L.J. (2004), Preparing to prevent severe acute respiratory syndrome and other respiratory infections. Lancet Infectious Diseases, 4 (11), 684-689.

677. Chan, P.K.S., To, W.K., Liu, E.Y.M., Ng, T.K., Tam, J.S., Sung, J.J.Y., Lacroix, J.M. and Houde, M. (2004), Evaluation of a peptide-based enzyme immunoassay for anti-SARS coronavirus IgG antibody. Journal of Medical Virology, 74 (4), 517-520.

678. Chiu, Y.C., Wu, K.L., Chou, Y.P., Fong, T.V., Tsai, T.L., Kuo, C.M., Kuo, C.H., Chiu, K.W., Liu, J.W., Eng, H.L., Dawan, B., Cheng, Y.F. and Chen, C.L. (2004), Diarrhea in medical care workers with severe acute respiratory syndrome. Journal of Clinical Gastroenterology, 38 (10), 880-882.

679. Kao, R.Y., To, A.P.C., Ng, L.W.Y., Tsui, W.H.W., Lee, T.S.W., Tsoi, H.W. and Yuen, K.Y. (2004), Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay. Febs Letters, 576 (3), 325-330.

680. Chang, L.Y., Huang, F.Y., Wu, Y.C., Su, I.J., Chiu, N.C., Chen, K.T., Wu, H.S., Lin, T.H., Peng, S.F., Kao, C.L., Lee, C.Y. and Huang, L.M. (2004), Childhood severe acute respiratory syndrome in Taiwan and how to differentiate it from childhood influenza infection. Archives of Pediatrics & Adolescent Medicine, 158 (11), 1037-1042.

681. Lau, A.C.W., So, L.K.Y., Miu, F.P.L., Yung, R.W.H., Poon, E., Cheung, T.M.T. and Yam, L.Y.C. (2004), Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol. Respirology, 9 (2), 173-183.

46

682. Tse, T.S., Tsui, K.L., Yam, L.Y.C., So, L.K.Y., Lau, A.C.W., Chan, K.K. and Li, S.K. (2004), Occult pneumomediastinum in a SARS patient presenting as recurrent chest pain and acute ECG changes mimicking acute coronary syndrome. Respirology, 9 (2), 271-273.

683. Marzi, A., Gramberg, T., Simmons, G., Moller, P., Rennekamp, A.J., Krumbiegel, M., Geier, M., Eisemann, J., Turza, N., Saunier, B., Steinkasserer, A., Becker, S., Bates, P., Hofmann, H. and Pohlmann, S. (2004), DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. Journal of Virology, 78 (21), 12090-12095.

684. Cheng, V.C.C., Tang, B.S.F., Wu, A.K.L., Chu, C.M. and Yuen, K.Y. (2004), Medical treatment if viral pneumonia including SARS in immunocompetent adult. Journal of Infection, 49 (4), 262-273.

685. Hofmann, H. and Pohlmann, S. (2004), Cellular entry of the SARS coronavirus. Trends in Microbiology, 12 (10), 466-472.

686. Foulongne, V., Lechiche, C., Reynes, J. and Segondy, M. (2004), Human metapneumovirus pneumonia in an adult patient hospitalized for suspected severe acute respiratory syndrome (SARS). Presse Medicale, 33 (15), 1006-1007.

687. Ho, J.C., Wu, A.Y., Lam, B., Ooi, G.C., Khong, P.L., Ho, R.L., Chan-Yeung, M., Zhong, N.S., Ko, C., Lam, W.K. and Tsang, K.W. (2004), Pentaglobin in steroid-resistant severe acute respiratory syndrome. International Journal of Tuberculosis and Lung Disease, 8 (10), 1173-1179.

688. Liu, W., Tang, F., Fontanet, A., Zhan, L., Zhao, Q.M., Zhang, P.H., Wu, X.M., Zuo, S.Q., Baril, L., Vabret, A., Xin, Z.T., Shao, Y.M., Yang, H. and Cao, W.C. (2004), Long-term SARS coronavirus excretion from patient cohort, China. Emerging Infectious Diseases, 10 (10), 1841-1843.

689. Ng, L.F., Hibberd, M.L., Ooi, E.E., Tang, K.F., Neo, S.Y., Tan, J., Murthy, K.R.K., Vega, V.B., Chia, J.M., Liu, E.T. and Ren, E.C. (2004), A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection. Bmc Infectious Diseases, 4.

690. Hogan, R.J., Cao, G.P., Rowe, T., Bell, P., Flieder, D., Paragas, J., Kobinger, G.P., Wivel, N.A., Crystal, R.G., Boyer, J., Feldmann, H., Voss, T.G. and Wilson, J.M. (2004), Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1. Journal of Virology, 78 (20), 11416-11421.

691. Kao, R.Y., Tsui, W.H.W., Lee, T.S.W., Tanner, J.A., Watt, R.M., Huang, J.D., Hu, L.H., Chen, G.H., Chen, Z.W., Zhang, L.Q., He, T., Chan, K.H., Tse, H., To, A.P.C., Ng, L.W.Y., Wong, B.C.W., Tsoi, H.W., Yang, D., Ho, D.D. and Yuen, K.Y. (2004), Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chemistry & Biology, 11 (9), 1293-1299.

692. Ko, S.F., Lee, T.Y., Huang, C.C., Cheng, Y.F., Ng, S.H., Kuo, Y.L., Lin, M.C., Liu, J.W., Yang, K.D., Chen, M.C. and Chen, C.L. (2004), Severe acute respiratory syndrome: Prognostic implications of chest radiographic findings in 52 patients. Radiology, 233 (1), 173-181.

693. Hsu, J.T.A., Kuo, C.J., Hsieh, H.P., Wang, Y.C., Huang, K.K., Lin, C.P.C., Huang, P.F., Chen, X. and Liang, P.H. (2004), Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV. Febs Letters, 574 (1-3), 116-120.

694. Cheung, T.M.T., Yam, L.Y.C., Lau, A.C.W., Kong, B.M.H. and Yung, R.W.H. (2004), Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome. Chest, 126 (3), 845-850.

695. Hussell, T., Snelgrove, R., Humphreys, I.R. and Williams, A.E. (2004), Co-stimulation: novel methods for preventing viral-induced lung inflammation. Trends in Molecular Medicine, 10 (8), 379-386.

696. Samaranayake, L.P. and Peiris, M. (2004), Severe acute respiratory syndrome and dentistry - A retrospective view. Journal of the American Dental Association, 135 (9), 1292-1302.

47

697. He, Y.X., Zhou, Y.S., Wu, H., Luo, B.J., Chen, J.M., Li, W.B. and Jiang, S.B. (2004), Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: Implication for developing SARS diagnostics and vaccines. Journal of Immunology, 173 (6), 4050-4057.

698. Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. and Van Ranst, M. (2004), In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochemical and Biophysical Research Communications, 323 (1), 264-268.

699. Parashar, U.D. and Anderson, L.J. (2004), Severe acute respiratory syndrome: review and lessons of the 2003 outbreak. International Journal of Epidemiology, 33 (4), 628-634.

700. Prentice, E., McAuliffe, J., Lu, X.T., Subbarao, K. and Denison, M.R. (2004), Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. Journal of Virology, 78 (18), 9977-9986.

701. Hung, I.F.N., Cheng, V.C.C., Wu, A.K.L., Tang, B.S.F., Chan, K.H., Chu, C.M., Wong, M.M.L., Hui, W.T., Poon, L.L.M., Tse, D.M.W., Chan, K.S., Woo, P.C.Y., Lau, S.K.P., Peiris, J.S.M. and Yuen, K.Y. (2004), Viral loads in clinical specimens and SARS manifestations. Emerging Infectious Diseases, 10 (9), 1550-1557.

702. Liu, H., Ding, Y.L., Han, W., Liu, M.Y., Tian, R.Y., Yang, S.L. and Gong, Y. (2004), Recombinant scFv antibodies against E protein and N protein of severe acute respiratory syndrome virus. Acta Biochimica et Biophysica Sinica, 36 (8), 541-547.

703. Ko, P.C.I., Chen, W.J., Ma, M.H.M., Chiang, W.C., Su, C.P., Huang, C.H., Lu, T.C., Shih, F.Y. and Lin, F.Y. (2004), Emergency medical services utilization during an outbreak of severe acute respiratory syndrome (SARS) and the incidence of SARS-associated coronavirus infection among emergency medical technicians. Academic Emergency Medicine, 11 (9), 903-911.

704. Ivanov, K.A., Hertzig, T., Rozanov, M., Bayer, S., Thiel, V., Gorbalenya, A.E. and Ziebuhr, J. (2004), Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proceedings of the National Academy of Sciences of the United States of America, 101 (34), 12694-12699.

705. De Clercq, E. (2004), Antivirals and antiviral strategies. Nature Reviews Microbiology, 2 (9), 704-720.

706. Nie, Y.C., Wang, G.W., Shi, X.L., Zhang, H., Qiu, Y., He, Z.P., Wang, W., Lian, G.W., Yin, X.L., Du, L.Y., Ren, L.L., Wang, J.W., He, X., Li, T.S., Deng, H.K. and Ding, M.X. (2004), Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. Journal of Infectious Diseases, 190 (6), 1119-1126.

707. Zhang, Y., Zheng, N., Hao, P. and Zhong, Y. (2004), Reconstruction of the most recent common ancestor sequences of SARS-Cov S gene and detection of adaptive evolution in the spike protein. Chinese Science Bulletin, 49 (12), 1311-1313.

708. Ziebuhr, J. (2004), Molecular biology of severe acute respiratory syndrome coronavirus. Current Opinion in Microbiology, 7 (4), 412-419.

709. Wu, K.L., Lu, S.N., Changchien, C.S., Chiu, K.W., Kuo, C.H., Chuah, S.K., Liu, J.W., Lin, M.C., Eng, H.L., Chen, S.S., Lee, C.N. and Chen, C.L. (2004), Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome. American Journal of Tropical Medicine and Hygiene, 71 (2), 125-128.

710. Giroglou, T., Cinatl, J., Rabenau, H., Drosten, C., Schwalbe, H., Doerr, H.W. and von Laer, D. (2004), Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein. Journal of Virology, 78 (17), 9007-9015.

711. Schickli, J.H., Thackray, L.B., Sawicki, S.G. and Holmes, K.V. (2004), The N-terminal region of the murine coronavirus spike glycoprotein is associated with the extended host range of viruses from persistently infected murine cells. Journal of Virology, 78 (17), 9073-9083.

712. Bener, A. and Al-Khal, A. (2004), Knowledge, attitude and practice towards SARS. Journal of the Royal Society for the Promotion of Health, 124 (4), 167-170.

48

713. Liu, J. (2004), A rate equation approach to model the denaturation or replication behavior of the SARS coronavirus. Forschung Im Ingenieurwesen-Engineering Research, 68 (4), 227-238.

714. Chau, T.N., Lee, P.O., Choi, K.W., Lee, C.M., Ma, K.F., Tsang, T.Y., Tso, Y.K., Chiu, M.C., Tong, W.L., Yu, W.C. and Lai, S.T. (2004), Value of initial chest radiographs for predicting clinical outcomes in patients with severe acute respiratory syndrome. American Journal of Medicine, 117 (4), 249-254.

715. Chan, T.Y., Miu, K.Y., Tsui, C.K., Yee, K.S. and Chan, M.H. (2004), A comparative study of clinical features and outcomes in young and older adults with severe acute respiratory syndrome. Journal of the American Geriatrics Society, 52 (8), 1321-1325.

716. Lin, C.L., Lu, Y.T., Peng, M.J., Chen, P.J., Lin, R.L., Wu, C.L. and Kuo, H.T. (2004), Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever. Chest, 126 (2), 509-517.

717. Chong, M.Y., Wang, W.C., Hsieh, W.C., Lee, C.Y., Chiu, N.M., Yeh, W.C., Huang, T.L., Wen, J.K. and Chen, C.L. (2004), Psychological impact of severe acute respiratory syndrome on health workers in a tertiary hospital. British Journal of Psychiatry, 185), 127-133.

718. Lim, P.A., Ng, Y.S. and Tay, B.K. (2004), Impact of a viral respiratory epidemic on the practice of medicine and rehabilitation: Severe acute respiratory syndrome. Archives of Physical Medicine and Rehabilitation, 85 (8), 1365-1370.

719. Wong, S.F., Chow, K.M., Leung, T.N., Ng, W.F., Ng, T.K., Shek, C.C., Ng, P.C., Lam, P.W.Y., Ho, L.C., To, W.W.K., Lai, S.T., Yan, W.W. and Tan, P.Y.H. (2004), Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. American Journal of Obstetrics and Gynecology, 191 (1), 292-297.

720. Nomura, R., Kiyota, A., Suzaki, E., Kataoka, K., Ohe, Y., Miyamoto, K., Senda, T. and Fujimoto, T. (2004), Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. Journal of Virology, 78 (16), 8701-8708.

721. Hui, D.S.C. and Wong, G.W.K. (2004), Advancements in the battle against severe acute respiratory syndrome. Expert Opinion on Pharmacotherapy, 5 (8), 1687-1693.

722. Lam, C.M., Wong, S.F., Leung, T.N., Chow, K.M., Yu, W.C., Wong, T.Y., Lai, S.T. and Ho, L.C. (2004), A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome. Bjog-An International Journal of Obstetrics and Gynaecology, 111 (8), 771-774.

723. Houng, H.S.H., Norwood, D., Ludwig, G.V., Sun, W., Lin, M.T. and Vaughn, D.W. (2004), Development and evaluation of an efficient 3 '-noncoding region based SARS coronavirus (SARS-CoV) RT-PCR assay for detection of SARS-CoV infections. Journal of Virological Methods, 120 (1), 33-40.

724. Chan, P.K.S., To, K.F., Lo, A.W.I., Cheung, J.L.K., Chu, I., Au, F.W.L., Tong, J.H.M., Tam, J.S., Sung, J.J.Y. and Ng, H.K. (2004), Persistent infection of SARS coronavirus in colonic cells in vitro. Journal of Medical Virology, 74 (1), 1-7.

725. Zheng, B.J., He, M.L., Wong, K.L., Lum, C.T., Poon, L.L.M., Peng, Y., Guan, Y., Lin, M.C.M. and Kung, H.F. (2004), Potent inhibition of SARS-associated coronavirus (SCoV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma). Journal of Interferon and Cytokine Research, 24 (7), 388-390.

726. Cheung, O.Y., Chan, J.W.M., Ng, C.K. and Koo, C.K. (2004), The spectrum of pathological changes in severe acute respiratory syndrome (SARS). Histopathology, 45 (2), 119-124.

727. Hsu, H.H., Tzao, C., Wu, C.P., Chang, W.C., Tsai, C.L., Tung, H.J. and Chen, C.Y. (2004), Correlation of high-resolution CT, symptoms, and pulmonary function in patients during recovery from severe acute respiratory syndrome. Chest, 126 (1), 149-158.

728. Han, D.P., Kim, H.G., Kim, Y.B., Poon, L.L.M. and Cho, M.W. (2004), Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein. Virology, 326 (1), 140-149.

49

729. Woo, P.C.Y., Lau, S.K.P., Wong, B.H.L., Chan, K.H., Chu, C.M., Tsoi, H.W., Huang, Y., Peiris, J.S.M. and Yuen, K.Y. (2004), Longitudinal profile of immunoglobulin G (IgG), IgM, and TgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clinical and Diagnostic Laboratory Immunology, 11 (4), 665-668.

730. Guan, M., Chan, K.H., Peiris, J.S.M., Kwan, S.W., Lam, S.Y., Pang, C.M., Chu, K.W., Chan, K.M., Chen, H.Y., Phuah, E.B. and Wong, C.J. (2004), Evaluation and validation of an enzyme-linked immunosorbent assay and an immunochromatographic test for serological diagnosis of severe acute respiratory syndrome. Clinical and Diagnostic Laboratory Immunology, 11 (4), 699-703.

731. He, Z.P., Dong, Q.M., Zhuang, H., Song, S.J., Peng, G., Luo, G.X. and Dwyer, D.E. (2004), Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS. Clinical and Diagnostic Laboratory Immunology, 11 (4), 792-794.

732. Sihoe, A.D.L., Wong, R.H.L., Lee, A.T.H., Lau, L.S., Leung, N.Y.Y., Law, K.I. and Yim, A.P.C. (2004), Severe acute respiratory syndrome complicated by spontaneous pneumothorax. Chest, 125 (6), 2345-2351.

733. Li, R.W.K., Leung, K.W.C., Sun, F.C.S. and Samaranayake, L.P. (2004), Severe Acute Respiratory Syndrome (SARS) and the GDP. Part I : Epidemiology, virology, pathology and general health issues. British Dental Journal, 197 (2), 77-80.

734. Wu, C.Y., Jan, J.T., Ma, S.H., Kuo, C.J., Juan, H.F., Cheng, Y.S.E., Hsu, H.H., Huang, H.C., Wu, D., Brik, A., Liang, F.S., Liu, R.S., Fang, J.M., Chen, S.T., Liang, P.H. and Wong, C.H. (2004), Small molecules targeting severe acute respiratory syndrome human coronavirus. Proceedings of the National Academy of Sciences of the United States of America, 101 (27), 10012-10017.

735. Hui, D.S.C., Chan, M.C.H., Wu, A.K. and Ng, P.C. (2004), Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgraduate Medical Journal, 80 (945), 373-381.

736. Bush, R.M. (2004), Influenza as a model system for studying the cross-species transfer and evolution of the SARS coronavirus. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences, 359 (1447), 1067-1073.

737. Peiris, J.S.M. and Guan, Y. (2004), Confronting SARS: a view from Hong kong. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences, 359 (1447), 1075-1079.

738. Bermingham, A., Heinen, P., Iturriza-Gomara, M., Gray, J., Appleton, H. and Zambon, M.C. (2004), Laboratory diagnosis of SARS. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences, 359 (1447), 1083-1089.

739. Anderson, R.M., Fraser, C., Ghani, A.C., Donnelly, C.A., Riley, S., Ferguson, N.M., Leung, G.M., Lam, T.H. and Hedley, A.J. (2004), Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences, 359 (1447), 1091-1105.

740. Maunder, R. (2004), The experience of the 2003 SARS outbreak as a traumatic stress among frontline healthcare workers in Toronto: lessons learned. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences, 359 (1447), 1117-1125.

741. Lau, S.K.P., Woo, P.C.Y., Wong, B.H.L., Tsoi, H.W., Woo, G.K.S., Poon, R.W.S., Chan, K.H., Wei, W.I., Peiris, J.S.M. and Yuen, K.Y. (2004), Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in SARS patients by enzyme-linked immunosorbent assay. Journal of Clinical Microbiology, 42 (7), 2884-2889.

742. Yang, M., Li, C.K., Li, K., Hon, K.L.E., Ng, M.H.L., Chan, P.K.S. and Fok, T.F. (2004), Hematological findings in SARS patients and possible mechanisms (Review). International Journal of Molecular Medicine, 14 (2), 311-315.

50

743. Ng, M.H.L., Lau, K.M., Li, L., Cheng, S.H., Chan, W.Y., Hui, P.K., Zee, B., Leung, C.B. and Sung, J.J.Y. (2004), Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. Journal of Infectious Diseases, 190 (3), 515-518.

744. Thackray, L.B. and Holmes, K.V. (2004), Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59. Virology, 324 (2), 510-524.

745. Wang, W.K., Chen, S.Y., Liu, I.J., Chen, Y.C., Chen, H.L., Yang, C.F., Chen, P.J., Yeh, S.H., Kao, C.L., Huang, L.M., Hsueh, P.R., Wang, J.T., Sheng, W.H., Fang, C.T., Hung, C.C., Hsieh, S.M., Su, C.P., Chiang, W.C., Yang, J.Y., Lin, J.H., Hsieh, S.C., Hu, H.P., Chiang, Y.P., Wang, J.T., Yang, P.C. and Chang, S.C. (2004), Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerging Infectious Diseases, 10 (7), 1213-1219.

746. Nitsche, A., Schweiger, B., Ellerbrok, H., Niedrig, M. and Pauli, G. (2004), SARS coronavirus detection. Emerging Infectious Diseases, 10 (7), 1300-1303.

747. Van Bever, H.P., Chng, S.Y. and Goh, D.Y. (2004), Childhood severe acute respiratory syndrome, coronavirus infections and asthma. Pediatric Allergy and Immunology, 15 (3), 206-209.

748. Leung, D.T.M., Tam, F.C.H., Ma, C.H., Chan, P.K.S., Cheung, J.L.K., Niu, H.T., Tam, J.S.L. and Lim, P.L. (2004), Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. Journal of Infectious Diseases, 190 (2), 379-386.

749. Lim, W.S., Anderson, S.R. and Read, R.C. (2004), Hospital management of adults with severe acute respiratory syndrome (SARS) if SARS re-emergesupdated 10 February 2004. Journal of Infection, 49 (1), 1-7.

750. Zeng, F.Y., Chan, C.W.M., Chan, M.N., Chen, J.D., Chow, K.Y.C., Hon, C.C., Hui, K.H., Li, J., Li, V.Y.Y., Wang, C.Y., Wang, P.Y., Guan, Y., Zheng, B., Poon, L.L.M., Chan, K.H., Yuen, K.Y., Peiris, J.S.M. and Leung, F.C. (2003), The complete genome sequence of severe acute respiratory syndrome caronavirus strain HKU-39849 (HK-39). Experimental Biology and Medicine, 228 (7), 866-873.

751. Hong, N. and Du, X.K. (2004), Avascular necrosis of bone in severe acute respiratory syndrome. Clinical Radiology, 59 (7), 602-608.

752. Wang, B.M., Chen, H.B., Jiang, X.D., Zhang, M.H., Wan, T., Li, N., Zhou, X.Y., Wu, Y.F., Yang, F., Yu, Y.Z., Wang, X.N., Yang, R.F. and Cao, X.T. (2004), Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope SSp-1 of SARS-CoV spike protein. Blood, 104 (1), 200-206.

753. Ng, P.C., Leung, C.W., Chiu, W.K., Wong, S.F. and Hon, E.K.L. (2004), SARS in newborns and children. Biology of the Neonate, 85 (4), 293-298.

754. Hofmann, H., Geier, M., Marzi, A., Krumbiegel, M., Peipp, M., Fey, G.H., Gramberg, T. and Pohlmann, S. (2004), Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochemical and Biophysical Research Communications, 319 (4), 1216-1221.

755. Tan, Y.J., Teng, E., Shen, S., Tan, T.H.P., Goh, P.Y., Fielding, B.C., Ooi, E.E., Tan, H.C., Lim, S.G. and Hong, W.J. (2004), A novel severe acute respiratory syndrome coronavirus protein U274, is transported to the cell surface and undergoes endocytosis. Journal of Virology, 78 (13), 6723-6734.

756. Zhang, H., Wang, G.W., Li, H., Nie, Y.C., Shi, X.L., Lian, G.W., Wang, W., Yin, X.L., Zhao, Y., Qu, X.X., Ding, M.X. and Deng, H.K. (2004), Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies. Journal of Virology, 78 (13), 6938-6945.

51

757. Hertzig, T., Scandella, E., Schelle, B., Ziebuhr, J., Siddell, S.G., Ludewig, B. and Thiel, V. (2004), Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA. Journal of General Virology, 85), 1717-1725.

758. Timani, K.A., Ye, L., Ye, L.B., Zhu, Y., Wu, Z.H. and Gong, Z.J. (2004), Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS. Journal of Clinical Virology, 30 (4), 309-312.

759. Hussell, T. and Williams, A. (2004), Menage a trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lung. Clinical and Experimental Immunology, 137 (1), 8-11.

760. Zhu, J.Q., Xiao, G.F., Xu, Y.H., Yuan, F., Zheng, C.Y., Liu, Y.Y., Yan, H.M., Cole, D.K., Bell, J.I., Rao, Z.H., Tien, P. and Gao, G.F. (2004), Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors. Biochemical and Biophysical Research Communications, 319 (1), 283-288.

761. Hua, R.H., Zhou, Y.J., Wang, Y.F., Hua, Y.Z. and Tong, G.Z. (2004), Identification of two antigenic epitopes on SARS-CoV spike protein. Biochemical and Biophysical Research Communications, 319 (3), 929-935.

762. Tan, T.K. (2004), How severe acute respiratory syndrome (SARS) affected the Department of Anaesthesia at Singapore General Hospital. Anaesthesia and Intensive Care, 32 (3), 394-400.

763. Ingallinella, P., Bianchi, E., Finotto, M., Cantoni, G., Eckert, D.M., Supekar, V.M., Bruckmann, C., Carfi, A. and Pessi, A. (2004), Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus. Proceedings of the National Academy of Sciences of the United States of America, 101 (23), 8709-8714.

764. Zeng, R., Ruan, H.Q., Jiang, X.S., Zhou, H., Shi, L., Zhang, L., Sheng, Q.H., Tu, Q., Xia, Q.C. and Wu, J.R. (2004), Proteomic analysis of SARS associated coronavirus using two-dimensional liquid chromatography mass spectrometry and one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by mass spectroemtric analysis. Journal of Proteome Research, 3 (3), 549-555.

765. Che, X.Y., Qiu, L.W., Pan, Y.X., Wen, K., Hao, W., Zhang, L.Y., Wang, Y.D., Liao, Z.Y., Hua, X., Cheng, V.C.C. and Yuen, K.Y. (2004), Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. Journal of Clinical Microbiology, 42 (6), 2629-2635.

766. Chu, C.M., Leung, Y.Y., Hui, J.Y.H., Hung, I.F.N., Chan, V.L., Leung, W.S., Law, K.I., Chan, C.S., Chan, K.S. and Yuen, K.Y. (2004), Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome. European Respiratory Journal, 23 (6), 802-804.

767. Wilder-Smith, A., Green, J.A. and Paton, N.I. (2004), Hospitalized patients with bacterial infections: a potential focus of SARS transmission during an outbreak. Epidemiology and Infection, 132 (3), 407-408.

768. Chin, T.W.F., Chant, C., Tanzini, R. and Wells, J. (2004), Severe acute respiratory syndrome (SARS): The pharmacist's role. Pharmacotherapy, 24 (6), 705-712.

769. Leung, C.W., Kwan, Y.W., Ko, P.W., Chiu, S.S., Loung, P.Y., Fong, N.C., Lee, L.P., Hui, Y.W., Law, H.K.W., Wong, W.H.S., Chan, K.H., Peiris, J.S.M., Lim, W.W.L., Lau, Y.L. and Chiu, M.C. (2004), Severe acute respiratory syndrome among children. Pediatrics, 113 (6), E535-E543.

770. Yang, S. and Rothman, R.E. (2004), PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infectious Diseases, 4 (6), 337-348.

52

771. Spiegel, M., Pichlmair, A., Muhlberger, E., Haller, O. and Weber, F. (2004), The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. Journal of Clinical Virology, 30 (3), 211-213.

772. Poon, L.L.M., Wong, B.W.Y., Chan, K.H., Leung, C.S.W., Yuen, K.Y., Guan, Y. and Peiris, J.S.M. (2004), A one step quantitative RT-PCR for detection of SARS coronavirus with an internal control for PCR inhibitors. Journal of Clinical Virology, 30 (3), 214-217.

773. Choy, W.Y., Lin, S.G., Chan, P.K.S., Tam, J.S.L., Lo, Y.M.D., Chu, I.M.T., Tsai, S.N., Zhong, M.Q., Fung, K.P., Waye, M.M.Y., Tsui, S.K.W., Ng, K.O., Shan, Z.X., Yang, M., Wu, Y.L., Lin, Z.Y. and Ngai, S.M. (2004), Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: Perspective for SARS vaccine development. Clinical Chemistry, 50 (6), 1036-1042.

774. Poon, L.L.M., Leung, C.S.W., Tashiro, M., Chan, K.H., Wong, B.W.Y., Yuen, K.Y., Guan, Y. and Peiris, J.S.M. (2004), Rapid detection of the severe acute respiratory syndrome (SARS) coronavirus by a loop-mediated isothermal amplification assay. Clinical Chemistry, 50 (6), 1050-1052.

775. Kuo, C.J., Chi, Y.H., Hsu, J.T.A. and Liang, P.H. (2004), Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate. Biochemical and Biophysical Research Communications, 318 (4), 862-867.

776. Hofmann, H., Hattermann, K., Marzi, A., Gramberg, T., Geier, M., Krumbiegel, M., Kuate, S., Uberla, K., Niedrig, M. and Pohlmann, S. (2004), S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. Journal of Virology, 78 (12), 6134-6142.

777. Zhang, Q.F., Cui, J.M., Huan, X.J., Zheng, H.Y., Huang, J.H., Ling, F., Li, K.P. and Zhang, J.Q. (2004), The life cycle of SARS coronavirus in Vero E6 cells. Journal of Medical Virology, 73 (3), 332-337.

778. Huang, L.R., Chiu, C.M., Yeh, S.H., Huang, W.H., Hsueh, P.R., Yang, W.Z., Yang, J.Y., Su, I.J., Chang, S.C. and Chen, P.J. (2004), Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA. Journal of Medical Virology, 73 (3), 338-346.

779. Wang, Y.H., Lin, A.S., Chao, T.Y., Lu, S.N., Liu, J.W., Chen, S.S. and Lin, M.C. (2004), A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan. Intensive Care Medicine, 30 (6), 1228-1231.

780. Louie, J.K., Hacker, J.K., Mark, J., Gavali, S.S., Yagi, S., Espinosa, A., Schnurr, D.P., Cossen, C.K., Isaacson, E.R., Glaser, C.A., Fischer, M., Reingold, A.L. and Vugia, D.J. (2004), SARS and common viral infections. Emerging Infectious Diseases, 10 (6), 1143-1146.

781. Ivanov, K.A., Thiel, V., Dobbe, J.C., van der Meer, Y., Snijder, E.J. and Ziebuhr, J. (2004), Multiple enzymatic activities associated with Severe acute respiratory syndrome coronavirus helicase. Journal of Virology, 78 (11), 5619-5632.

782. Ding, Y.Q., He, L., Zhang, Q.L., Huang, Z.X., Che, X.Y., Hou, J.L., Wang, H.J., Shen, H., Qiu, L.W., Li, Z.G., Geng, J., Cai, J.J., Han, H.X., Li, X., Kang, W., Weng, D.S., Liang, P. and Jiang, S.B. (2004), Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. Journal of Pathology, 203 (2), 622-630.

783. Hamming, I., Timens, W., Bulthuis, M.L.C., Lely, A.T., Navis, G.J. and van Goor, H. (2004), Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Journal of Pathology, 203 (2), 631-637.

784. Thai, H.T.C., Le, M.Q., Vuong, C.D., Parida, M., Minekawa, H., Notomi, T., Hasebe, F. and Morita, K. (2004), Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus. Journal of Clinical Microbiology, 42 (5), 1956-1961.

53

785. Hui, R.K.H., Zeng, F.Y., Chan, C.M.N., Yuen, K.Y., Peiris, J.S.M. and Leung, F.C.C. (2004), Reverse transcriptase PCR diagnostic assay for the coronavirus associated with severe acute respiratory syndrome. Journal of Clinical Microbiology, 42 (5), 1994-1999.

786. Drosten, C., Chiu, L.L., Panning, M., Leong, H.N., Preiser, W., Tam, J.S., Gunther, S., Kramme, S., Emmerich, P., Ng, W.L., Schmitz, H. and Koay, E.S.C. (2004), Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. Journal of Clinical Microbiology, 42 (5), 2043-2047.

787. Woo, P.C.Y., Lau, S.K.P., Wong, B.H.L., Tsoi, H., Fung, A.M.Y., Chan, K.H., Tam, V.K.P., Peiris, J.S.M. and Yuen, K. (2004), Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. Journal of Clinical Microbiology, 42 (5), 2306-2309.

788. Sun, Z.F. and Meng, X.J. (2004), Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: Implication for SARS diagnosis. Journal of Clinical Microbiology, 42 (5), 2351-2352.

789. Puthucheary, J., Lim, D., Chan, I., Chay, O.M. and Choo, P. (2004), Severe acute respiratory syndrome in Singapore. Archives of Disease in Childhood, 89 (6), 551-556.

790. Ter Chee, V.W., Khoo, M.L.C., Lee, S.F., Lai, Y.C. and Chin, N.M. (2004), Infection control measures for operative procedures in severe acute respiratory syndrome-related patients. Anesthesiology, 100 (6), 1394-1398.

791. Kuiken, T., van den Hoogen, B.G., van Riel, D.A.J., Laman, J.D., van Amerongen, G., Sprong, L., Fouchier, R.A.M. and Osterhaus, A.D.M.E. (2004), Experimental human metapneumovirus infection of cynomolgus Macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. American Journal of Pathology, 164 (6), 1893-1900.

792. Wu, Q.F., Xu, Z.Y., Wei, T., Zeng, H.P., Li, J.X., Gang, H.X., Sun, M., Jiang, F.B., Wang, X., Dong, W., Yang, L. and Wang, J. (2004), Development of taqman RT-nested PCR system for clinical SARS-CoV detection. Journal of Virological Methods, 119 (1), 17-23.

793. Hsueh, P.R. and Yang, P.C. (2003), Severe acute respiratory syndrome (SARS) anemerging infection of the 21st century. Journal of the Formosan Medical Association, 102 (12), 825-839.

794. Chen, W.J., Xu, Z.Y., Mu, J.S., Yang, L., Gan, H.X., Mu, F., Fan, B.X., He, B., Huang, S.Y., You, B., Yang, Y.K., Tang, X.J., Qiu, L., Qiu, Y., Wen, J., Fang, J.Q. and Wang, J. (2004), Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection. Journal of Medical Microbiology, 53 (5), 435-438.

795. Cheng, P.K.C., Wong, D.A., Tong, L.K.L., Ip, S.M., Lo, A.C.T., Lau, C.S., Yeung, E.Y.H. and Lim, W.W.L. (2004), Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome. Lancet, 363 (9422), 1699-1700.

796. Tripet, B., Howard, M.W., Jobling, M., Holmes, R.K., Holmes, K.V. and Hodges, R.S. (2004), Structural characterization of the SARS-coronavirus spike S fusion protein core. Journal of Biological Chemistry, 279 (20), 20836-20849.

797. Naylor, C.D., Chantler, C. and Griffiths, S. (2004), Learning from SARS in Hong Kong and Toronto. Jama-Journal of the American Medical Association, 291 (20), 2483-2487.

798. Chan, P.K.S., To, W.K., Ng, K.C., Lam, R.K.Y., Ng, T.K., Chan, R.C.W., Wu, A., Yu, W.C., Lee, N., Hui, D.S.C., Lai, S.T., Hon, E.K.L., Li, C.K., Sung, J.J.Y. and Tam, J.S. (2004), Laboratory diagnosis of SARS. Emerging Infectious Diseases, 10 (5), 825-831.

799. Swayne, D.E., Suarez, D.L., Spackman, E., Tumpey, T.M., Beck, J.R., Erdman, D., Rollin, P.E. and Ksiazek, T.G. (2004), Domestic poultry and SARS coronavirus, southern China. Emerging Infectious Diseases, 10 (5), 914-916.

54

800. Christian, M.D., Poutanen, S.M., Loutfy, M.R., Muller, M.P. and Low, D.E. (2004), Severe acute respiratory syndrome. Clinical Infectious Diseases, 38 (10), 1420-1427.

801. Bisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P.L., Murphy, B.R., Subbarao, K. and Moss, B. (2004), Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proceedings of the National Academy of Sciences of the United States of America, 101 (17), 6641-6646.

802. Mahony, J.B., Petrich, A., Louie, L., Song, X.Y., Chong, S., Smieja, M., Chernesky, M., Loeb, M. and Richardson, S. (2004), Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-PCR assays for detection of severe acute respiratory syndrome coronavirus. Journal of Clinical Microbiology, 42 (4), 1471-1476.

803. Lu, L.Q., Manopo, I., Leung, B.P., Chng, H.H., Ling, A.E., Chee, L.L., Ooi, E.E., Chan, S.W. and Kwang, J. (2004), Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. Journal of Clinical Microbiology, 42 (4), 1570-1576.

804. Fouchier, R.A.M., Hartwig, N.G., Bestebroer, T.M., Niemeyer, B., de Jong, J.C., Simon, J.H. and Osterhaus, A.D.M.E. (2004), A previously undescribed coronavirus associated with respiratory disease in humans. Proceedings of the National Academy of Sciences of the United States of America, 101 (16), 6212-6216.

805. Babcock, G.J., Esshaki, D.J., Thomas, W.D. and Ambrosino, D.M. (2004), Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. Journal of Virology, 78 (9), 4552-4560.

806. Kim, T.W., Lee, J.H., Hung, C.F., Peng, S.W., Roden, R., Wang, M.C., Viscidi, R., Tsai, Y.C., He, L.M., Chen, P.J., Boyd, D.A.K. and Wu, T.C. (2004), Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. Journal of Virology, 78 (9), 4638-4645.

807. Rainer, T.H. (2004), Severe acute respiratory syndrome: clinical features, diagnosis, and management. Current Opinion in Pulmonary Medicine, 10 (3), 159-165.

808. Chan, H.L.Y., Leung, W.K., To, K.F., Chan, P.K.S., Lee, N., Wu, A., Tam, J.S.L. and Sung, J.J.Y. (2004), Retrospective analysis of liver function derangement in severe acute respiratory syndrome. American Journal of Medicine, 116 (8), 566-567.

809. Rainer, T.H., Chan, P.K.S., Ip, M., Lee, N., Hui, D.S., Smit, D., Wu, A., Ahuja, A.T., Tam, J.S., Sung, J.J.Y. and Cameron, P. (2004), The spectrum of severe acute respiratory syndrome-associated coronavirus infection. Annals of Internal Medicine, 140 (8), 614-619.

810. Keeler, N. and Lingappa, J. (2004), Severe acute respiratory syndrome: public health response and clinical practice update for an emerging disease. Current Opinion in Pediatrics, 16 (1), 61-69.

811. Davidson, A. and Siddell, S. (2003), Potential for antiviral treatment of severe acute respiratory syndrome. Current Opinion in Infectious Diseases, 16 (6), 565-571.

812. Wang, J.T. and Chang, S.C. (2004), Severe acute respiratory syndrome. Current Opinion in Infectious Diseases, 17 (2), 143-148.

813. Ooi, S.B.S. and Tambyah, P.A. (2004), Transmission of severe acute respiratory syndrome in an emergency department. American Journal of Medicine, 116 (7), 486-489.

814. Farr, B.M. (2004), The state of the science. American Journal of Infection Control, 32 (2), 106-113.

815. Schmidt, M., Brixner, V., Ruster, B., Hourfar, M.K., Drosten, C., Preiser, W., Seifried, E. and Roth, W.K. (2004), NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions. Transfusion, 44 (4), 470-475.

816. Abdullah, A.S.M., Thomas, G.N., Mcghee, S.M. and Morisky, D.E. (2004), Impact of severe acute respiratory syndrome (SARS) on travel and population mobility: Implications for travel medicine practitioners. Journal of Travel Medicine, 11 (2), 107-111.

55

817. Simmons, G., Reeves, J.D., Rennekamp, A.J., Amberg, S.M., Piefer, A.J. and Bates, P. (2004), Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proceedings of the National Academy of Sciences of the United States of America, 101 (12), 4240-4245.

818. Stadler, K., Masignani, V., Eickmann, M., Becker, S., Abrignani, S., Klenk, H.D. and Rappuoli, R. (2003), SARS - Beginning to understand a new virus. Nature Reviews Microbiology, 1 (3), 209-218.

819. Pennington, H. (2004), Politics, media and microbiologists. Nature Reviews Microbiology, 2 (3), 259-262.

820. Leung, T.F., Ng, P.C., Cheng, F.W.T., Lyon, D.J., So, K.W., Hon, E.K.L., Li, A.M., Li, C.K., Wong, G.W.K., Nelson, E.A.S., Hui, J., Sung, R.Y.T., Yam, M.C. and Fok, T.F. (2004), Infection control for SARS in a tertiary paediatric centre in Hong Kong. Journal of Hospital Infection, 56 (3), 215-222.

821. Tse, G.M.K., Hui, P.K., Ma, T.K.F., Lo, A.W.I., To, K.F., Chan, W.Y., Chow, L.T.C. and Ng, H.K. (2004), Sputum cytology of patients with severe acute respiratory syndrome (SARS). Journal of Clinical Pathology, 57 (3), 256-259.

822. Tse, G.M.K., To, K.F., Chan, P.K.S., Lo, A.W.I., Ng, K.C., Wu, A., Lee, N., Wong, H.C., Mak, S.M., Chan, K.F., Hui, D.S.C., Sung, J.J.Y. and Ng, H.K. (2004), Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). Journal of Clinical Pathology, 57 (3), 260-265.

823. Bressler, A.M. and Nolte, F.S. (2004), Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus. Journal of Clinical Microbiology, 42 (3), 987-991.

824. Tan, Y.J., Goh, P.Y., Fielding, B.C., Shen, S., Chou, C.F., Fu, J.L., Leong, H.N., Leo, Y.S., Ooi, E.E., Ling, A.E., Lim, S.G. and Hong, W.J. (2004), Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clinical and Diagnostic Laboratory Immunology, 11 (2), 362-371.

825. He, Q.G., Chong, K.H., Chng, H.H., Leung, B., Ling, A.E., Wei, T., Chan, S.W., Ooi, E.E. and Kwang, J. (2004), Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome. Clinical and Diagnostic Laboratory Immunology, 11 (2), 417-422.

826. Zheng, K.W., Yu, Q.S., Wang, Y.H., Zhang, B. and Hu, G.X. (2004), Electrostatic and hydrophobic interactions in SARS coronavirus main proteinase dimer. Acta Chimica Sinica, 62 (6), 542-549.

827. Egloff, M.P., Ferron, F., Campanacci, V., Longhi, S., Rancurel, C., Dutartre, H., Snijder, E.J., Gorbalenya, A.E., Cambillau, C. and Canard, B. (2004), The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proceedings of the National Academy of Sciences of the United States of America, 101 (11), 3792-3796.

828. Chan, M.H.M., Wong, V.W.S., Wong, C.K., Chan, P.K.S., Chu, C.M., Hui, D.S.C., Suen, M.W.M., Sung, J.J.Y., Chung, S.S.C. and Lam, C.W.K. (2004), Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome. Journal of Internal Medicine, 255 (4), 512-518.

829. Humar, A., McGilvray, I., Phillips, M.J. and Levy, G.A. (2004), Severe acute respiratory syndrome and the liver. Hepatology, 39 (2), 291-294.

830. Chau, T.N., Lee, K.C., Yao, H., Tsang, T.Y., Chow, T.C., Yeung, Y.C., Choi, K.W., Tso, Y.K., Lau, T., Lai, S.T. and Lai, C.L. (2004), SARS-associated viral hepatitis caused by a novel coronavirus: Report of three cases. Hepatology, 39 (2), 302-310.

831. Wong, C.K., Lam, C.W.K., Wu, A.K.L., Ip, W.K., Lee, N.L.S., Chan, I.H.S., Lit, L.C.W., Hui, D.S.C., Chan, M.H.M., Chung, S.S.C. and Sung, J.J.Y. (2004), Plasma inflammatory

56

cytokines and chemokines in severe acute respiratory syndrome. Clinical and Experimental Immunology, 136 (1), 95-103.

832. Paul, N.S., Roberts, H., Butany, J., Chung, T.B., Gold, W., Mehta, S., Konen, E., Rao, A., Provost, Y., Hong, H.H., Zelovitsky, L. and Weisbrod, G.L. (2004), Radiologic pattern of disease in patients with severe acute respiratory syndrome: The Toronto experience. Radiographics, 24 (2), 553-563.

833. Lu, H.C., Zhao, Y., Zhang, J.F., Wang, Y.L., Li, W., Zhu, X.P., Sun, S.W., Xu, J.Y., Ling, L.J., Cai, L., Bu, D.B. and Chen, R.S. (2004), Date of origin of the SARS coronavirus strains. Bmc Infectious Diseases, 4.

834. Yeh, S.H., Wang, H.Y., Tsai, C.Y., Kao, C.L., Yang, J.Y., Liu, H.W., Su, I.J., Tsai, S.F., Chen, D.S. and Chen, P.J. (2004), Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: Molecular epidemiology and genome evolution. Proceedings of the National Academy of Sciences of the United States of America, 101 (8), 2542-2547.

835. Woo, P.C.Y., Lau, S.K.P., Tsoi, H.W., Chan, K.H., Wong, B.H.L., Che, X.Y., Tam, V.K.P., Tam, S.C.F., Cheng, V.C.C., Hung, I.F.N., Wong, S.S.Y., Zheng, B.J., Guan, Y. and Yuen, K.Y. (2004), Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet, 363 (9412), 841-845.

836. Liu, S.W., Xiao, G.F., Chen, Y.B., He, Y.X., Niu, J.K., Escalante, C.R., Xiong, H.B., Farmar, J., Debnath, A.K., Tien, P. and Jiang, S.B. (2004), Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. Lancet, 363 (9413), 938-947.

837. Navas-Martin, S. and Weiss, S.R. (2004), Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. Journal of Neurovirology, 10 (2), 75-85.

838. Lopez, V., Chan, K.S. and Wong, Y.C. (2004), Nursing care of patients with severe acute respiratory syndrome in the intensive care unit: case reports in Hong Kong. International Journal of Nursing Studies , 41 (3), 263-272.

839. Muller, M.P., McGeer, A., Straus, S.E., Hawryluck, L. and Gold, W.L. (2004), Clinical trials and novel pathogens: Lessons learned from SARS. Emerging Infectious Diseases, 10 (3), 389-394.

840. Vicenzi, E., Canducci, F., Pinna, D., Mancini, N., Carletti, S., Lazzarin, A., Bordignon, C., Poli, G. and Clementi, M. (2004), Coronaviridae and SARS-associated coronavirus strain HSR1. Emerging Infectious Diseases, 10 (3), 413-418.

841. Hsueh, P.R., Chen, P.J., Hsiao, C.H., Yeh, S.H., Cheng, W.C., Wang, J.L., Chiang, B.L., Chang, S.C., Chang, F.Y., Wong, W.W., Kao, C.L. and Yang, P.C. (2004), Patient data, early SARS epidemic, Taiwan. Emerging Infectious Diseases, 10 (3), 489-493.

842. Chan, P.K.S., Ng, K.C., Chan, R.C.W., Lam, R.K.Y., Chow, V.C.Y., Hui, M.M., Wu, A., Lee, N., Yap, F.H.Y., Cheng, F.W.T., Sung, J.J.Y. and Tam, J.S. (2004), Immunofluorescence assay for serologic diagnosis of SARS. Emerging Infectious Diseases, 10 (3), 530-532.

843. Zeng, F.Y., Chow, K.Y.C., Hon, C.C., Law, K.M., Yip, C.W., Chan, K.H., Peiris, J.S.M. and Leung, F.C.C. (2004), Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments. Biochemical and Biophysical Research Communications, 315 (4), 1134-1139.

844. Haagmans, B.L., Kuiken, T., Martina, B.E., Fouchier, R.A.M., Rimmelzwaan, G.F., van Amerongen, G., van Riel, D., de Jong, T., Itamura, S., Chan, K.H., Tashiro, M. and Osterhaus, A.D.M.E. (2004), Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nature Medicine, 10 (3), 290-293.

845. Gomersall, C.D., Joynt, G.M., Lam, P., Li, T., Yap, F., Lam, D., Buckley, T.A., Sung, J.J.Y., Hui, D.S., Antonio, G.E., Ahuja, A.T. and Leung, P. (2004), Short-term outcome of

57

critically ill patients with severe acute respiratory syndrome. Intensive Care Medicine, 30 (3), 381-387.

846. Zhang, Y.J., Li, T.S., Fu, L., Yu, C.M., Li, Y.H., Xu, X.L., Wang, Y.Y., Ning, H.X., Zhang, S.P., Chen, W., Babiuk, L.A. and Chang, Z.J. (2004), Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference. Febs Letters, 560 (1-3), 141-146.

847. Chu, C.M., Cheng, V.C.C., Hung, I.F.N., Wong, M.M.L., Chan, K.H., Chan, K.S., Kao, R.Y.T., Poon, L.L.M., Wong, C.L.P., Guan, Y., Peiris, J.S.M. and Yuen, K.Y. (2004), Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax, 59 (3), 252-256.

848. Ooi, G.C., Khong, P.L., Muller, N.L., Yiu, W.C., Zhou, L.J., Ho, J.C.M., Lam, B., Nicolaou, S. and Tsang, K.W.T. (2004), Severe acute respiratory syndrome: Temporal lung changes at thin-section CT in 30 patients. Radiology, 230 (3), 836-844.

849. Ying, W.T., Hao, Y.W., Zhang, Y.J., Peng, W.M., Qin, E., Cai, Y., Wei, K.H., Wang, J., Chang, G.H., Sun, W., Dai, S.J., Li, X.H., Zhu, Y.P., Li, J.Q., Wu, S.F., Guo, L.H., Dai, J.Q., Wang, J.L., Wan, P., Chen, T.G., Du, C.J., Li, D., Wan, J., Kuai, X.Z., Li, W.H., Shi, R., Wei, H.D., Cao, C., Yu, M., Liu, H., Dong, F.T., Wang, D.G., Zhang, X.M., Qian, X.H., Zhu, Q.Y. and He, F.C. (2004), Proteomic analysis on structural proteins of Severe Acute Respiratory Syndrome coronavirus. Proteomics, 4 (2), 492-504.

850. Wong, S.F., Chow, K.M., Shek, C.C., Leung, Y.P., Chiu, A., Lam, P.W.Y. and Ho, L.C. (2004), Measures to prevent healtcare workers from contracting severe acute respiratory syndrome during high-risk surgical procedures. European Journal of Clinical Microbiology & Infectious Diseases, 23 (2), 131-133.

851. Jones, B.M., Ma, E.S.K., Peiris, J.S.M., Wong, P.C., Ho, J.C.M., Lam, B., Lai, K.N. and Tsang, K.W.T. (2004), Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. Clinical and Experimental Immunology, 135 (3), 467-473.

852. Wu, W., Wang, J.F., Liu, P.M., Jiang, S.P., Chen, Q.Y., Chen, W.X., Yin, S.M., Yan, L., Zhan, J., Chen, X.L. and Li, J.G. (2004), Comparison of clinical course of patients with severe acute respiratory syndrome among the multiple generations of nosocomial transmission. Chinese Medical Journal, 117 (1), 14-18.

853. Yao, W.Z., Chen, Y.H., Zhang, L.Q., Wang, X.H., Sun, Y.C., Sun, W., Han, J.L., Zhang, F.C., Zheng, Y.A., Sun, B.Z., He, B. and Zhao, M.W. (2004), Chest X ray changes in severe acute respiratory syndrome cases after discontinuation of glucocorticosteroids treatment. Chinese Medical Journal, 117 (1), 143-144.

854. Tang, P., Louie, M., Richardson, S.E., Smieja, M., Simor, A.E., Jamieson, F., Fearon, M., Poutanen, S.M., Mazzulli, T., Tellier, R., Mahony, J., Loeb, M., Petrich, A., Chernesky, M., McGeer, A., Low, D.E., Phillips, E., Jones, S., Bastien, N., Li, Y., Dick, D., Grolla, A., Fernando, L., Booth, T.F., Henry, B., Rachlis, A.R., Matukas, L.M., Rose, D.B., Lovinsky, R., Walmsley, S., Gold, W.L. and Krajden, S. (2004), Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. Canadian Medical Association Journal, 170 (1), 47-54.

855. Low, D.E. (2004), Why SARS will not return: a polemic. Canadian Medical Association Journal, 170 (1), 68-69.

856. Ho, K.Y., Singh, K.S., Habib, A.G., Ong, B.K., Lim, T.K., Ooi, E.E., Sil, B.K., Ling, A.E., Bai, X.L. and Tambyah, P.A. (2004), Mild illness associated with severe acute respiratory syndrome coronavirus infection: Lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore. Journal of Infectious Diseases, 189 (4), 642-647.

857. Li, T.S., Qiu, Z.F., Zhang, L.Q., Han, Y., He, W., Liu, Z.Y., Ma, X.J., Fan, H.W., Lu, W., Xie, J., Wang, H.L., Deng, G.H. and Wang, A. (2004), Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. Journal of Infectious Diseases, 189 (4), 648-651.

58

858. Oxford, J., Balasingam, S. and Lambkin, R. (2004), A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community. Journal of Antimicrobial Chemotherapy, 53 (2), 133-136.

859. Lingappa, J.R., McDonald, L.C., Simone, P. and Parashar, U.D. (2004), Wresting SARS from uncertainty. Emerging Infectious Diseases, 10 (2), 167-170.

860. Zheng, B.J., Guan, Y., Wong, K.H., Zhou, J., Wong, K.L., Young, B.W.Y., Lu, L.W. and Lee, S.S. (2004), SARS-related virus predating SARS outbreak, Hong Kong. Emerging Infectious Diseases, 10 (2), 176-178.

861. Schrag, S.J., Brooks, J.T., Van Beneden, C., Parashar, U.D., Griffin, P.M., Anderson, L.J., Bellini, W.J., Benson, R.F., Erdman, D.D., Klimov, A., Ksiazek, T.G., Peret, T.C.T., Talkington, D.F., Thacker, W.L., Tondella, M.L., Sampson, J.S., Hightower, A.W., Nordenberg, D.F., Plikaytis, B.D., Khan, A.S., Rosenstein, N.E., Treadwell, T.A., Whitney, C.G., Fiore, A.E., Durant, T.M., Perz, J.F., Wasley, A., Feikin, D., Herndon, J.L., Bower, W.A., Kilbourn, B.W., Levy, D.A., Coronado, V.G., Buffington, J., Dykewicz, C.A., Khabbaz, R.F. and Chamberland, M.E. (2004), SARS surveillance during emergency public health response, United States, March-July 2003. Emerging Infectious Diseases, 10 (2), 185-194.

862. Meltzer, M.I. (2004), Multiple contact dates and SARS incubation periods. Emerging Infectious Diseases, 10 (2), 207-209.

863. Wu, J., Xu, F.J., Zhou, W.G., Feikin, D.R., Lin, C.Y., He, X., Zhu, Z.H., Liang, W.N., Chin, D.P. and Schuchat, A. (2004), Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerging Infectious Diseases, 10 (2), 210-216.

864. Isakbaeva, E.T., Khetsuriani, N., Beard, R.S., Peck, A., Erdman, D., Monroe, S.S., Tong, S.X., Ksiazek, T.G., Lowther, S., Pandya-Smith, I., Anderson, L.J., Lingappa, J. and Widdowson, M.A. (2004), SARS-associated coronavirus transmission, United States. Emerging Infectious Diseases, 10 (2), 225-231.

865. Tee, A.K.H., Oh, H.M.L., Hui, K.P., Lien, C.T.C., Narendran, K., Heng, B.H. and Ling, A.E. (2004), Atypical SARS in geriatric patient. Emerging Infectious Diseases, 10 (2), 261-264.

866. Wong, T.W., Lee, C.K., Tam, W., Lau, J.T.F., Yu, T.S., Lui, S.F., Chan, P.K.S., Li, Y.G., Bresee, J.S., Sung, J.J.Y. and Parashar, U.D. (2004), Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerging Infectious Diseases, 10 (2), 269-276.

867. Chan, K.H., Poon, L.L.L.M., Cheng, V.C.C., Guan, Y., Hung, I.F.N., Kong, J., Yam, L.Y.C., Seto, W.H., Yuen, K.Y. and Peiris, J.S.M. (2004), Detection of SARS coronavirus in patients with suspected SARS. Emerging Infectious Diseases, 10 (2), 294-299.

868. Zhai, J.H., Briese, T., Dai, E., Wang, X.Y., Pang, X., Du, Z.M., Liu, H.H., Wang, J., Wang, H.X., Guo, Z.B., Chen, Z.L., Jiang, L.X., Zhou, D.S., Han, Y.P., Jabado, O., Palacios, G., Lipkin, W.I. and Yang, R.F. (2004), Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003. Emerging Infectious Diseases, 10 (2), 300-303.

869. Wu, H.S., Chiu, S.C., Tseng, T.C., Lin, S.F., Lin, J.H., Hsu, Y.F., Wang, M.C., Lin, T.L., Yang, W.Z., Ferng, T.L., Huang, K.H., Hsu, L.C., Lee, L.L., Yang, J.Y., Chen, H.Y., Su, S.P., Yang, S.Y., Lin, T.H. and Su, L.J. (2004), Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan. Emerging Infectious Diseases, 10 (2), 304-310.

870. Hensley, L.E., Fritz, E.A., Jahrling, P.B., Karp, C.L., Huggins, J.W. and Geisbert, T.W. (2004), Interferon-beta 1a and SARS coronavirus replication. Emerging Infectious Diseases, 10 (2), 317-319.

871. Goldsmith, C.S., Tatti, K.M., Ksiazek, T.G., Rollin, P.E., Comer, J.A., Lee, W.W., Rota, P.A., Bankamp, B., Bellini, W.J. and Zaki, S.R. (2004), Ultrastructural characterization of SARS coronavirus. Emerging Infectious Diseases, 10 (2), 320-326.

59

872. Vu, H.T., Leitmeyer, K.C., Le, D.H., Miller, M.J., Nguyen, Q.H., Uyeki, T.M., Reynolds, M.G., Aagesen, J., Nicholson, K.G., Vu, Q.H., Bach, H.A. and Plant, A.J. (2004), Clinical description of a completed outbreak of SARS in Vietnam, February-May 2003. Emerging Infectious Diseases, 10 (2), 334-338.

873. Tan, T.T., Tan, B.H., Kurup, A., Oon, L.L.E., Heng, D., Thoe, S.Y.S., Bai, X.L., Chan, K.P. and Ling, A.E. (2004), Atypical SARS and Escherichia coli bacteremia. Emerging Infectious Diseases, 10 (2), 349-352.

874. Joynt, G.M., Antonio, G.E., Lam, P., Wong, K.T., Li, T., Gomersall, C.D. and Ahuja, A.T. (2004), Late-stage adult respiratory distress syndrome caused by severe acute respiratory syndrome: Abnormal findings at thin-section CT. Radiology, 230 (2), 339-346.

875. Fong, N.C., Kwan, Y.W., Hui, Y.W., Yuen, L.K., Yau, E.K.C., Leung, C.W. and Chiu, M.C. (2004), Adolescent twin sisters with severe acute respiratory syndrome (SARS). Pediatrics, 113 (2), 146-149.

876. Van den Hoogen, B.G., Osterhaus, A.D.M.E. and Fouchier, R.A.M. (2004), Clinical impact and diagnosis of human metapneumovirus infection. Pediatric Infectious Disease Journal, 23 (1), S25-S32.

877. Mejias, A., Chavez-Bueno, S. and Ramilo, O. (2004), Human metapneumovirus: a not so new virus. Pediatric Infectious Disease Journal, 23 (1), 1-7.

878. Salzberger, B., Gluck, T. and Franzen, C. (2004), Infectious diseases - Part I: Epidemiology. Medizinische Klinik, 99 (1), 35-42.

879. To, K., Tong, J.H.M., Chan, P.K.S., Au, F.W.L., Chim, S.S.C., Chan, K.C.A., Cheung, J.L.K., Liu, E.Y.M., Tse, G.M.K., Lo, A.W.I., Lo, Y.M.D. and Ng, H.K. (2004), Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. Journal of Pathology, 202 (2), 157-163.

880. Cheng, V.C.C., Hung, I.F.N., Tang, B.S.F., Chu, C.M., Wong, M.M.L., Chan, K.H., Wu, A.K.L., Tse, D.M.W., Chan, K.S., Zheng, B.J., Peiris, J.S.M., Sung, J.J.Y. and Yuen, K.Y. (2004), Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome. Clinical Infectious Diseases, 38 (4), 467-475.

881. Zou, Z.S., Yang, Y.P., Chen, J.M., Xin, S.J., Zhang, W., Zhou, X.Z., Mao, Y.L., Hu, L.P., Liu, D.J., Chang, B.X., Chang, W.H., Liu, Y.P., Ma, X.M., Wang, Y.D. and Liu, X.Q. (2004), Prognostic factors for severe acute respiratory syndrome: A clinical analysis of 165 cases. Clinical Infectious Diseases, 38 (4), 483-489.

882. Wang, H.Y., Rong, F., Ke, F.J. and Bai, Y.L. (2003), Control dynamics of severe acute respiratory syndrome transmission. Chinese Science Bulletin, 48 (24), 2684-2687.

883. Karlberg, J., Chong, D.S.Y. and Lai, W.Y.Y. (2004), Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? American Journal of Epidemiology, 159 (3), 229-231.

884. Berger, A., Drosten, C., Doerr, H.W., Sturmer, M. and Preiser, W. (2004), Severe acute respiratory syndrome (SARS) - paradigm of an emerging viral infection. Journal of Clinical Virology, 29 (1), 13-22.

885. Chan, M.S.M., Chan, I.Y.F., Fung, K.H., Poon, E., Yam, L.Y.C. and Lau, K.Y. (2004), High-resolution CT findings in patients with severe acute respiratory syndrome: A pattern-based approach. American Journal of Roentgenology, 182 (1), 49-56.

886. Liu, W.L., Lu, Y. and Chen, Y.H. (2003), Bioinformatics analysis of SARS-Cov M protein provides information for vaccine development. Progress in Natural Science, 13 (11), 844-847.

887. Tsou, I.Y., Loh, L.E., Kaw, G.J., Chan, I. and Chee, T.S. (2004), Severe acute respiratory syndrome (SARS) in a paediatric cluster in Singapore. Pediatric Radiology, 34 (1), 43-46.

888. Babyn, P.S., Chu, W.C.W., Tsou, I.Y.Y., Wansaicheong, G.K.L., Allen, U., Bitnun, A., Chee, T.S.G., Cheng, F.W.T., Chiu, M.C., Fok, T.F., Hon, E.K.L., Gahunia, H.K., Kaw, G.J.L., Khong, P.L., Leung, C.W., Li, A.M., Manson, D., Metreweli, C., Ng, P.C., Read, S.

60

and Stringer, D.A. (2004), Severe acute respiratory syndrome (SARS): chest radiographic features in children. Pediatric Radiology, 34 (1), 47-58.

889. Jang, T.N., Yeh, D.Y., Shen, S.H., Huang, C.H., Jiang, J.S. and Kao, S.J. (2004), Severe acute respiratory syndrome in Taiwan: analysis of epidemiological characteristics in 29 cases. Journal of Infection , 48 (1), 23-31.

890. Thompson, D.R., Lopez, V., Lee, D. and Twinn, S. (2004), SARS - a perspective from a school of nursing in Hong Kong. Journal of Clinical Nursing, 13 (2), 131-135.

891. Ng, L.F.P., Wong, M., Koh, S., Ooi, E.E., Tang, K.F., Leong, H.N., Ling, A.E., Agathe, L.V., Tan, J., Liu, E.T., Ren, E.C., Ng, L.C. and Hibberd, M.L. (2004), Detection of severe acute respiratory syndrome coronavirus in blood of infected patients. Journal of Clinical Microbiology, 42 (1), 347-350.

892. Wu, H.S., Hsieh, Y.C., Su, I.J., Lin, T.H., Chiu, S.C., Hsu, Y.F., Lin, J.H., Wang, M.C., Chen, J.Y., Hsiao, P.W., Chang, G.D., Wang, A.H.J., Ting, H.W., Chou, C.M. and Huang, C.J. (2004), Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients. Journal of Biomedical Science, 11 (1), 117-126.

893. Poon, L.L.M., Chan, K.H., Wong, O.K., Cheung, T.K.W., Ng, I., Zheng, B.J., Seto, W.H., Yuen, K.Y., Guan, Y. and Peiris, J.S.M. (2004), Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Clinical Chemistry, 50 (1), 67-72.

894. Chim, S.S.C., Tong, Y.K., Hung, E.C.W., Chiu, R.W.K. and Lo, Y.M.D. (2004), Genomic Sequencing of a SARS coronavirus isolate that predated the Metropole Hotel case cluster in Hong Kong. Clinical Chemistry , 50 (1), 231-233.

895. Hui, J.Y.H., Hon, T.Y.W., Yang, M.K.W., Cho, D.H.Y., Luk, W.H., Chan, R.Y.Y., Chan, K.S., Loke, T.K.L. and Chan, J.C.S. (2004), High-resolution computed tomography is useful for early diagnosis of severe acute respiratory syndrome-associated coronavirus pneumonia in patients with normal chest radiographs. Journal of Computer Assisted Tomography, 28 (1), 1-9.

896. Mazzulli, T., Farcas, G.A., Poutanen, S.M., Willey, B.M., Low, D.E., Butany, J., Asa, S.L. and Kain, K.C. (2004), Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerging Infectious Diseases, 10 (1), 20-24.

897. Liang, W.N., Zhu, Z.H., Guo, J.Y., Liu, Z.J., He, X., Zhou, W.G., Chin, D.P. and Schuchat, A. (2004), Severe acute respiratory syndrome, Beijing, 2003. Emerging Infectious Diseases, 10 (1), 25-31.

898. Kuiken, T., Fouchier, R., Rimmelzwaan, G. and Osterhaus, A. (2003), Emerging viral infections in a rapidly changing world. Current Opinion in Biotechnology, 14 (6), 641-646.

899. Ho, T.Y., Wu, S.L., Cheng, S.E., Wei, Y.C., Huang, S.P. and Hsiang, C.Y. (2004), Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein. Biochemical and Biophysical Research Communications, 313 (4), 938-947.

900. Wang, T.L., Jang, T.N., Huang, C.H., Kao, S.J., Lin, C.M., Lee, F.N., Liu, C.Y., Chong, C.F., Lin, C.M., Dorji, H., Teng, H.J. and Chang, H. (2004), Establishing a clinical decision rule of severe acute respiratory syndrome at the emergency department. Annals of Emergency Medicine, 43 (1), 17-22.

901. Goldrick, B.A. (2004), Emerging infections - 21st-century emerging and reemerging infections. American Journal of Nursing, 104 (1), 67-70.

902. Vaque, J. and Calico, I. (2003), Severe acute respiratory syndrome: will it come back? Medicina Clinica, 121 (18), 700-702.

903. Guan, Y., Peiris, J.S.M., Zheng, B., Poon, L.L.M., Chan, K.H., Zeng, F.Y., Chan, C.W.M., Chan, M.N., Chen, J.D., Chow, K.Y.C., Hon, C.C., Hui, K.H., Li, J., Li, V.Y.Y., Wang, Y., Leung, S.W., Yuen, K.Y. and Leung, F.C. (2004), Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome. Lancet, 363 (9403), 99-104.

61

904. Xu, X., Liu, Y.Q., Weiss, S., Arnold, E., Sarafianos, S.G. and Ding, J.P. (2003), Molecular model of SARS coronavirus polymerase: Implications for biochemical functions and drug design. Nucleic Acids Research, 31 (24), 7117-7130.

905. Stavrinides, J. and Guttman, D.S. (2004), Mosaic evolution of the severe acute respiratory syndrome coronavirus. Journal of Virology, 78 (1), 76-82.

906. Poon, L.L.M., Chan, K.H., Wong, O.K., Yam, W.C., Yuen, K.Y., Guan, Y., Lo, Y.M.D. and Peiris, J.S.M. (2003), Early diagnosis of SARS Coronavirus infection by real time RT-PCR. Journal of Clinical Virology , 28 (3), 233-238.

907. Peiris, J.S.M. (2003), Severe Acute Respiratory Syndrome (SARS). Journal of Clinical Virology, 28 (3), 245-247.

908. Levett, J. (2003), Severe acute respiratory syndrome (SARS): Loud clang of the leper's bell. Croatian Medical Journal, 44 (6), 674-680.

909. Jiang, S.S., Chen, T.C., Yang, J.Y., Hsiung, C.A., Su, I.J., Liu, Y.L., Chen, P.C. and Juang, J.L. (2004), Sensitive and quantitative detection of severe acute respiratory syndrome coronavirus infection by real-time nested polymerase chain reaction. Clinical Infectious Diseases, 38 (2), 293-296.

910. Poon, L.L.M., Chan, K.H. and Peiris, J.S.M. (2004), Crouching tiger, hidden dragon: The laboratory diagnosis of severe acute respiratory syndrome. Clinical Infectious Diseases, 38 (2), 297-299.

911. [Anon]. (2003), Consensus for the management of severe acute respiratory syndrome. Chinese Medical Journal, 116 (11), 1603-1636.

912. Lam, M.F., Ooi, G.C., Lam, B., Ho, J.C., Seto, W.H., Ho, P.L., Wong, P.C., Liang, R., Lam, W.K. and Tsang, K.W. (2004), An indolent case of severe acute respiratory syndrome. American Journal of Respiratory and Critical Care Medicine, 169 (1), 125-128.

913. Zhang, X.L., Wang, J.R., Zhang, Y., Chen, M.L., Zhang, W., Yang, S. and Jiang, W.H. (2003), Expression, purification and identification of recombinant SARS coronavirus membrane protein. Acta Biochimica et Biophysica Sinica, 35 (12), 1140-1144.

914. Narayanan, K., Kirn, K.H. and Makino, S. (2003), Characterization of N protein self-association in coronavirus ribonucleoprotein complexes. Virus Research, 98 (2), 131-140.

915. Lam, W.K., Zhong, N.S. and Tan, W.C. (2003), Overview on SARS in Asia and the world. Respirology, 8), S2-S5.

916. Nicholls, J., Dong, X.P., Jiang, G. and Peiris, M. (2003), SARS: clinical virology and pathogenesis. Respirology, 8), S6-S8.

917. Chan-Yeung, M. and Xu, R.H. (2003), SARS: Epidemiology. Respirology, 8), S9-S14.918. Ooi, G.C. and Ma, D.Q. (2003), SARS: radiological features. Respirology, 8), S15-S19.919. Sun, H.F., Luo, H.B., Yu, C.Y., Sun, T., Chen, J., Peng, S.Y., Qin, J., Shen, J.H., Yang,

Y.M., Xie, Y.H., Chen, K.X., Wang, Y., Shen, X. and Jiang, H.L. (2003), Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus. Protein Expression and Purification, 32 (2), 302-308.

920. Lau, L.T., Fung, Y.W.W., Wong, F.P.F., Lin, S.S.W., Wang, C.R., Li, H.L., Dillon, N., Collins, R.A., Tam, J.S.L., Chan, P.K.S., Wang, C.G. and Yu, A.C.H. (2003), A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification. Biochemical and Biophysical Research Communications, 312 (4), 1290-1296.

921. Hughes, J.M. (2003), The SARS response - Building and assessing an evidence-based approach to future global microbial threats. Jama-Journal of the American Medical Association, 290 (24), 3251-3253.

922. Smales, F.C. and Samaranyake, L.P. (2003), Maintaining dental education and specialist dental care during an outbreak of a new coronavirus infection. Part 2: Control of the disease, then elimination. British Dental Journal, 195 (12), 679-681.

923. Ho, J.C., Ooi, G.C., Mok, T.Y., Chan, J.W., Hung, I., Lam, B., Wong, P.C., Li, P.C., Ho, P.L., Lam, W.K., Ng, C.K., Ip, M.S., Lai, K.N., Chan-Yeung, M. and Tsang, K.W. (2003), High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory

62

syndrome. American Journal of Respiratory and Critical Care Medicine, 168 (12), 1449-1456.

924. Peiris, J.S.M., Yuen, K.Y., Osterhaus, A.D.M.E. and Stohr, K. (2003), Current concepts: The severe acute respiratory syndrome. New England Journal of Medicine, 349 (25), 2431-2441.

925. Chan-Yeung, M., Ooi, G.C., Hui, D.S., Ho, P.L. and Tsang, K.W. (2003), Severe acute respiratory syndrome. International Journal of Tuberculosis and Lung Disease, 7 (12), 1117-1130.

926. Lang, Z.W., Zhang, L.J., Zhang, S.J., Meng, X., Li, J.Q., Song, C.Z., Sun, L., Zhou, Y.S. and Dwyer, D.E. (2003), A clinicopathological study of three cases of severe acute respiratory syndrome (SARS). Pathology, 35 (6), 526-531.

927. Lai, M.M.C. (2003), SARS virus: The beginning of the unraveling of a new coronavirus. Journal of Biomedical Science, 10 (6), 664-675.

928. Ng, E.K.O., Hui, D.S., Chan, K.C.A., Hung, E.C.W., Chiu, R.W.K., Lee, N., Wu, A., Chim, S.S.C., Tong, Y.K., Sung, J.J.Y., Tam, J.S. and Lo, Y.M.D. (2003), Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clinical Chemistry, 49 (12), 1976-1980.

929. Ng, E.K.O., Ng, P.C., Hon, K.L.E., Cheng, W.T.F., Hung, E.C.W., Chan, K.C.A., Chiu, R.W.K., Li, A.M., Poon, L.L.M., Hui, D.S., Tams, J.S., Fok, T.F. and Lo, Y.M.D. (2003), Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome. Clinical Chemistry, 49 (12), 2085-2088.

930. Hung, E.C.W., Chim, S.S.C., Chan, P.K.S., Tong, Y.K., Ng, E.K.O., Chiu, R.W.K., Leung, C.B., Sung, J.J.Y., Tam, J.S. and Lo, Y.M.D. (2003), Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clinical Chemistry, 49 (12), 2108-2109.

931. Zhaori, G. (2003), Antiviral treatment of SARS: Can we draw any conclusions? Canadian Medical Association Journal, 169 (11), 1165-1166.

932. Hui, J.Y.H., Cho, D.H.Y., Yang, M.K.W., Wang, K., Lo, K.K.L., Fan, W.C., Chan, C.C., Chu, C.M., Loke, T.K.L. and Chan, J.C.S. (2003), Pictorial review - Severe acute respiratory syndrome: Spectrum of high-resolution CT findings and temporal progression of the disease. American Journal of Roentgenology, 181 (6), 1525-1538.

933. Eickmann, M., Becker, S., Klenk, H.D., Doerr, H.W., Stadler, K., Censini, S., Guidotti, S., Masignani, V., Scarselli, M., Mora, M., Donati, C., Han, J.H., Song, H.C., Abrignani, S., Covacci, A. and Rappuoli, R. (2003), Phylogeny of the SARS coronavirus. Science, 302 (5650), 1504-1505.

934. Yang, H.T., Yang, M.J., Ding, Y., Liu, Y.W., Lou, Z.Y., Zhou, Z., Sun, L., Mo, L.J., Ye, S., Pang, H., Gao, G.F., Anand, K., Bartlam, M., Hilgenfeld, R. and Rao, Z.H. (2003), The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100 (23), 13190-13195.

935. Wong, W.M., Ho, J.C., Hung, I.F., Ng, W., Lam, Y.M., Tam, W.O., Wong, B.C.Y., Wong, P.C., Lai, C.L., Lam, W.K., Lam, S.K., Tsang, K.W., Ooi, G.C., Ho, P.L., Mok, T. and Chan, J. (2003), Temporal patterns of hepatic dysfunction and disease severity in patients with SARS. Jama-Journal of the American Medical Association, 290 (20), 2663-2665.

936. He, M.L., Zheng, B.J., Peng, Y., Peiris, J.S.M., Poon, L.L.M., Yuen, K.Y., Lin, M.C.M., Kung, H.F. and Guan, Y. (2003), Inhibition of SARS-associated coronavirus infection and replication by RNA interference. Jama-Journal of the American Medical Association, 290 (20), 2665-2666.

937. Manocha, S., Walley, K.R. and Russell, J.A. (2003), Severe acute respiratory distress syndrome (SARS): A critical care perspective. Critical Care Medicine, 31 (11), 2684-2692.

63

938. Smales, F.C. and Samaranyake, L.P. (2003), Maintaining dental education and specialist dental care during an outbreak of a new coronavirus infection. Part 1: A deadly viral epidemic begins. British Dental Journal, 195 (10), 557-561.

939. Tsang, O.T.Y., Chau, T.N., Choi, K.W., Tso, E.Y.K., Lim, W., Chiu, M.C., Tong, W.L., Lee, P.O., Lam, B.H.S., Ng, T.K., Lai, J.Y., Yu, W.C. and Lai, S.T. (2003), Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality. Emerging Infectious Diseases, 9 (11), 1381-1387.

940. Chan, P.K.S., Ip, M., Ng, K.C., Chan, R.C.W., Wu, A., Lee, N., Rainer, T.H., Joynt, G.M., Sung, J.J.Y. and Tam, J.S. (2003), Severe acute respiratory syndrome-associated coronavirus infection. Emerging Infectious Diseases, 9 (11), 1453-1454.

941. Lee, H.K.K., Tso, E.Y., Chau, T.N., Tsang, O.T.Y., Choi, K.W. and Lai, T.S.T. (2003), Asymptomatic severe acute respiratory syndrome-associated coronavirus infection. Emerging Infectious Diseases, 9 (11), 1491-1492.

942. Jenwitheesuk, E. and Samudrala, R. (2003), Identifying inhibitors of the SARS coronavirus proteinase. Bioorganic & Medicinal Chemistry Letters, 13 (22), 3989-3992.

943. Wong, P.N., Mak, S.K., Lo, K.Y., Tong, G.M.W., Wong, Y., Watt, C.L. and Wong, A.K.M. (2003), Clinical presentation and outcome of severe acute respiratory syndrome in dialysis patients. American Journal of Kidney Diseases, 42 (5), 1075-1081.

944. Yount, B., Curtis, K.M., Fritz, E.A., Hensley, L.E., Jahrling, P.B., Prentice, E., Denison, M.R., Geisbert, T.W. and Baric, R.S. (2003), Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proceedings of the National Academy of Sciences of the United States of America, 100 (22), 12995-13000.

945. Savarino, A., Boelaert, J.R., Cassone, A., Majori, G. and Cauda, R. (2003), Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infectious Diseases, 3 (11), 722-727.

946. Choi, K.W., Chau, T.N., Tsang, O., Tso, E., Chiu, M.C., Tong, W.L., Lee, P.O., Ng, T.K., Ng, W.F., Lee, K.C., Lam, W., Yu, W.C., Lai, J.Y. and Lai, S.T. (2003), Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Annals of Internal Medicine, 139 (9), 715-723.

947. Ooi, C.G.C., Khong, P.L., Ho, J.C.M., Lam, B., Wong, W.M., Yiu, W.C., Wong, P.C., Wong, C.F., Lai, K.N. and Tsang, K.W.T. (2003), Severe acute respiratory syndrome: Radiographic evaluation and clinical outcome measures. Radiology, 229 (2), 500-506.

948. Bossi, P., Guihot, A., Ansart, S. and Bricaire, F. (2003), Severe acute respiratory syndrome: update. Revue de Medecine Interne, 24 (10), 672-680.

949. Groneberg, D.A., Zhang, L., Welte, T., Zabel, P. and Chung, K.F. (2003), Severe acute respiratory syndrome: global initiatives for disease diagnosis. Qjm-An International Journal of Medicine, 96 (11), 845-852.

950. Tiwari, A., Chan, S., Wong, A., Tai, J., Cheng, K., Chan, J. and Tsang, K. (2003), Severe Acute Respiratory Syndrome (SARS) in Hong Kong: Patients' experiences. Nursing Outlook, 51 (5), 212-219.

951. Martina, B.E.E., Haagmans, B.L., Kuiken, T., Fouchier, R.A.M., Rimmelzwaan, G.F., van Amerongen, G., Peiris, J.S.M., Lim, W. and Osterhaus, A.D.M.E. (2003), SARS virus infection of cats and ferrets. Nature, 425 (6961), 915.

952. Dominguez, A., Gudiol, F., Pumarola, T. and Salleras, L. (2003), Severe acute respiratory syndrome epidemics: End or parenthesis of epidemics? Medicina Clinica, 121 (9), 340-346.

953. Rezza, G. (2003), Identification and control are the priority. Journal of Epidemiology and Community Health, 57 (10), 772.

954. Gao, F., Ou, H.Y., Chen, L.L., Zheng, W.X. and Zhang, C.T. (2003), Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes. Febs Letters , 553 (3), 451-456.

955. Smith, R. and Renaud, R.C. (2003), From the analyst's couch - Vaccines of the future. Nature Reviews Drug Discovery, 2 (10), 767-7U5.

64

956. Zhong, N.S., Zheng, B.J., Li, Y.M., Poon, L.L.M., Xie, Z.H., Chan, K.H., Li, P.H., Tan, S.Y., Chang, Q., Xie, J.P., Liu, X.Q., Xu, J., Li, D.X., Yuen, K.Y., Peiris, J.S.M. and Guan, Y. (2003), Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet, 362 (9393), 1353-1358.

957. Chen, X.P., Li, G.H., Tang, X.P., Xiong, Y., Chen, X.J. and Cao, Y.Z. (2003), Lack of severe acute respiratory syndrome in 19 AIDS patients hospitalized together. Jaids-Journal of Acquired Immune Deficiency Syndromes, 34 (2), 242-243.

958. Kliger, Y. and Levanon, E.Y. (2003), Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy. Bmc Microbiology, 3.

959. Tang, H.L., Cheuk, A., Chu, K.H., Lee, W., Wong, S.H., Cheng, Y.L., Yu, A.W.Y., Fung, K.S., Tsang, W.K., Chan, H.W.H. and Tong, K.L. (2003), Severe acute respiratory syndrome in haemodialysis patients: a report of two cases. Nephrology Dialysis Transplantation, 18 (10), 2178-2181.

960. Tanner, J.A., Watt, R.M., Chai, Y.B., Lu, L.Y., Lin, M.C., Peiris, J.S.M., Poon, L.L.M., Kung, H.F. and Huang, J.D. (2003), The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5 ' to 3 ' viral helicases. Journal of Biological Chemistry, 278 (41), 39578-39582.

961. Duan, S.M., Zhao, X.S., Wen, R.F., Huang, J.J., Pi, G.H., Zhang, S.X., Han, J., Bi, S.L., Ruan, L. and Dong, X.P. (2003), Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomedical and Environmental Sciences, 16 (3), 246-255.

962. Ho, A.S., Sung, J.J.Y. and Chan-Yeung, M. (2003), An outbreak of severe acute respiratory syndrome among hospital workers in a community hospital in Hong Kong. Annals of Internal Medicine, 139 (7), 564-567.

963. Guan, Y., Zheng, B.J., He, Y.Q., Liu, X.L., Zhuang, Z.X., Cheung, C.L., Luo, S.W., Li, P.H., Zhang, L.J., Guan, Y.J., Butt, K.M., Wong, K.L., Chan, K.W., Lim, W., Shortridge, K.F., Yuen, K.Y., Peiris, J.S.M. and Poon, L.L.M. (2003), Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. Science, 302 (5643), 276-278.

964. Tsang, K.W., Mok, T.Y., Wong, P.C. and Ooi, G.C. (2003), Severe acute respiratory syndrome (SARS) in Hong Kong. Respirology, 8 (3), 259-265.

965. Sit, S.C., Yau, E.K.C., Lam, Y.Y., Ng, D.K.K., Fong, N.C., Hui, Y.W., Cheng, W.F., Leung, C.W. and Chiu, M.C. (2003), A young infant with severe acute respiratory syndrome. Pediatrics, 112 (4), E257-E260.

966. Bitnun, A., Allen, U., Heurter, H., King, S.M., Opavsky, M.A., Ford-Jones, E.L., Matlow, A., Kitai, I., Tellier, R., Richardson, S., Manson, D., Babyn, P. and Read, S. (2003), Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics, 112 (4), E261-E268.

967. Ng, M.L., Tan, S.H., See, E.E., Ooi, E.E. and Ling, A.E. (2003), Early events of SARS coronavirus infection in Vero cells. Journal of Medical Virology, 71 (3), 323-331.

968. Pene, F., Merlat, A., Vabret, A., Rozenberg, F., Buzyn, A.S., Dreyfus, F., Cariou, A., Freymuth, F.O. and Lebon, P. (2003), Coronavirus 229E-related pneumonia in immunocompromised patients. Clinical Infectious Diseases, 37 (7), 929-932.

969. Li, L.J., Wang, Z.G., Lu, Y.Y., Bao, Q.Y., Chen, S.H., Wu, N.P., Cheng, S.Y., Weng, J.Q., Zhang, Y.J., Yan, J.Y., Mei, L.L., Wang, X.M., Zhu, H.P., Yu, Y.P., Zhang, M.L., Li, M.H., Yao, J., Lu, Q.Y., Yao, P.P., Bo, X.C., Wo, J.N., Wang, S.Q. and Hu, S.N. (2003), Severe acute respiratory syndrome-associated coronavirus genotype and its characterization. Chinese Medical Journal, 116 (9), 1288-1292.

970. Lesens, O., Hustache-Mathieu, L., Hansmann, Y., Remy, V., Hoen, B. and Christmann, D. (2003), Severe acute respiratory syndrome (SARS) - The questions raised by the management of a patient in Besancon and Strasbourg. Presse Medicale, 32 (29), 1359-1364.

65

971. Cui, W., Fan, Y., Wu, W., Zhang, F., Wang, J.Y. and Ni, A.P. (2003), Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome. Clinical Infectious Diseases, 37 (6), 857-859.

972. Knudsen, T.B., Kledal, T.N., Andersen, O., Eugen-Olsen, J. and Kristiansen, T.B. (2003), Severe acute respiratory syndrome - a new coronavirus from the Chinese dragon's lair. Scandinavian Journal of Immunology, 58 (3), 277-284.

973. Tratner, I. (2003), SARS-CoV: 1. The virus. M S-Medecine Sciences, 19 (8-9), 885-891.974. Kiechle, F.L. and Holland-Staley, C.A. (2003), Genomics, transcriptomics, proteomics, and

numbers. Archives of Pathology & Laboratory Medicine, 127 (9), 1089-1097.975. Ng, P.C., So, K.W., Leung, T.F., Cheng, F.W.T., Lyon, D.J., Wong, W., Cheung, K.L.,

Fung, K.S.C., Lee, C.H., Li, A.M., Hon, K.L.E., Li, C.K. and Fok, T.F. (2003), Infection control for SARS in a tertiary neonatal centre. Archives of Disease in Childhood, 88 (5), F405-F409.

976. Breiman, R.F., Evans, M.R., Preiser, W., Maguire, J., Schnur, A., Li, A., Bekedam, H. and MacKenzie, J.S. (2003), Role of China in the quest to define and control severe acute respiratory syndrome. Emerging Infectious Diseases, 9 (9), 1037-1041.

977. Chan, P.K.S., Tam, J.S., Lam, C.W., Chan, E., Wu, A., Li, C.K., Buckley, T.A., Ng, K.C., Joynt, G.M., Cheng, F.W.T., To, K.F., Lee, N., Hui, D.S.C., Cheung, J.L.K., Chu, I., Liu, E., Chung, S.C.A. and Sung, J.J.Y. (2003), Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerging Infectious Diseases, 9 (9), 1058-1063.

978. Tsui, P.T., Kwok, M.L., Yuen, H. and Lai, S.T. (2003), Severe acute respiratory syndrome: Clinical outcome and prognostic correlates. Emerging Infectious Diseases, 9 (9), 1064-1069.

979. Hsueh, P.R., Hsiao, C.H., Yeh, S.H., Wang, W.K., Chen, P.J., Wang, J.T., Chang, S.C., Kao, C.L. and Yang, P.C. (2003), Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerging Infectious Diseases, 9 (9), 1163-1167.

980. Tsang, O.T.Y., Chau, T.N., Choi, K.W., Tso, E.Y.K., Lim, W., Chiu, M.C., Tong, W.L., Lee, P.O., Lam, B.H.S., Ng, T.K., Lai, J.Y., Yu, W.C. and Lai, S.T. (2003), Severe acute respiratory syndrome: Relapse? Hospital infection? Emerging Infectious Diseases, 9 (9), 1180-1181.

981. Li, G., Zhao, Z.X., Chen, L.B. and Zhou, Y.H. (2003), Mild severe acute respiratory syndrome. Emerging Infectious Diseases, 9 (9), 1182-1183.

982. Chan, H.L.Y., Tsui, S.K.W. and Sung, J.J.Y. (2003), Coronavirus in severe acute respiratory syndrome (SARS). Trends in Molecular Medicine, 9 (8), 323-325.

983. Drosten, C., Preiser, W., Gunther, S., Schmitz, H. and Doerr, H.W. (2003), Severe acute respiratory syndrome: identification of the etiological agent. Trends in Molecular Medicine, 9 (8), 325-327.

984. Snijder, E.J., Bredenbeek, P.J., Dobbe, J.C., Thiel, V., Ziebuhr, J., Poon, L.L.M., Guan, Y., Rozanov, M., Spaan, W.J.M. and Gorbalenya, A.E. (2003), Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. Journal of Molecular Biology, 331 (5), 991-1004.

985. Thiel, V., Ivanov, K.A., Putics, A., Hertzig, T., Schelle, B., Bayer, S., Weissbrich, B., Snijder, E.J., Rabenau, H., Doerr, H.W., Gorbalenya, A.E. and Ziebuhr, J. (2003), Mechanisms and enzymes involved in SARS coronavirus genome expression. Journal of General Virology, 84), 2305-2315.

986. Ziebuhr, J. (2003), SARS - Unprecedented global response to a newly emerging disease. International Journal of Medical Microbiology, 293 (4), 229-231.

987. Chen, Y.T., Luo, Z.L. and Ding, J.D. (2003), Preliminary computer simulation of spatial structure of SARS coronavirus E-protein. Chemical Journal of Chinese Universities-Chinese, 24 (8), 1406-1409.

66

988. Yu, H., Yang, Y., Zhang, W., Xie, Y.H., Qin, J., Wang, Y., Zheng, H.B., Zhao, G.P., Yang, S. and Jiang, W.H. (2003), Expression and purification of recombinant SARS coronavirus spike protein. Acta Biochimica et Biophysica Sinica, 35 (8), 774-778.

989. Varia, M., Wilson, S., Sarwal, S., McGeer, A., Gournis, E., Galanis, E. and Henry, B. (2003), Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. Canadian Medical Association Journal, 169 (4), 285-292.

990. Tan, D.Y.L., Kaw, G.J.L., Tsou, I.Y.Y., Wansaicheong, G.K.L., Green, J.A., Tai, D.Y.H. and Chee, T.S.G. (2003), Radiographic features of a case of severe acute respiratory syndrome with fatal outcome. Annals Academy of Medicine Singapore, 32 (4), 542-546.

991. Dib, J.G. (2003), Severe acute respiratory syndrome and children. American Journal of Health-System Pharmacy, 60 (16), 1694.

992. Campanacci, V., Egloff, M.P., Longhi, S., Ferron, F., Rancurel, C., Salomoni, A., Durousseau, C., Tocque, F., Bremond, N., Dobbe, J.C., Snijder, E.J., Canard, B. and Cambillau, C. (2003), Structural genomics of the SARS coronavirus: cloning, expression, crystallization and preliminary crystallographic study of the Nsp9 protein. Acta Crystallographica Section D-Biological Crystallography, 59), 1628-1631.

993. van Vonderen, M.G.A., Bos, J.C., Prins, J.M., Wertheim-van Dillen, P. and Speelman, P. (2003), Ribavirin in the treatment of severe acute respiratory syndrome (SARS). Netherlands Journal of Medicine, 61 (7), 238-241.

994. Hawkey, P.M., Bhagani, S. and Gillespie, S.H. (2003), Severe acute respiratory syndrome (SARS): breathtaking progress. Journal of Medical Microbiology, 52 (8), 609-613.

995. Zhao, Z., Zhang, F., Xu, M., Huang, K., Zhong, W., Cai, W., Yin, Z., Huang, S., Deng, Z., Wei, M., Xiong, J. and Hawkey, P.M. (2003), Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. Journal of Medical Microbiology, 52 (8), 715-720.

996. Tsang, K.W. and Lam, W.K. (2003), Management of severe acute respiratory syndrome: The Hong Kong university experience. American Journal of Respiratory and Critical Care Medicine, 168 (4), 417-424.

997. Hu, L.D., Zheng, G.Y., Jiang, H.S., Xia, Y., Zhang, Y. and Kong, X.Y. (2003), Mutation analysis of 20 SARS virus genome sequences: evidence for negative selection in replicase ORF1b and spike gene. Acta Pharmacologica Sinica, 24 (8), 741-745.

998. Ng, S.K.C. (2003), Possible role of an animal vector in the SARS outbreak at Amoy Gardens. Lancet, 362 (9383), 570-572.

999. Wu, X.W., Cheng, G., Di, B., Yin, A.H., He, Y.S., Wang, M., Zhou, X.Y., He, L.J., Luo, K. and Du, L. (2003), Establishment of a fluorescent polymerase chain reaction method for the detection of the SARS-associated coronavirus and its clinical application. Chinese Medical Journal, 116 (7), 988-990.

1000. Chan, J.W.M., Ng, C.K., Chan, Y.H., Mok, T.Y.W., Lee, S., Chu, S.Y.Y., Law, W.L., Lee, M.P. and Li, P.C.K. (2003), Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax, 58 (8), 686-689.

1001. Bosch, B.J., van der Zee, R., de Haan, C.A.M. and Rottier, P.J.M. (2003), The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. Journal of Virology, 77 (16), 8801-8811.

1002. Liu, S.Q., Guo, T., Li, X.L. and Sun, Z.R. (2003), Bioinformatical study on the proteomics and evolution of SARS-CoV. Chinese Science Bulletin, 48 (13), 1277-1287.

1003. Duan, Q., Zhu, H., Yang, Y., Li, W.H., Zhou, T., Song, L.H., Gan, Y.H., Tan, H., Jin, B.F., Li, H.Y., Zuo, T.T., Chen, D.H. and Zhang, X.M. (2003), Reovirus, isolated from SARS patients. Chinese Science Bulletin, 48 (13), 1293-1296.

1004. Krokhin, O., Li, Y., Andonov, A., Feldmann, H., Flick, R., Jones, S., Stroeher, U., Bastien, N., Dasuri, K.V.N., Cheng, K.D., Simonsen, J.N., Perreault, H., Wilkins, J., Ens, W., Plummer, F. and Standing, K.G. (2003), Mass spectrometric characterization of proteins

67

from the SARS virus - A preliminary report. Molecular & Cellular Proteomics, 2 (5), 346-356.

1005. Kuiken, T., Fouchier, R.A.M., Schutten, M., Rimmelzwaan, G.F., van Amerongen, G., van Riel, D., Laman, J.D., de Jong, T., van Doornum, G., Lim, W., Ling, A.E., Chan, P.K.S., Tam, J.S., Zambon, M.C., Gopal, R., Drosten, C., van der Werf, S., Escriou, N., Manuguerra, J.C., Stohr, K., Peiris, J.S.M. and Osterhaus, A.D.M.E. (2003), Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet, 362 (9380), 263-270.

1006. Kee, W.D.N. and Leung, T.N. (2003), Severe acute respiratory syndrome (SARS). International Journal of Obstetric Anesthesia, 12 (3), 151-152.

1007. Hui, D.S.C. and Sung, J.J.Y. (2003), Severe acute respiratory syndrome. Chest, 124 (1), 12-15.

1008. Chen, L.L., Ou, H.Y., Zhang, R. and Zhang, C.T. (2003), ZCURVE_CoV: a new system to recognize protein coding genes in coronavirus genomes, and its applications in analyzing SARS-CoV genomes. Biochemical and Biophysical Research Communications, 307 (2), 382-388.

1009. Franco-Paredes, C., Kuri-Morales, P., varez-Lucas, C., Palacios-Zavala, E., Nava-Frias, M., Betancourt-Cravioto, M., Santos-Preciado, J.I. and Tapia-Conyer, R. (2003), Severe acute respiratory syndrome: A global view of the epidemic. Salud Publica de Mexico, 45 (3), 211-220.

1010. Gillissen, A. and Ruf, B.R. (2003), Severe acute respiratory syndrome (SARS). Medizinische Klinik, 98 (6), 319-325.

1011. Wallington, T., Berger, L., Henry, B., Shahin, R., Yaffe, B., Mederski, B., Berall, G., Christian, M., McGeer, A., Low, D., Wong, T., Tam, T., Ofner, M., Hansen, L., Gravel, D. and King, A. (2003), Update: Severe acute respiratory syndrome - Toronto, Canada, 2003 (Reprinted from MMWR, vol 52, pg 547-550, 2003). Jama-Journal of the American Medical Association, 290 (4), 457-458.

1012. Wong, G.W.K. and Hui, D.S.C. (2003), Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and management. Thorax, 58 (7), 558-560.

1013. Marsden, P.A., Ning, Q., Fung, L.S., Luo, X.P., Chen, Y., Mendicino, M., Ghanekar, A., Scott, J.A., Miller, T., Chan, C.W.Y., Chan, M.W.C., He, W., Gorczynski, R.M., Grant, D.R., Clark, D.A., Phillips, M.J. and Levy, G.A. (2003), The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. Journal of Clinical Investigation, 112 (1), 58-66.

1014. Avendano, M., Derkach, P. and Swan, S. (2003), Clinical course and management of SARS in health care workers in Toronto: a case series. Canadian Medical Association Journal, 168 (13), 1649-1660.

1015. Zhang, J.Z. (2003), Severe acute respiratory syndrome and its lesions in digestive system. World Journal of Gastroenterology , 9 (6), 1135-1138.

1016. Nie, Q.H., Luo, X.D. and Hui, W.L. (2003), Advances in clinical diagnosis and treatment of severe acute respiratory syndrome. World Journal of Gastroenterology, 9 (6), 1139-1143.

1017. Tsui, S.K.W., Chim, S.S.C. and Lo, Y.M.D. (2003), Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome. New England Journal of Medicine, 349 (2), 187-188.

1018. Pearson, H. (2003), SARS - What have we learned? Nature, 424 (6945), 121-126.1019. Maki, D.G. (2003), SARS: 1918 revisited? The urgent need for global collaboration in

public health. Mayo Clinic Proceedings, 78 (7), 813-816.1020. Sampathkumar, P., Temesgen, Z., Smith, T.F. and Thompson, R.L. (2003), SARS:

Epidemiology, clinical presentation, management, and infection control measures. Mayo Clinic Proceedings, 78 (7), 882-890.

1021. Ruef, C. (2003), SARS - A fast moving infectious disease. Infection, 31 (3), 135.

68

1022. Wang, C.Z. and Chi, C.W. (2003), The biological characteristics of SARS virus and its related coronaviruses. Acta Biochimica et Biophysica Sinica, 35 (6), 495-502.

1023. Shiu, S.Y.W., Reiter, R.J., Tan, D.X. and Pang, S.F. (2003), Urgent search for safe and effective treatments of severe acute respiratory syndrome: is melatonin a promising candidate drug? Journal of Pineal Research, 35 (1), 69-70.

1024. Oxford, J.S., Bossuyt, S. and Lambkin, R. (2003), A new infectious disease challenge: Urbani severe acute respiratory syndrome (SARS) associated coronavirus. Immunology, 109 (3), 326-328.

1025. Yu, X.J., Luo, C., Lin, J.C., Hao, P., He, Y.Y., Guo, Z.M., Qin, L., Su, J., Liu, B.S., Huang, Y., Nan, P., Li, C.S., Xiong, B., Luo, X.M., Zhao, G.P., Pei, G., Chen, K.X., Shen, X., Shen, J.H., Zou, J.P., He, W.Z., Shi, T.L., Zhong, Y., Jiang, H.L. and Li, Y.X. (2003), Putative hAPN receptor binding sites in SARS_CoV spike protein. Acta Pharmacologica Sinica, 24 (6), 481-488.

1026. Qin, L., Xiong, B., Luo, C., Guo, Z.M., Hao, P., Su, J., Nan, P., Feng, Y., Shi, Y.X., Yu, X.J., Luo, X.M., Chen, K.X., Shen, X., Shen, J.H., Zou, J.P., Zhao, G.P., Shi, T.L., He, W.Z., Zhong, Y., Jiagn, H.L. and Li, Y.X. (2003), Identification of probable genomic packaging signal sequence from SARS-CoV genome by bioinformatics analysis. Acta Pharmacologica Sinica, 24 (6), 489-496.

1027. Riley, S., Fraser, C., Donnelly, C.A., Ghani, A.C., bu-Raddad, L.J., Hedley, A.J., Leung, G.M., Ho, L.M., Lam, T.H., Thach, T.Q., Chau, P., Chan, K.P., Leung, P.Y., Tsang, T., Ho, W., Lee, K.H., Lau, E.M.C., Ferguson, N.M. and Anderson, R.M. (2003), Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions. Science, 300 (5627), 1961-1966.

1028. Salleras, L. (2003), Severe acute respiratory syndrome. A new emergent infectious disease. Medicina Clinica, 120 (16), 619-621.

1029. Fisher, D.A., Chew, M.H.L., Lim, Y.T. and Tambyah, P.A. (2003), Preventing local transmission of SARS: lessons from Singapore. Medical Journal of Australia, 178 (11), 555-558.

1030. Chan-Yeung, M. (2003), War against the virus - who is winning? International Journal of Tuberculosis and Lung Disease, 7 (6), 505-506.

1031. Qin, E., Zhu, Q.Y., Yu, M., Fan, B.C., Chang, G.H., Si, B.Y., Yang, B.A., Peng, W.M., Jiang, T., Liu, B.H., Deng, Y.Q., Liu, H., Zhang, Y., Wang, C., Li, Y.Q., Gan, Y.H., Li, X.Y., Lu, F.S., Tan, G., Cao, W.C., Yang, R.F., Wang, J., Li, W., Xu, Z.Y., Li, Y., Wu, Q.F., Lin, W., Chen, W.J., Tang, L., Deng, Y.F., Han, Y.J., Li, C.F., Lei, M., Li, G.Q., Li, W.J., Lu, H., Shi, J.P., Tong, Z.Z., Zhang, F., Li, S.G., Liu, B., Liu, S.Q., Dong, W., Wang, J., Wong, G.K.S., Yu, J. and Yang, H.M. (2003), A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01). Chinese Science Bulletin, 48 (10), 941-948.

1032. Rainer, T.H., Cameron, P.A., Smit, D., Ong, K.L., Hung, A.N.W., Nin, D.C.P., Ahuja, A.T., Si, L.C.Y. and Sung, J.J.Y. (2003), Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. British Medical Journal, 326 (7403), 1354-1358.

1033. Wong, R.S.M., Wu, A., To, K.F., Lee, N., Lam, C.W.K., Wong, C.K., Chan, P.K.S., Ng, M.H.L., Yu, L.M., Hui, D.S., Tam, J.S., Cheng, G. and Sung, J.J.Y. (2003), Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. British Medical Journal, 326 (7403), 1358-1362.

1034. Chan-Yeung, M., Seto, W.H. and Sung, J.J.Y. (2003), Severe acute respiratory syndrome - Patients were epidemiologically linked. British Medical Journal, 326 (7403), 1393.

1035. Harnden, A. and Mayon-White, R. (2003), Severe acute respiratory syndrome - novel virus, recurring theme. British Journal of General Practice, 53 (491), 434-435.

1036. Holmes, K.V. (2003), SARS coronavirus: a new challenge for prevention and therapy. Journal of Clinical Investigation, 111 (11), 1605-1609.

69

1037. Rickerts, V., Wolf, T., Rottmann, C., Preiser, W., Drosten, C., Jakobi, V., Leong, H.N. and Brodt, H.R. (2003), Clinical presentation and management of the severe acute respiratory syndrome (SARS). Deutsche Medizinische Wochenschrift, 128 (20), 1109-1114.

1038. Al-Mobeireek, A.F. and Saleemi, S.A. (2003), Facing the severe acute respiratory syndrome epidemic - Hope for the best and prepare for the worst. Saudi Medical Journal, 24 (4), E1-E2.

1039. Rota, P.A., Oberste, M.S., Monroe, S.S., Nix, W.A., Campagnoli, R., Icenogle, J.P., Penaranda, S., Bankamp, B., Maher, K., Chen, M.H., Tong, S.X., Tamin, A., Lowe, L., Frace, M., Derisi, J.L., Chen, Q., Wang, D., Erdman, D.D., Peret, T.C.T., Burns, C., Ksiazek, T.G., Rollin, P.E., Sanchez, A., Liffick, S., Holloway, B., Limor, J., McCaustland, K., Olsen-Rasmussen, M., Fouchier, R., Gunther, S., Osterhaus, A.D.M.E., Drosten, C., Pallansch, M.A., Anderson, L.J. and Bellini, W.J. (2003), Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science, 300 (5624), 1394-1399.

1040. Brown, E.G. and Tetro, J.A. (2003), Comparative analysis of the SARS coronavirus genome: a good start to a long journey. Lancet, 361 (9371), 1756-1757.

1041. Donnelly, C.A., Ghani, A.C., Leung, G.M., Hedley, A.J., Fraser, C., Riley, S., bu-Raddad, L.J., Ho, L.M., Thach, T.Q., Chau, P., Chan, K.P., Lam, T.H., Tse, L.Y., Tsang, T., Liu, S.H., Kong, J.H.B., Lau, E.M.C., Ferguson, N.M. and Anderson, R.M. (2003), Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet, 361 (9371), 1761-1766.

1042. Peiris, J.S.M., Chu, C.M., Cheng, V.C.C., Chan, K.S., Hung, I.F.N., Poon, L.L.M., Law, K.I., Tang, B.S.F., Hon, T.Y.W., Chan, C.S., Chan, K.H., Ng, J.S.C., Zheng, B.J., Ng, W.L., Lai, R.W.M., Guan, Y. and Yuen, K.Y. (2003), Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet, 361 (9371), 1767-1772.

1043. Nicholls, J.M., Poon, L.L.M., Lee, K.C., Ng, W.F., Lai, S.T., Leung, C.Y., Chu, C.M., Hui, P.K., Mak, K.L., Lim, W., Yan, K.W., Chan, K.H., Tsang, N.C., Guan, Y., Yuen, K.Y. and Peiris, J.S.M. (2003), Lung pathology of fatal severe acute respiratory syndrome. Lancet, 361 (9371), 1773-1778.

1044. Ruan, Y.J., Wei, C.L., Ee, L.A., Vega, V.B., Thoreau, H., Yun, S.T.S., Chia, J.M., Ng, P., Chiu, K.P., Lim, L., Tao, Z., Peng, C.K., Ean, L.O.L., Lee, N.M., Sin, L.Y., Ng, L.F.P., Chee, R.E., Stanton, L.W., Long, P.M. and Liu, E.T. (2003), Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet, 361 (9371), 1779-1785.

1045. Baker, S.J. (2003), SARS: screening, disease associations, and response. Lancet, 361 (9372), 1905.

1046. Masur, H., Emanuel, E. and Lane, H.C. (2003), Severe acute respiratory syndrome - Providing care in the face of uncertainty. Jama-Journal of the American Medical Association, 289 (21), 2861-2863.

1047. Hon, K.L.E., Leung, C.W., Cheng, W.T.F., Chan, P.K.S., Chu, W.C.W., Kwan, Y.W., Li, A.M., Fong, N.C., Ng, P.C., Chiu, M.C., Li, C.K., Tam, J.S. and Fok, T.F. (2003), Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet, 361 (9370), 1701-1703.

1048. Stohr, K. (2003), A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet, 361 (9370), 1730-1733.

1049. Fisher, D.A., Lim, T.K., Lim, Y.T., Singh, K.S. and Tambyah, P.A. (2003), Atypical presentations of SARS. Lancet, 361 (9370), 1740.

1050. Holmes, K.V. (2003), SARS-associated coronavirus. New England Journal of Medicine, 348 (20), 1948-1951.

70

1051. Fouchier, R.A.M., Kuiken, T., Schutten, M., van Amerongen, G., van Doornum, J., van den Hoogen, B.G., Peiris, M., Lim, W., Stohr, K. and Osterhaus, A.D.M.E. (2003), Aetiology - Koch's postulates fulfilled for SARS virus. Nature, 423 (6937), 240.

1052. Tomlinson, B. and Cockram, C. (2003), SARS: experience at Prince of Wales Hospital, Hong Kong. Lancet, 361 (9368), 1486-1487.

1053. Seto, W.H., Tsang, D., Yung, R.W.H., Ching, T.Y., Ng, T.K., Ho, M., Ho, L.M. and Peiris, J.S.M. (2003), Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet, 361 (9368), 1519-1520.

1054. So, L.K.Y., Lau, A.C.W., Yam, L.Y.C., Cheung, T.M.T., Poon, E., Yung, R.W.H. and Yuen, K.Y. (2003), Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet, 361 (9369), 1615-1617.

1055. Shortridge, K.F. (2003), SARS exposed, pandemic influenza lurks. Lancet, 361 (9369), 1649.

A bias would appear in “times self cited” if any two or more authors have the same name.

71